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Abstract 
Respiratory distress syndrome and pulmonary oedema often result in poor health and in the 
worst case scenario, death. Several studies have proposed that the eventual resolution of these 
dangerous conditions is due to active sodium reabsorption through the epithelial sodium 
channel (ENaC), which is crucial for lung fluid clearance. Although clinical prognosis can be 
improved by using glucocorticoid hormones to augment the ENaC-dependent removal of 
liquid from the lungs, we still require a better understanding of the underlying mechanism in 
order to improve treatments in the future. This thesis, therefore explores the role of serum / 
glucocorticoid-inducible protein kinase 1 (SGK1) and protein kinase A (PKA) in the responses 
of hormone-stimulated H441 human airway cells. Dexamethasone, a synthetic glucocorticoid 
hormone, is thought to evoke expression of the gene encoding SGK1 and, to become 
catalytically active, this gene product must then be phosphorylated via TORC2 and PDK1, 
protein kinases activated via the P13-kinase pathway. Once activated, SGK1 appears to exert 
control over the surface abundance of ENaC subunits by phosphorylation, and thus 
inactivating, a ubiquitin ligase (Nedd4-2), that normally mediate the withdrawal of ENaC 
subunits from the plasma membrane. Protein kinase A (PKA) may contribute to this control 
mechanism by also phosphorylating Nedd4-2. In order to clarify the way in which these 
pathways contribute to glucocorticoid-induced lung liquid clearance, the present thesis has 
explored the effects of dexamethasone and / or PKA activation upon the overall / surface 
expression of ENaC subunits, the activities of SGK1 and PKA and the phosphorylation status 
of physiologically-important residues within Nedd4-2 itself.  
 1 
 
1 
Introduction 
 
1.1 The respiratory system 
The human body consists of cells that can replicate, defend and maintain the optimum 
condition. All cells require energy to conduct this work, and this is primarily derived from 
oxidative metabolism and this, in turn, implies that oxygen (O2) must be taken into the body. 
Moreover, the carbon dioxide (CO2) produced by respiring tissues must also be eliminated, and 
multicellular organisms therefore need specialised structures to permit gas exchange. 
Organisms that live in water achieve this either via direct diffusion across the body surface or 
via specialist structures known as gills (e.g. fish, amphibian larvae, crustaceans). On land, this 
function is fulfilled by the lungs. The exchange of gases takes place across the alveolar 
epithelium which is very thin in order to allow gas exchange (Boucher, 1999). Since the body 
can require considerable amounts of oxygen, a large surface area must be available for gas 
exchange and, in an adult human, the overall area of the alveolar epithelium has been estimated 
to 70-140 m2, which is 35 times the surface area of the body (Martini, 2004a). Therefore, the 
 2 
development of the structures of the lung was vital for the evolution of large complex 
organisms. However, the respiratory system does not simply act as a gas exchange region, it 
also accounts for many problems which the lung has evolved to overcome. 
 
1.1.1 Gas exchange 
The primary function of the respiratory system is to serve as a site for gas exchange. However, 
this system must be initiated by breathing. Air is inspired from the atmosphere through the nose 
and passes through the nasopharynx which performs the vital function of warming and 
humidifying the air.  This process is crucial to preserve the optimal body temperature (37oC), 
otherwise enzymatic function could not be maintained. The inspired air has a much lower 
humidity than air in the respiratory system, thus without being humidified, water vapour would 
move into the air from the lining of the respiratory system, thereby reducing airway surface 
hydration. When the inspired air reaches the alveolar lung for gas exchange, the pressure of O2 
(~100 mmHg) is lower than the atmospheric O2 (~159 mmHg). This is due to the partial 
pressure of O2 (PO2) in the alveoli as a result of the combination of the O2 uptake and supply. 
In parallel, the pulmonary artery carries blood which has a low concentration of O2 (O2 is ~40 
mmHg) to the lungs, therefore the difference in pressure will result in diffusion. However, O2 
must first dissolve into the fluid lining of the alveoli before it can move via diffusion into the 
blood. This acts as a barrier which coordinates well with Fick‘s law of diffusion; the net rate of 
diffusion of a substance is inversely proportional to the thickness of what it must cross. This 
indicates the importance of the liquid lining of the alveoli. This can be marked by the control of 
its depth; if the depth were to increase, then the time taken for O2 to move into the blood would 
greatly increase and could lead to insufficient gas exchange. The reverse is true for CO2 where 
the partial pressure of CO2 (PCO2) is higher in the blood than in the alveoli and CO2 is 
expelled. Therefore, tight regulation of alveolar hydration is vital to the healthy function of the 
respiratory system. If this hydration is not controlled properly it can lead to excess fluid in the 
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lung, which has been shown to cause inefficient gas exchange (Berger et al., 1996) and is a 
contributory factor in respiratory distress syndrome (RDS), a leading cause of death in 
premature and newborn infants (O‘Brodovich, 1996).  
 
1.1.2 Development of the respiratory system 
 
 Figure 1-1: Schematic diagram of the human respiratory system 
(www.lung.ca/respiratory_system) 
 
The respiratory system begins to develop after the fourth week of gestation (Boyden, 1977). 
When considering the development of this system it is important to review the development of 
the foregut, and the development of the endoderm overall. It is also important to consider the 
development of the respiratory system in terms of its many constituent components. The 
respiratory system commences at the nasal cavity and consists of a conducting portion and a 
respiratory portion. The conducting portion includes the nasal cavity, pharynx, larynx, trachea, 
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bronchi, and bronchioles (Figure 1-1). The respiratory portion consists of the alveolar ducts, 
alveolar sacs and the alveoli, and gaseous exchange occurs in the alveoli.  
 
The development of the respiratory system involves the endoderm and the mesoderm that 
surrounds it. First, the embryo undergoes lateral body folding and during this process the 
endoderm forms into a gut tube. This gastrointestinal tube begins cephalically at the oral plate 
and continues until it reaches the anal plate. At the time the body folding is completed, the gut 
tube can be subdivided into three divisions: a foregut, a midgut and a hindgut (O‘Rahilly et al., 
2004). The larynx is first seen as an outgrowth from the foregut. This outgrowth of tissue is 
called the respiratory diverticulum or the lung bud. The formation of the lung bud occurs when 
two lateral folds of mesoderm and endoderm meet at the midline and separate the larynx and 
trachea from the oesophagus. The lung bud is a ventral diverticulum of the endoderm that arises 
from the floor of the foregut caudal to the pharynx. The diverticulum forms a groove in the 
floor of the pharynx called the laryngotracheal groove (O‘Rahilly et al., 2004).  
The trachea then develops caudal to the larynx. The epithelium develops from the endoderm 
and the tracheal cartilage and muscles develop from the mesoderm. Early in development the 
trachea bifurcates into the left and right bronchi (Haefeli-Bleuer,1988). As the bronchi develop 
they continue to branch. The right bronchus gives off three lung buds and the left bronchus 
gives off two lung buds (Figure 1-2). These lung buds become the lobar bronchi and indicate 
that the right lung will have three lobes and the left lung will have two lobes (Bucher et al., 
1961). Each of the bronchi at this stage will divide into smaller bronchi. The branching of the 
bronchi continues until the bronchioles begin to form. In all there are 17 divisions of the 
bronchi until the sixth foetal month is reached (Bucher et al., 1961). However, by early 
childhood there will be a total of 24 generations of branching as seen in Figure 1-3 (Harding & 
Hooper, 1996). 
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Figure 1-2: Schematic diagram of human lung formation 
(http://www.embryo.chronolab.com). 
(A) The lung buds2 start to branch out from the trachea to become a 
bronchus. (B) The right bronchus will further branch out to form three lung 
buds1 whilst the left bronchus gives off two. (C) The lung buds will become 
bronchial buds7 within the characteristic inner layer of splanchnic 
mesoderm6. There are three lobes in the right lung and two lobes in the left 
lung in the delicate serous membrane of the visceral pleura8.  
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Figure 1-3: Schematic representation of the sequence of airway branches as a 
function of generation z. Bronchi (BR), bronchioles (BL), terminal 
(TBL), and respiratory (RBL) bronchioles are followed by alveolar ducts 
(AD) and sacs (AS) in the terminal generation. T=23 (Weibel, 1963). 
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As the lungs develop and divide into smaller divisions there are changes to the vascular supply 
of the lungs. The lungs can be described as undergoing 4 phases of development (Figure 1-3). 
During the first phase of development, the pseudoglandular period, the bronchi divide into 
smaller and smaller branches, the bronchioles (Wiebel et al., 1963). This period occurs from 
the 2nd month through to the end of the 4th month. During the next 2 and 1/2 months the 
respiratory bronchioles are formed. They will give rise to alveolar ducts. This is called the 
canalicular period. During this time period the epithelium remains as a cuboidal epithelium and 
the capillaries, while proliferating, begin to approach the respiratory epithelium.  
The next phase of development occurs from the 7th month until birth. During this period, the 
terminal saccular, the number of capillaries increases and they approach the respiratory 
epithelium. At the same time the terminal sacs form (Zeltner & Burri, 1987). This results in the 
formation of a squamous epithelium made up of type I alveolar epithelial cells, which will 
permit gaseous exchange. Hence, from the 7th month on the foetus is capable of survival. In the 
7th month the type II alveolar epithelial cells also start to develop. These type II cells produce 
surfactant, the fluid that reduces the surface tension at the alveolar cell surface (Mason et al., 
1991). Finally, from the 8th month onwards, the mature alveoli continue to be formed with an 
increase in the amount of surface area where capillaries and alveolar cells are in contact. The 
functional alveolar epithelial cells appear in the prospective alveoli to differentiate between the 
type I and type II-like phenotype by flattening and increasing the epithelial surface to create the 
gaseous barrier (Schneeberger, 1991). This is eventually marked by the development of fully 
mature alveoli. This period of lung development is the alveolar period and actually can last 
through to the age of ten. The growth of the lungs after birth is mainly the result of increases in 
the number of alveoli during this time. The period of lung development is summarised in 
Figure 1-4. 
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Figure 1-4 Stages and timing of human lung development.  
Open-ended bars indicate that the exact start and end stages are still unknown. From Zeltner & Burri (1987). 
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1.2 Alveolar anatomy 
 
1.2.1 Alveolar epithelial type I 
 
 
The alveolar epithelial type I (ATI) cells are squamous epithelial cells that cover more than 
95% of the surface area of the lung (Mutlu & Sznajder, 2005). The cells are highly flattened, 
and this morphological feature is important since it implies that the cells provide a significant 
barrier to the diffusion of gases (Junqueira et al., 1998). Apart from gaseous exchange, the cells 
are now known to express aquaporin-5 (AQP5), a water channel, and at least two types of 
sodium-permeable ion channels (these include epithelium sodium channels; ENaC and cyclic 
nucleotide-gated channels; CNG) on the apical membrane (Dobbs et al., 1998, Borok et al., 
2002; Johnson et al., 2006) hence suggesting that the type I cells may contribute to another 
role; in the transport of ions and water.  
 
While expressing these channels, the other functional purpose of ATI cells is to assist in the 
efficient diffusion of gas into and out of the blood supply. However, this characteristic leads to 
a major obstacle in the study of this cell type as they are extremely fragile and the isolation 
necessary to create cultured ATI cells is very difficult to achieve. Only with recent 
advancements in techniques for the isolation of ATI cells and the discovery of the epithelial 
Na+ channel (ENaC) has it been possible to change the original view that ATII cells were the 
main source of Na+ transport that drives the absorption of fluid; which also suggests that ATI 
cells play a vital role in ion transport (Johnson et al., 2002; Bourke et al., 2005; Helms et al., 
2006; Wilkinson et al., 2011). 
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1.2.2 Alveolar epithelial type II 
 
Type II alveolar cells are cuboidal epithelial cells found in the alveolar surface. They are 
characterised by the unique ability to synthesise and secrete surfactant protein and by the 
distinct of secretory granules called lamellar bodies. The surfactant contains a surface-active 
lipoprotein complex (phospholipoprotein), comprised of both a hydrophilic and a hydrophobic 
region. It was found in the late 1920s by von Neergaard, who identified the pulmonary 
surfactant by increasing the compliance of the lungs by reducing surface tension; the 
importance of having low surface tension is crucial in lungs of newborn infants (von 
Neergaard, 1929). However, the significance of his discovery was not properly understood at 
that time. Later in 1950s, Pattle and Clements rediscovered the importance of surfactant and 
low surface tension in the lungs. It was then that the discovery of the cause of respiratory 
distress syndrome (RDS) through the lack of the surfactant protein was determined. In early 
1954, Macklin had postulated that the surfactant is secreted by alveolar type II cells (Macklin, 
1954) and later in 1977, Mason and Williams developed the concept of alveolar epithelial type 
II cells as a defender of the alveolus. It was established that ATII cells synthesise and secrete 
surface-active material (Mason & Williams, 1977). Taken together, these findings suggest that 
the surfactant lipid produced by ATII is important for reducing surface tension, and preventing 
collapse of the alveolus. The immaturity of the cells is a major contributing factor to RDS in 
premature infants (O‘Brodovich, 1996). Thus  many studies have used this type of cell as it  has 
become  much easier to isolate and culture since Kikkawa and Yoneda  first  proposed a 
method of isolation for in vitro studies in 1974 (Kikkawa & Yoneda, 1974).  
 
Since then, ATII were thought to be the primary source of Na+ transport in the alveoli and 
various studies have shown that this type of cell contains ENaC subunits using Northern Blot 
Analyses, RT-PCR, immunoprecipitation and in situ hybridisation (Yue et al., 1995; Farman et 
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al., 1997; Talbot et al., 1999). Although it was originally thought that the ATII cells were the 
only side of active Na+ transport in the alveolar region, studies using the isolated ATI cells and 
lung slice preparations have shown that these cells are also capable of active Na+ transport 
(Johnson et al., 2002; Bourke et al., 2005; Helms et al., 2006; Eaton et al., 2006; Wilkinson et 
al., 2011). ATII and ATI cells may thus contribute to the removal of liquid from the alveolar 
region, more recent work suggests that the type I cells might also contribute to this process 
(Wilkinson et al., 2011). It is therefore clear that both alveolar type I and type II cells can 
express the transport proteins needed to allow a paradigm for fluid absorption, in which the 
uptake of Na+ generates the osmotic gradients that fluid then follows passively. It was first 
thought that the bulk of Na+ transport occurred via ENaC in the ATII cells, while ATI provided 
a route for water movement via the aquaporin-5 channel (Nielson et al., 1997). However, due to 
the large surface area of ATI cells, it seemed likely that they too, might play a significant role 
in fluid absorption. 
 
1.2.3 Functions of the blood-air barrier of the alveolus 
In the alveolus, gases, liquids and solutes (e.g., metabolites) are exchanged or transported 
between the blood and air compartments. Moreover, the surfactant and exogenously presented 
material is taken up for degradation or inactivation into various cells. The trafficking molecules 
have to travel through different extracellular and cellular compartments by passive and 
sometimes also active processes. Therefore, there is a need for both ATI and ATII cells to be 
organised in the blood / gas barrier. Concomitant with the development of various lung struc-
tures is the cellular differentiation of ATI and ATII cells occurring as the alveolar epithelium 
matures. Therefore, during the first four months of gestation the epithelial lining is more or less 
columnar to cuboidal (Boyden, 1977; Mason & Williams, 1977; Fehrenbach, 2001). By six 
months, ATI and ATII cells can be distinguished in the more localised and differentiated zones 
of pseudo-cuboidal cells. 
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Since ATI cells contain an abundance of caveolae, they are thought to be involved in various 
transport processes. A growing body of evidence suggests that caveolae are more stable 
structures than coated pits, and that they also pinch off from the plasma membrane and form 
small vesicles in the cytoplasm (McElroy et al., 2004; Barth et al., 2009; Wang et al., 2011; 
Maniatis et al., 2012). Furthermore, several receptors are expressed/congregate in the caveolae, 
which might act as the centre for control of the activity of receptors and molecules involved in 
cell signalling. Insights into the importance of caveolin-1 for the function of the distal lung 
blood–air barrier have mainly emerged from knockout mice studies, where the loss of caveolin-
1 resulted in severe lung abnormalities and thickened alveolar septa (Razani et al., 2001). 
Under pathophysiological conditions, the alveolar epithelial cell damage is associated with 
lower levels of caveolin-1, which is probably mainly due to the high vulnerability of ATI cells 
and consequently the significant loss of ATI cells in response to several sources of injury 
(Kasper et al., 1998). 
 
ATII cells are identified by their granular and cuboidal appearance, which is a result of the 
dense packing of cytoplasmic organelles (indicating metabolically active cells) and lamellar 
bodies, which are dense and layered organelles that synthesise and store pulmonary surfactants 
(Boyden, 1977; Mason & Williams, 1977; Crapo et al., 1980; Fehrenbach, 2001). The major 
function of a surfactant, which is a mixture of proteins and the lipid disaturated dipalmitoyl 
phosphatidylcholine, is to reduce the surface tension, thus facilitating lung expansion during 
inhalation. Although ATII cells are small in diameter (~400 μm3 in rats and ~900 μm3 in 
humans), they are still essential for proper gas exchange. Situated at the corners of the alveolar 
sacs, ATII cells represent little obstruction to gaseous diffusion and are fed by a capillary 
network. Haddard (2002) in his review further added that these cells are intracellularly 
furnished with cytoplasmic organelles associated with the biosynthesis of surfactant 
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phospholipid and related proteins. The characteristics are to serve ATII cells as thin, gas-
permeable entities for diffusion and act as a protective barrier against water and electrolyte 
leakage (Boyden, 1977; Mason & Williams, 1977; Fehrenbach, 2001). 
 
1.3 Fluid transport processes within the lung 
1.3.1 Fluid secretion 
It has long been known that the lung develops as a fluid filled organ, and it is also clear that this 
liquid must be removed from the airspaces by the time of birth since the retention of even a 
small volume of liquid in the alveolar space will provide a significant barrier to gas exchange. 
This view derived initially from Potter & Bohlender, (1941) who noted that the lung tissues 
distal to congenital airway obstructions became distended with liquid, implying that liquid must 
be produced within the lung tissues themselves. This view is concurrent with that of Jost & 
Policard (1948), who were studying a ligated foetal rabbit trachea and attempting to induce 
hypopituitarism, when they noted that the lung tissue distal to this artificial obstruction became 
distended with liquid. The most compelling explanation for foetal lung liquid was simply 
inhaled amniotic fluid, based on the analysis of the composition of foetal lung liquid and 
amniotic fluid. These analyses showed that lung liquid contained higher levels of Na+ (150 mM 
vs 113 mM) and Cl- (157 mM vs 87 mM) but lower concentrations of protein (27 µgml-1 vs 100 
µgml-1) and bicarbonate (2.8 mM vs 19 mM) which disproved the notion that the lung liquid 
was simply inhaled amniotic fluid (Adams et al., 1963; Adamson et al., 1969). Furthermore, 
parallel analyses showed that foetal lung liquid also differed from plasma implying that it must 
be formed by an active secretory process rather than as a plasma ultra filtrate (the maintenance 
of the solute concentration differences require that the lung epithelium be a barrier to 
diffusion). This view is supported via radioisotope flux studies, which indicated that Cl- was 
being actively secreted into the lung lumen whilst Na+ followed by passive electro-diffusion 
(Olver & Strang, 1974). Subsequent studies also showed that changes in vascular filtration 
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pressure had no effect upon the rate at which this liquid was produced (Carlton et al., 1992 a,b). 
The prerequisite for net secretion is dependent on the impermeable and the experiments using 
water soluble non-electrolytes confirmed that the foetal lung epithelium is ‗tight‘. In terms of 
pore theory, the permeability pathways can be characterised as cylindrical pores of 0.6 nm 
radius, compared to pores of 15 nm in the pulmonary endothelium (Normand et al., 1971).  
 
The mechanism proposed by earlier observations has been further investigated by subsequent 
studies of a model in several different vertebrate epithelia, including the elasmobranch rectal 
gland, the avian salt gland (Silva et al., 1977) and in the canine tracheal epithelium (Welsh et 
al., 1980). These tissues, in common with the secretory epithelia of the foetal lung, actively 
secrete Cl- into the lumen, and Cl- influx across the basolateral membrane of the secretory cells 
is mediated via an electroneutral Na+-K+-2Cl- co transport system which utilises the inwardly 
directed electrochemical Na+ gradient, maintained by the Na+-K+-ATPase, as a source of 
potential energy. Confirmation of the Cl- influx mechanism in the lung has come from several 
studies of sheep and guinea pigs (Cassin et al., 1986; Thom & Perks, 1990). This secondary 
active ion transport process can thus raise intracellular Cl- above the electrochemical 
equilibrium and so establish an outwardly directed, electrochemical Cl- gradient. Cl- can 
therefore enter the lumen via apically located anion channels and, since the efflux process is 
electrogenic, this establishes an electric driving force for the passive movement of Na+. 
Together, the movement of these ions provide an osmotic gradient favouring water movement 
into the lung lumen. This model was subsequently shown to provide an almost universal 
mechanism that allowed vertebrate epithelia to secrete fluid. 
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1.3.2 Fluid reabsorption 
Whilst the secretion of liquid into the lumen of the developing lung is clearly important for the 
proper growth and differentiation of the lung tissues, it is imperative that this liquid is removed 
from the potential airspaces at birth since the presence of even a small volume of liquid can 
impair the proper oxygenation of the blood. Indeed, the retention of liquid in the lung, together 
with impaired surfactant secretion, are characteristic features of neonatal Respiratory Distress 
Syndrome (RDS), the most common cause of death amongst newborn and premature infants in 
the developed world. The first indication that birth is associated with significant changes to 
lung fluid balance came from studies conducted by Faure-Fremiet & Dragiou (1923), who 
simply measured the water content of lungs obtained from new-born lambs. The lungs of the 
newborn lambs had a water content of 76%-78%, which was lower than foetal tissue (87%-
89%). About 4 decades later, a detailed study was conducted in a similar way, but with rabbit 
lungs (Aherne & Dawkins, 1964). Both studies confirmed that birth is associated with a fall in 
lung water content and the data suggested that this process begins immediately after birth and is 
completed within two hours. 
 
The removal of lung liquid was believed to be an entirely passive process that was dependent 
upon the compression of the chest during birth. However, several studies indicate that this is 
not the case as births by caesarean section do not impair the removal of liquid from the lung 
(Bland et al., 1980 a, b). Moreover, a physical occlusion of the trachea does not prevent the 
removal of liquid from the lungs of experimental animals (Berger et al., 1998; Brown et al., 
1983). The lung starts to reabsorb fluid during labour, and this is first mediated via adrenaline 
(Lagercrantz & Bistoletti, 1977), indicating a possible role for this hormone as the trigger for 
fluid clearance. Subsequent experiments conducted by Brown and colleagues showed that 
sensitivity to adrenaline increased with gestational age in foetal lambs, which caused a slowing 
of liquid secretion (before 130 days) turning to liquid absorption after 147 days (Brown et al., 
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1983). This observation was confirmed by Olver et al., (1986) through ionic flux. Using similar 
methods to Olver & Strang, (1974), they found that Na+ is actively transported from the lung 
lumen to the plasma. Furthermore, they found that Na+ transport could be blocked by amiloride, 
which also prevented adrenaline induced liquid absorption (Olver et al., 1986). Therefore, the 
data suggested that Na+ flux could be the determining factor in driving liquid absorption. They 
also proposed that Na+ and Cl- transport were connected and that Cl- transport was a result of 
co-transport with Na+ driven by the Na+-K+-ATPase via, at the time, an unidentified transporter 
in the basolateral membrane. The opening of apical Na+ channels would lead to Na+ absorption 
also driven by Na+-K+-ATPase, which would cause the uptake of fluid due to a change in 
osmotic gradients. In the early nineties, a study investigating the administration of amiloride to 
the trachea of newborn guinea pigs revealed a phenotype in the animals similar to RDS 
(O‘Brodovich et al., 1990). This study also provided evidence indicating that Na+ absorption 
was mediated through an apical Na+ channel and therefore was thought to play a role in 
clearing the lung fluid. The effect of adrenaline also appears to be mediated via cyclic 
adenosine monophosphate (cAMP), as administration of cAMP to the foetal lambs‘ lung 
mimics its effects and the response can be blocked by amiloride (Walters et al., 1990). This 
indicates that this mechanism involves epithelial sodium channels (ENaC). However, Na+ 
transport can also be assisted by other cation channels; cyclic nucleotide-gated channels (CNG) 
and perhaps nonselective cation channels (NSCC). 
 
1.3.3 The ionic transport in fluid secretion and absorption 
The hydration of the lung is very important for optimal function, therefore water movement 
across a selective permeable membrane of cells must be monitored through osmosis, from an 
area of high water concentration (or low solute concentration) to an area of low water 
concentration (or high solute concentration). Proteins that span the plasma membrane form 
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channels that allow for the selective transport of ions. The active transport of specific ions leads 
to the generation of an osmotic gradient that either favours fluid secretion or absorption.  
 
Prior to the maintenance of lung hydration through fluid secretion, Cl- enters the cell via the 
basolateral Na+-K+-2Cl- co-transporter (NKCC) thereby elevating the intracellular Cl- 
concentration, allowing Cl- to exit the apical Cl- channels (Figure 1-5i). The apical entry for Cl- 
can be mediated by few channels; the cystic fibrosis transmembrane conductance regulator 
(CFTR), Ca2+ activated Cl- channels and voltage or volume regulated (CIC family) Cl- channels 
(see review, Anderson et al., 1992). The action of secretion generates a negative potential in the 
lung cells and thus creates a driving force for Na+ to be passively transported into the cells to 
compensate for the difference and maintain a stable gradient. Whilst the osmotic gradient is 
established, water flows down through the cells towards the apical cells to provide hydration.  
This was first suggested by Silva et al., (1977) as a form of secondary active transport. 
 
This secretory characteristic of the foetal lung epithelium becomes absorptive through 
activation of Na+ channels in the apical membrane at birth and is sustained into adult life 
(Figure 1-5ii). The maintenance of a thin liquid film is important for gas exchange, since the 
presence of even a small volume of fluid will provide a significant barrier to the diffusion of 
gases. This can be done through an active transport of Na+ which will then generate an osmotic 
gradient to favour fluid re-absorption. The secondary active transport would be through the 
Na+/K+-ATPase exchanger in the basolateral membrane, to pump out Na+ at a ratio of three Na+ 
ions out for two K+ ions in. This helps to keep the intracellular concentration of Na+ low (~10 
mM), therefore creating an electrochemical gradient that favours the apical entry of Na+ from 
the surrounding fluid in the apical membrane. The ratio of Na+ out to K+ ions in means that 
there is a net loss of positive charge from the cell, resulting in a negative potential; thus the 
effect of the Na+/K+-ATPase is to generate an electrochemical gradient that favours Na+ entry 
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into the cell, for example via ENaC. In order to prevent depolarisation of the cell from the build 
up of K+, K+ channels present in the basolateral membrane will allow K+ to ―leak-out‖ out of 
the cell down the chemical gradient. The polarised nature of the respiratory epithelium means 
that vectorial transport of ions can be achieved.  
 
The regulation of Na+ absorption and Cl- secretion and the balance between these is the major 
determinate of respiratory hydration and therefore the mechanism involved in their regulation is 
of critical importance. Furthermore, the identification of the specific channels involved is of 
equal importance so that strategies can be developed to treat diseases which result from 
impairment of these processes. 
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Figure 1-5: Schematic diagram of lung fluid secretion and absorption 
 
(i) Chloride ions (Cl-) enter the cells via the Na+-K+-Cl- channel co-transporter, 
thus raising the intracellular [Cl-] and Cl- is secreted through apical Cl- channels. 
This allows Na+ transport into the cells and creates an osmotic gradient that 
favours the secretion of fluid through the paracellular pathway or possibly 
through aquaporins (AQP). K+ channels help to prevent depolarisation. 
 
(ii) Na+-K+-ATPase pumps out 3 Na+ from the basolateral membrane (whereas 
only 2 K+ is pumped in), to create a loss of positive charge in the cells which 
favours Na+ entry via apical Na+ channels, thus creating an osmotic gradient 
favouring fluid absorption via the paracellular pathway or via AQP located in the 
membrane. K+ exits the cell via the basolateral K+ channels to prevent 
depolarisation from K+ build up.  
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1.3.4 The hormonal regulation of lung fluid absorption 
Walters & Olver, (1978)  showed that the infusion of adrenaline or isoprenaline slowed the rate 
of lung fluid secretion in mature foetal sheep. This concurs with the study performed by 
Lagercrantz and Bistoletti (1977) who showed that the concentration of adrenaline in the foetal 
plasma rose to very high concentrations during labour and birth. The reabsorption of lung fluid 
occurs during the last few hours before birth (Brown et al., 1983). As gestation advances, these 
hormones inhibit fluid secretion until labour, when the direction is reversed to induce fluid 
absorption (Walters & Olver, 1978). The authors also suggested that the switch could be 
induced by β-adrenoceptors and mimicked by a cell-permeant cAMP analogue (Walters & 
Olver, 1978; Olver et al., 1986; Walters et al., 1990). Moreover, adrenaline and cAMP-evoked 
liquid absorption are both inhibited by amiloride (Olver et al., 1986; Walters et al., 1990), a 
Na+ channel antagonist that also abolishes the natural occurrence of lung liquid seen during 
labour and birth (O‘Brodovich, et al., 1990). As β-adrenoceptor antagonists also inhibit this 
process (Brown et al., 1983), this body of work indicates that adrenaline-evoked Na+ transport 
underlies the absorption of lung liquid seen at birth. Subsequent studies suggested that this 
effect could be mimicked by intratracheal administration of dibutyryl cyclic adenosine 
monophosphate (db-cAMP) (Olver et al., 1987; Walters et al., 1990), thyroid hormones of 
triiodothyronine (T3) (Barker et al., 1990), and hydrocortisone (Barker et al., 1990, 1991). 
 
1.3.5 The role of glucocorticoids and thyroid hormone 
The increased level of adrenaline is preceded by a rise in circulating glucocorticoids (GC) and 
thyroid hormone before labour (Baines et al., 2000) suggesting that both hormones are involved 
in the maturation of the Na+- absorptive phenotype to allow adrenaline to stimulate Na+ 
absorption. This was demonstrated by the lack of thyroid in an immature foetal sheep which 
prevented a normal response to adrenaline (Barker et al., 1988). The authors also suggested that 
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adrenaline is dependent on a component downstream of cAMP, where a thyrodectomy has 
reduced the response to both adrenaline and synthetic cAMP (db-cAMP) (Barker et al., 1988).  
A subsequent study (Figure 1-6) also confirmed that such absorptive features in the 
thyrodectomised immature foetus produced a better prognosis by clearing more water from the 
lung when infused simultaneously with both thyroid and glucocorticoid hormones (Barker et 
al., 1991).  
 
 
Figure 1-6: Effects of thyroid (T3) and glucocorticoid (HC, hydrocortisone) hormones on 
the thyroidectomised foetal sheep (Barker et al., 1991).  
(A) A thyroidectomised foetal sheep failed to respond to adrenaline whilst (B) 
the absorption rate increased (- Jv, i.e., fluid clearance from the lung) when 
infused with both T3 and hydrocortisone (Hc). 
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Later on, subsequent studies of rat foetal distal lung epithelial (FDLE) cells also showed that 
the β-adrenoceptor isoproterenol did not evoke an increase in Na+ transport when applied to 
cells that had been maintained in a fully defined medium that was devoid of hormones 
(Ramminger et al., 2002). Since this result contrasts with several earlier studies of cells 
maintained in hormone-supplemented medium (Barker et al., 1993; Barquin et al., 1997; 
Baines et al., 2000), the data illustrate that the action of β-adrenoceptor agonists is dependent 
on prior exposure to other hormones. Since earlier studies of foetal lambs had suggested that 
the adrenaline-evoked removal of liquid from the lung was dependent upon prior exposure to 
thyroid / GC hormones, subsequent experiments explored the effects of exposing them to T3 
and dexamethasone (thyroid and GC hormone respectively), either alone or in combination. 
Although exposure to the individual hormones did not restore sensitivity to the β-adrenoceptor 
agonist of isoproterenol, clear responses were seen in cells that had been exposed to both 
hormones (Collett et al., 2002). Experiments undertaken in vivo and in vitro therefore 
demonstrate that adrenaline-induced Na transport is dependent on prior exposure to T3 / GCs 
(Ramminger et al., 2000; Ramminger et al., 2002). Taken together, these data demonstrate the 
importance of both hormones for the maturation of lung, as they work synergistically allowing 
additional treatment with adrenaline to stimulate the response of Na+ and to clear the lung fluid. 
Such stimulation is recognised through the sensitivity to amiloride (Olver et al., 2004).
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1.4  The epithelial sodium channel (ENaC) 
One of the molecular candidates that affects Na+ absorption in the lung is the epithelial Na+ 
channel (ENaC). The idea that ENaC was critical for liquid clearance came from Hummler‘s 
studies of α-ENaC knock-out mice. These animals had water logged lungs and were therefore 
unable to survive for more than ~48 h. It was subsequently shown that the expression of a rat α-
ENaC transgene rescued this phenotype. These mice did however, have abnormally low rates of 
sodium absorption. Although they did not display any physiological abnormalities under 
standard conditions, they were abnormally susceptible to pulmonary oedema (Hummler et al., 
1996). These studies are particularly important because they provide a link between the studies 
of foetal lambs undertaken by Olver & Walters, (1979), Barker et al., (1983) and later studies 
of ENaC in different cell types. 
 
 
1.4.1 Structure of ENaC 
 
 
 
 
 
 
 
 
 
 
Figure 1-7  The classical epithelium sodium channel (ENaC) 
 
ENaC is composed of three subunits: α-, β-, and γ- which each have an 
intracellular carboxy (C) and amino (N) terminal. 
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The ENaCs are composed of three  homologous subunits (Figure 1-7),  called alpha (α), beta 
(β) and gamma (γ); they consist of intracellular amino and carboxyl termini and two membrane 
spanning domains connected by large extracellular loops (Carattino et al., 2006; Bruns et al., 
2007; Hughey et al., 2004b). These subunits are structurally homologous, and their amino acid 
sequences display ~30% similarity (Canessa et al., 1994). However, the preliminary study 
identified that the ENaC α-subunit regions in the Xenopus laevis oocyte expression system 
produce amiloride sensitive Na+ currents (Canessa et al., 1993). Whilst this is similar in a 
heterologous system, these currents were not noticed for either β- or γ-ENaC (Canessa et al., 
1994). Studies of channel subunits expressed in Xenopus oocytes suggest that the independent 
expression of -ENaC, but not  or -ENaC, is associated with an amiloride sensitive Na+ 
current. However, the co-expression of all three subunits increases the magnitude of this current 
~100 fold, a result which suggests that all three subunits are needed to form functional 
channels. It would therefore appear that fully functional ENaC is composed of three separate 
subunits, α-ENaC being the major pore forming subunit, while β-ENaC and γ-ENaC subunits 
confer selectivity. 
 
The functionality of the multimeric protein can be determined by observing the interaction of 
the subunits in a rat‘s ENaC (Canessa et al., 1994); followed by the identification of channel 
co-expression with each subunit (McDonald et al., 1995; Bruns et al., 2003). Taken together, 
the data from previous studies proposed that α-ENaC can generate a small current on its own 
but potentiates a maximum current when expressed with β- and γ-ENaC (Canessa et al., 1994; 
McDonald et al., 1995; Awayda et al., 1997; Bruns et al., 2003). Therefore, it is thought that all 
subunits are required for the development of the fully functional form of ENaC. While the 
stoichiometry of the subunits is not clear, it is generally thought be a heterotrimer, 1α : 1β : 1γ. 
This is structurally similar to that determined from the crystal structure of the acid-sensing ion 
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channel 1 (ASIC1) in the chicken (Jasti et al., 2007). However, other stoichiometries have been 
proposed, such as 2α : 1β : 1γ (Firsov et al., 1998, Kosari et al., 1998, Anantharam & Palmer, 
2007) and the nonameric structure of 3α : 3β : 3γ (Snyder et al., 1998; Eskandari et al., 1999; 
Staruschenko et al., 2005). 
 
A molecular basis for the interaction of subunits was first suggested after observing their 
presence at the surface of the apical membrane (Firsov et al., 1996). Where the three subunits 
are structurally similar, they are thought to form a pore (Schild et al., 1997; Benos & Stanton, 
1999). The subunits are assembled in the endoplasmic reticulum, post-translationally modified 
in the Golgi network and then trafficked to the plasma membrane together (Cheng et al., 1998; 
Fyfe et al., 1998; Horisberger, 1998). However, the channels formed by the co-expression of α- 
and γ-ENaC in the absence of the -subunit have better channel activity because they stimulate 
more Na+ transport and are more sensitive to amiloride than those formed by the co-expression 
of α- and β-ENaC which display a lower sensitivity to amiloride (McNicholas & Canessa, 
1997). The finding also suggests that all three subunits contribute to the channel pore, 
indicating that α-ENaC cannot form the pore by itself, but that the other subunits serve as 
chaperones to transport and stabilise it in the membrane (Canessa et al., 1994; Waldmann et al., 
1995; Prince & Welsh, 1998). However, there is a possibility that native cells contain a variety 
of different channel types with different stoichiometries (McNicholas & Canessa, 1997) which 
could account for the variability of properties of amiloride-sensitive channels found in different 
tissues (Smith & Benos, 1991; Palmer, 1992). 
 
The ENaC protein consists of an N- and a C-terminus, and together these play a role in protein 
function at the cell surface. The cytoplasmic N-terminus of ENaC is thought to be involved in 
the assembly of the subunits (Benos & Stanton, 1999) and endocytic retrieval  (Gründer et al., 
1997; Horisberger, 1998; Prince & Welsh, 1998) which involves lysine residues (Staub et al., 
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1997a; Goulet et al., 1998). The hydrophobic region of the N-terminus is also thought to form 
part of the channel pore (Canessa et al., 1995) in addition to playing a role in channel gating 
(Po) (Grunder et al., 1997, Berdiev et al., 1998). The N-terminus in α-ENaC is required for 
maximal activity whilst β- and γ-ENaC play an important role in determining the half-life of the 
channel (Staub et al., 1997a). In addition to this, amino acids in each protein subunit in the 
extracellular domain distinguish the functionality of ENaC. This ensures the utility of the 
domain where each subunit can interact with the extracellular solution. This involves 
glycosylation (Rotin et al., 2001) and amiloride binding (Benos, 1982) which may exist in the 
α-subunit (Berdiev et al., 1998) but not in both β- and γ-ENaC subunits (Schild et al., 1997). 
 
The C-terminal transmembrane domain appears to face the extracellular serine-proteases that 
lead to ENaC activation. This is associated with a linker region that lies in a catalytic domain 
that allows ENaC interaction with other proteins at the cell surface (Hooper et al., 2001). This 
domain is involved in the protease cleavage that potentiates an amiloride sensitive 
transepithelial current in the epithelial cells of kidney (Kleyman et al., 2006; Sheng et al., 
2006) and lung (Planés et al., 2005; O‘Brodovich et al., 2008; Mace & Baines, 2009).  The 
cleavage initiates full activation of ENaC, especially in both α- and γ-ENaC (Knight et al., 
2008). This region also contains an internalisation sequence which is rich in proline motifs 
(PY-motif). A mutation or deletion of the PY-motif can result in increased ENaC activity which 
can lead to Liddle‘s Syndrome, an inherited form of hypertension.  
 
1.4.2 ENaC expression in the lungs 
ENaC mediates a rate-limiting step in transepithelial sodium absorption in airway epithelial 
cells. In the developing rat foetal lung, all mRNA subunits of ENaC are expressed even before 
birth when there is no Na+ absorption. However, the proteins are expressed after birth which 
coincides with the phenotype switches that trigger reabsorption of the liquid from the alveolar 
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lumen (Tchepichev et al., 1995; Watanabe et al., 1998; Talbot et al., 1999). Kellenberger and 
Schild, (2002) suggested that liquid clearance might correspond to the expression of α- and γ-
ENaC in the distal foetal mouse lung. Similarly, Talbot et al., (1999) and Smith et al., (2000) 
revealed an increment in these subunits in late foetal and early post-natal life, when the lung 
turns from a secretory to an absorptive condition. However, recently Beard and colleagues 
found that by using sucrose gradient separation they could observe ENaC protein trafficking to 
the membrane. With this they have proposed that only α- and β-ENaC subunits are trafficked 
towards the cell membrane to allow fluid absorption (Beard et al., 2011). The discrepancy 
between the expression of α-β-ENaC and α-γ-ENaC still needs to be elucidated, however it 
appears that α-ENaC plays the most important role in activating ENaC. The importance of  α-
ENaC was demonstrated by the neonatal death of mice that lacked an α-subunit, which 
impaired the sodium transport-mediated lung liquid clearance at birth (Hummler et al., 1996). 
The heterologous expression of the α-ENaC transgene can rescue this lethal phenotype; 
however, it only allows a low rate of Na+ transport and corresponds to the prognosis of oedema 
(Egli et al., 2004). These two significant findings, together with those of other subsequent 
studies, have indicated the importance of the α-subunit in the clearance of fluid in the distal 
lung epithelium (Egli et al., 2004; Helve et al., 2004; Li & Folkesson, 2006; Janér et al., 2010; 
Deng et al., 2011).  
 
Low expression of the β-ENaC subunit has also been shown to impair lung fluid clearance in 
the mouse (Randrianarison et al., 2007). However, the lack of this subunit results in α- and γ-
ENaC adopting a compensatory role to maintain ENaC activity. The importance of β-ENaC has 
been extensively studied by Mall and colleagues who have reported that the overexpression of 
the β-subunit augments sodium absorption in vivo (Mall et al., 2004; Zhou et al., 2008; Mall et 
al., 2010; Zhou et al., 2011). The over-expression of the β-subunit of ENaC in the lung cells of 
mice is notably similar to the clinical and pathological description of early cystic fibrosis lung 
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disease (Mall et al., 2004; Zhou et al., 2008; Mall et al., 2010; Zhou et al., 2011), and the lack 
of this subunit contributes to the clinical phenotype of pseudohypoaldesteronism (PHA) 
(Thomas et al., 2002). However, such β-subunit expression did not affect foetal survival, in 
contrast to the lack of expression of α-ENaC. 
 
The relative importance of γ-ENaC in neonatal lung fluid clearance can be demonstrated by 
generating mice with a γ-subunit knock-out (Barker et al., 1998). Newborn mice lacking γ-
ENaC have been shown to clear the fluid more slowly than control mates, suggesting that it 
only facilitates the clearance. It is thought that γ-ENaC  is critical for renal Na+ and K+ 
transport but not transport in the lung (Barker et al., 1998). When the γ-ENaC gene is mutated 
it produces a pathophysiology that results in the elevation of blood pressure (hypertension) in 
patients with Liddle‘s Syndrome (Födinger et al., 1998; Gao et al., 2001). It also contributes to 
the clinical phenotype of cystic fibrosis by decreasing ENaC activity (Viel et al., 2008). 
 
1.5 Factors in ENaC regulation 
Many studies have been conducted on the effects of β-adrenergic agonists, oxygen, GCs and 
thyroid hormones that are known to contribute to the switch from fluid secretion to fluid 
absorption at birth, a process that requires the developmental regulation of membrane transport 
proteins responsible for transepithelial Na+ transport (Sayegh et al., 1999; O‘Brodovich, 2004; 
Olver et al., 2004). These are found to be intercalated to stimulate Na+ absorption by increasing 
Na+  pump activity and apical Na+ conductance (GNa+) to bring about the switch from net 
secretion to net absorption as lung liquid is cleared at birth.  The mechanism by which ENaC 
can be regulated by other known factors will be described in subsequent sections.  
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1.5.1 Serum and Glucocorticoid-regulated Kinase (SGK)  
SGK is a novel serine/threonine kinase protein that was originally cloned from a rat mammary 
tumour cell line (Webster et al., 1993). It was first identified as a gene activated in a screen for 
hepatocellular gene regulation in a response to cellular hydration or cell swelling (Waldegger et 
al., 1997). Cellular hydration is a catabolic signal, stimulating glycogenolysis and proteolysis, 
and inhibiting protein and glycogen synthesis. This kinase has been shown to be important in 
activating certain potassium (e.g., Yoo et al., 2003), sodium (e.g., Chen et al., 1999), and 
chloride channels (e.g., Embark et al., 2004).  The protein kinase belongs to the Protein Kinase 
A/G/C (AGC) family and can be activated and regulated by GCs (i.e., dexamethasone), serum 
and mineralocorticoids, hence the name (Webster et al., 1993; Chen et al., 1999; Itani et al., 
2002a,b). The regulation is due to the glucocorticoid response element (GRE) in the 5‘ flanking 
end of the sgk1 gene (Itani et al., 2002b) and the two additional related genes; sgk2 and sgk3 
(Kobayashi et al., 1999). Whilst both SGK2 and SGK3 were thought to be responsible for 
ENaC (Friedrich et al., 2003), they were not modulated by GCs (Kobayashi et al., 1999), 
however SGK1 affected ENaC by increasing sodium reabsorption in Xenopus laevis (Chen et 
al., 1999; Naray-Fejes-Toth et al., 1999), A6 cells (Faletti et al., 2002), murine cortical 
collecting duct cells (Helms et al., 2003) and H441 lung cells (Brown et al., 2008; Watt et al., 
2012). 
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1.5.1.1  Activation of SGK1 
SGK1 activation is dependent on the phosphorylation of a Thr256 in the T-loop and a serine 
residue at Ser422; these sites are located within the hydrophobic motif of the SGK1 protein. The 
activity of SGK1 has been shown to be dependent on phosphoinositide-3-kinases (PI3K) 
(Kobayashi & Cohen, 1999; Park et al., 1999). There has been considerable debate in regard to 
how SGK1 is regulated. It was thought to be first phosphorylated on the hydrophobic motif by 
the mammalian target of the rapamycin complex 2 (mTORC2) (Garcia-Martinez & Alessi, 
2008). The activation was also thought to be dependent on mTORC1 (Hong et al., 2008). 
However, Garcia-Martinez and Alessi disputed the findings from Hong et al., (2008) by 
demonstrating SGK1 activity in the presence of the mTORC1 inhibitor rapamycin, this concurs 
with other studies (Kobayashi & Cohen, 1999; Park et al., 1999). This view is further supported 
by a recent study, suggesting that mTORC2 is required for the phosphorylation of SGK1 at the 
hydrophobic motif to confer Na+ transport (Lu et al., 2010). Therefore, mTORC2 is required for 
the activation of SGK1 at the hydrophobic motif to promote interaction with PDK1, which 
results in the phosphorylation of the activation loop of SGK1 (Biondi et al., 2001) and thus 
activity.  
 
1.5.2 Target of rapamycin (TOR) 
The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that has been 
known to play a central role in cell metabolism, growth and proliferation. mTOR also senses 
cellular nutrient and energy levels and redox status (Tokunaga et al., 2004). When this pathway 
is disrupted it can result in disease, especially cancer.  
 
mTOR exists as two catalytic subunits of a molecular complex, mTORC1 and mTORC2; both 
consisting of a different associated protein. mTOR was named thus because the target of 
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rapamycin (TOR) was first discovered via genetic and molecular studies of rapamycin-resistant 
mutants of Saccharomyces cerevisae that identified mTORC1 and mTORC2 as the targets of 
rapamycin (Wedaman et al., 2003). mTORC1 contains the regulatory associated protein TOR 
(Raptor) (Kim et al., 2002) and a G-protein β subunit like protein, also known as LST8 (Kim et 
al., 2003). The complex of mTORC1 has been recently identified as a binding partner of 
proline-rich PKB substrate 40 kDa (PRAS40) thus showing the role of PRAS40 as a substrate 
for TORC1 phosphorylation (Fonsesca et al., 2007; Oshiro et al., 2007). In addition, there are 
also other characterised targets of TORC1; p70-S6 Kinase 1 (S6K1) (Fingar et al., 2004) and 
4E-BP1, the eukaryotic initiation factor 4E binding protein (Hara et al., 1997). Therefore, the 
phosphorylation of S6K1 at residue Thr389 is often used for the mTORC1 assay as well as 
PRAS40 (Yang et al., 2006; McGee et al., 2008; Mansley & Wilson, 2010). mTORC1 activity 
can be inhibited using rapamycin, which has been described as an exquisitely specific inhibitor 
of TORC1 (Bain et al., 2007). 
 
mTORC2 is composed of mTOR, a rapamycin-insensitive companion of mTOR (Rictor) 
(Sarbassov et al., 2004), LST8, mammalian stress-activated protein kinase interacting protein 1 
(mSin1) (Jacinto et al., 2006) and proline-rich protein 5 (Woo et al., 2007). mTORC2 appears 
to possess the activity of a previously elusive protein known as ‗PDK2‘ by phosphorylating the 
serine/threonine protein kinase B (PKB) at Ser473 (Garcia-Martinez & Alessi, 2008) and further 
stimulates PKB phosphorylation at Thr308 by PDK1 leading to full PKB activation (Sarbassov 
et al., 2005). mTORC2 is acutely insensitive to rapamycin, however prolonged treatment with 
rapamycin inhibits assembly of the complex (Sarbassov et al., 2006). The recent discovery of 
the specific inhibitor of TOR, TORIN1 (Thoreen et al., 2009; Feldman et al., 2009) has given 
new insights into the role of mTORC2.  
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1.5.3 Glucocorticoids (GCs) 
As the name glucocorticoid implies, it involves a role in glucose metabolism, synthesis in the 
adrenal cortex and their steroidal structure. GCs are required for the negative feedback 
mechanism in the overactive immune system, such as allergies, asthma, and autoimmune 
diseases. Therefore, they have a wide range of effects throughout the body including 
stimulation of gluconeogenesis (Christ-Crain et al., 2008; Buren et al., 2008), immunity 
(Ricardi et al., 2010; Cutolo et al., 2011) and lung maturation (Shanks et al., 2010). One of the 
most widely used clinical GCs is dexamethasone, a synthetic cortisol, which is used to support 
the essential function of cardiovascular, metabolic, immunologic and homeostatic processes. 
However, the effect of dexamethasone is long-acting and its potency is about 25 times greater 
than that of hydrocortisone (cortisol) (Zoorob et al., 1998). It is often used in the therapeutic 
treatment of inflammatory disease, including lung injury (Dagenais et al., 2006), prevention of 
RDS (Liggins & Howie, 1972), paediatric asthma (Ebrahimi & Sarkari, 2007) and clearing 
alveolar epithelial fluid from the adult lung (Folkesson et al., 2000). 
 
Dexamethasone also has an effect on oxidative stress as shown by Xu & Chu (2007). This 
study demonstrated that dexamethasone could still activate α-ENaC expression in the presence 
of H2O2, which induces pulmonary oedema and acute lung injury. This finding supports the 
research done by Otulakowski et al., (2006) which demonstrated a specific translational 
regulation of α-ENaC in response to physiological regulators such as steroid hormones and O2. 
Otulakowski and his colleagues conducted a subsequent study investigating the integrated 
effects of synthetic glucocorticoid on the changes in partial pressure of oxygen (PO2) in foetal 
distal lung epithelia (Otulakowski et al., 2007). They concluded that dexamethasone increases 
the expression of α-ENaC in the apical membrane in an appropriate percentage of O2, which 
corresponds to the postnatal O2 environment. This result concurs with previous findings, which 
revealed that short term up-regulation of dexamethasone augments ENaC trafficking via the 
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serum and glucocorticoid regulated kinase (SGK-1) (Itani et al., 2002a,b). Guney et al., (2007) 
undertook studies which explored the extent to which dexamethasone was able to expose the 
effects of hypoxia-induced inhibition of alveolar Na+ transport. Dexamethasone successfully 
induced a two-fold increase in alveolar fluid clearance in a normoxic rat, whilst decreasing 
reabsorption could be seen under hypoxia conditions; thus, the hormone prevented the hypoxia-
induced inhibition.  Furthermore, dexamethasone slightly increased the expression of α- and γ-
ENaC in the whole rat lung (Otulakowski et al., 2006).  
 
GCs are involved in ENaC regulation through the redistribution of ENaC subunits from 
intracellular compartments to the membrane (Masilamani et al., 1999; Loffing et al., 2000; 
Frindt et al., 2001; Ergonul et al., 2006) particularly during the early response. Given this, GCs 
play an important role in increasing Na+ transport. To achieve this process, a GC binds to a 
cytosolic GC receptor complex which targets steroid response elements and alters gene 
transcription of ENaC. This can be seen after 1 h of exposure to the hormone (Itani et al., 
2002a). The increment is dependent on the gene transcription and translation of ENaC subunits 
to produce more protein at the surface. It has been suggested that SGK1 might also be involved 
in this increase in ENaC gene transcription (Boyd & Náray-Fejes-Tóth, 2005) which leads to an 
increase in Na+ absorption at the apical membrane. A subsequent study by Brown et al., (2008), 
which was recently continued by Watt et al. (2012), has demonstrated that dexamethasone-
induced airway epithelial H441 cells promote a depolarisation of the membrane potential 
resulting in an increase in Na+ conductance. Such an increment is thought to be synchronised 
through the stimulation of transcription of ENaC subunits. However, α-ENaC contains 
glucocorticoid response elements (GRE) at its 5‘ flanking region that respond to the action of 
dexamethasone (Otulakowski et al., 1999; Sayegh et al., 1999; Itani et al., 2002b; Thomas & 
Itani, 2004; McTavish et al., 2009) which is not found in other subunits. Whilst the idea that 
SGK1 directly regulates α-ENaC transcription is tempting, a recent study (McTavish et al., 
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2009) found that the α-ENaC gene promoter can be regulated independently of SGK1, although 
the SGK1 pathway does provide a mechanism that allows this transcriptional response to 
dexamethasone to be enhanced. 
 
1.5.4  Insulin 
The main physiological role of insulin is to stimulate the uptake of glucose into the liver, 
muscle and fat. Insulin is secreted from the endocrine pancreas in response to increased levels 
of circulating glucose, possibly through stimulating ENaC via phosphatidylinositol-3-kinase 
(PI3-kinase). Although a recent study on the mouse cortical collecting duct conducted by 
Mansley & Wilson (2010b) has shown that basal Na+ transport can occur independently of the 
P13K pathway. This pathway seems to be essential for insulin induced Na+ transport as it can 
be triggered by increased expression of α- and γ-ENaC in mouse renal tissue which is induced 
by insulin (Tiwari et al., 2007). Insulin perfusion in the mouse renal tissue has been shown to 
increase the apical localisation of each ENaC subunit in cortical collecting duct principal cells 
(Song et al., 2006). This is consistent with the finding of  Wagner et al., (2001), who suggested 
that insulin significantly induces PI3K and the protein to further increase Na+ reabsorption 
through ENaC in A6 cells and cortical collecting duct cell lines via activation, likely 
phosphorylation, of SGK1 (Pearce, 2001; Wang et al., 2001; Pearce & Kleyman, 2007). Insulin 
also appears to be involved in stimulating fluid clearance in diabetic patients (Guazzi et al., 
2002a; 2002b), which may be due to the control of pulmonary Na+ transport (Hagiwara et al., 
1992). However, in the airway epithelial cells of H441, insulin-induced cells cannot exert such 
control over Na+ transport, and the same is true for hormone-deprived cells; further 
augmentation of the natriferic effects by GC-induced cells is required (Brown et al., 2008). 
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1.5.4.1  Possible mechanism of insulin 
 
The activity of PI3K can be increased by several hormones / growth factors, including insulin, 
to activate the signalling cascade. This functions as a localised messenger and results in 
membrane localisation of the serine/threonine protein kinase B (PKB) and their pleckstrin 
homology (PH) domain  (Alessi & Cohen, 1998).  
 
 
PI3-kinase is characterised by its ability to phosphorylate plasma membrane phospholipids such 
as phosphatidylinositol-4,5 phosphate (PIP2) and thus catalyse the formation of biologically 
active second messengers such as phosphatidylinositol-3,4,5 phosphate (PIP3) (Rameh & 
Cantley, 1999). The increased abundance of PIP3 in the plasma membrane results in the 
translocation of phosphoinositol dependent kinase (PDK1) to the membrane and this leads to 
increased phosphorylation of substances, which in turn catalyse the activation of Thr256 of 
SGK1 (Kobayashi & Cohen, 1999). The second messenger PIP3 also activates TORC2 (Mora et 
al., 2004), and this signalling complex, in turn catalyses the phosphorylation of SGK1 at Ser422 
(Kobayashi & Cohen, 1999; Park et al., 1999).  This step is necessary as it allows PDK1 to 
phosphorylate the SGK1 protein at Thr256, leading to full activation of SGK1 (Biondi et al., 
2001; Pearce et al., 2010). 
 
Insulin-induced Na+ transport in A6 cells is the result of Na+ channel density (Blazer-Yost et 
al., 1998). Blazer-Yost et al. (1998) found that both PI3K and ENaC were co-localised as a 
result of insulin stimulation. This was thought to be dependent upon PI3K, as LY294002 
prevented the natriferic response, as well as the translocation of the PI3K-ENaC complex to the 
membrane (Blazer-Yost et al., 2003). They further speculated that the lack of the PI3K second 
messenger (PIP3) was the cause of this. They were able to confirm this using confocal 
fluorescence microscopy which showed that the distribution of PIP3 followed the translocation 
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of the PI3K-ENaC complex. Consequently, their model proposed that ENaC insertion into the 
membrane was a result of changes in lipid composition (Blazer-Yost & Nofzigar, 2004). In 
addition, PIP2/3 can alter channel kinetics (Staruschenko et al., 2007; Pochyunyuk et al., 2007b) 
by augmenting ENaC activity by binding directly to ENaC subunits (Pochyunyuk et al., 2007) 
which in results in Na+ transport. However, these studies were conducted on renal epithelia and 
the effects were transient, indicating an acute regulation of ENaC. The PI3K inhibitor 
(LY294002) is now known to exert non-specific effects, therefore it has been advised that its 
use as an inhibitor be discontinued (Bain et al., 2007). Nevertheless, these studies have 
extensively suggested a possible mechanism of action for insulin on ENaC via PI3K. This 
mechanism is SGK1 independent, therefore could explain why the sgk1 gene knock-out mice 
do not display any overt lung phenotype. This leads to a possible role for insulin / PI3K in the 
control of Na+ transport in the lung. Although this notion has received much less attention, 
Brown et al., (2008) have conducted experiments on the effect of insulin on GC mediated Na+ 
transport to further show that insulin could augment the effect of dexamethasone in the 
pulmonary epithelium. However, this is not the case in single H441 cells which produce 
different responses to groups of cells (Brown et al., 2008). Insulin also has been linked to Na+ 
transport in the foetal lung (Hagiwara et al., 1992) and this hormone does appear to improve 
gas diffusion in diabetic patients (Guazzi et al., 2002a; 2002b). 
 
1.5.5 cAMP agonists 
The other candidates for Na+ regulation are cyclic Adenosine Monophosphate (cAMP) 
agonists. Initial studies conducted by O‘Brodovich et al., (1990) and Walters et al., (1990) have 
examined the importance of cAMP in gestation-dependent absorption of foetal lung liquid. In 
kidney cells, vasopressin is known to elevate ENaC expression prior to the defence of 
hypovolemia, hypotension and increased plasma osmolality (Snyder, 2000; Gaeggeler et al., 
2011).  In FRT epithelia expressing ENaC, cAMP agonists induce ENaC translocation towards 
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the cell surface and increase vesicle ENaC trafficking (Snyder, 2000). These agonists activate 
the Protein Kinase A (PKA) pathway which promotes Nedd4-2 interaction with the PY–motif 
of ENaC at the cell surface, via direct phosphorylation of Nedd4-2. This might elevate channel 
translocation, therefore in cases of Liddle‘s Syndrome such mutations at the PY-motif might 
disrupt cAMP-mediated stimulation. This stimulation has been shown to exist on both the 
mammalian kidney collecting duct and amphibian epithelia (Garty & Palmer, 1997), but it has 
not been confirmed in the distal colon (Garty & Palmer, 1997), the CFTR of human airway 
epithelia (Mall et al., 1998) or in Xenopus laevis oocytes (Awayda et al., 1996; Mall et al., 
1996). However, a series of studies have proposed that cAMP agonists can regulate Na+ 
absorption in human lung cell lines such as H441 (Lazrak & Matalon, 2003; Clunes et al., 
2004; Inglis et al., 2009). Hence, there is evidence to show that PKA, a downstream effector of 
cAMP, increases ENaC expression in the membrane (Snyder et al., 2004a,b). 
 
1.5.6 Nedd4-2 
The ubiquitin ligase, neural precursor cell-expressed developmentally down-regulated protein 4 
(Nedd4), is a ubiquitin ligase that can target ENaC channel complexes for internalisation / 
degradation by binding to specific sites within a C-terminal region of each ENaC subunit 
(Staub et al., 1996; Staub et al., 1997b; Dinudom et al., 2001). Whilst Nedd4 was found to 
interact with ENaC in vitro (Staub et al., 1996) and in vivo (Staub et al., 1997b), the isoforms 
of Nedd4-2 revealed close conservation sites to Nedd4 (Snyder et al., 2004b) but exhibited a 
higher affinity to bind to PY-motifs of ENaC subunits compared to Nedd4/1 (Kamynina et al., 
2001a; b). 
 
When co-expressed with the ENaC subunits in Xenopus laevis oocytes Nedd4-2 has been 
shown to inhibit the ENaC-dependent Na+ current by reducing the surface abundance of the 
channel subunits (Goulet et al., 1998; Abriel et al., 1999; Harvey et al., 2001; Kamynina et al., 
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2001a, b). The interaction between Nedd4-2 and ENaC is dependent on a conserved proline-
rich motif, PPPXYXXL (or proline motif, PPXY) present in the C terminal region of each 
ENaC subunit that serves as tyrosine-based internalisation sequence (Chen & Sudol, 1995; 
Staub et al., 1996; Staub et al., 1997a,b; Farr et al., 2000; Macias et al., 2002; Ilsley et al., 
2002). The binding between Nedd4-2 and ENaC permits ubiquitination and this, in turn, serves 
as a marker for endocytosis and degradation (Staub et al., 2000). Evidence that the interaction 
between ENaC and Nedd4-2 is physiologically important comes from naturally occurring 
mutations that disrupt the PY motifs in β- and γ-ENaC. These mutations cause Liddle‘s 
syndrome, a severe form of Na+-sensitive hypertension that is due to excessive Na+ retention 
via ENaC in the distal nephron, which is secondary to an increase in the apical abundance of 
ENaC, that reflects the impaired internalisation of these channels (Schild et al., 1996; Dinudom 
et al., 2001).  
 
Further evidence for the role of Nedd4-2 in vivo was provided by a recent knock-out mouse 
model (Nedd4-2 -/-) that produced cystic-fibrosis (CF)-like symptoms in the airway and 
premature ENaC activation in the lung (Boase et al., 2011). Nedd4-2 has also been shown to 
regulate ENaC in a ubiquitination-dependent manner in Xenopus laevis oocytes (Debonneville 
et al., 2001; Konstas et al., 2002; Snyder et al., 2002; Fotia et al., 2003; Ichimura et al., 2005; 
Nagaki et al., 2006; Hallows et al., 2010; Zhang et al., 2010) and epithelial cells (Snyder et al., 
2002; Zhou & Snyder, 2005; Ichimura et al., 2005; Bruce et al., 2008; Raikwar & Thomas, 
2008;  Zhang et al., 2010, Kimura et al., 2011) to indirectly increase ENaC expression at the 
cell surface, as a result of preventing the internalisation/ withdrawal of ENaC subunits from the 
membrane.  
 
Nedd4-2 associates with ENaC by ubiquitinating all subunits (Zhou et al., 2007; Kabra et al., 
2008; Eaton et al., 2010). The association between Nedd4-2 and ENaC appears to be SGK1 
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dependent, as this stimulates ENaC activity, by phosphorylating Nedd4-2 to prevent binding to 
ENaC and therefore increasing the chance of ENaC being expressed at the cell surface (Chen et 
al., 1999; Náray-Fejes-Tóth et al., 1999; Alvarez de la Rosa et al., 1999; Loffing et al., 2001; 
Staub et al., 2005). This can be demonstrated by mutating SGK1‘s PY-motif (Snyder et al., 
2002), which impairs its ability to bind to ENaC (Debonneville et al., 2001; Snyder et al., 
2002). As a result, the ubiquitination process reduces ENaC at the plasma membrane and 
significantly decreases the Na+ current, as found in Xenopus laevis oocytes and Fischer rat 
thyroid cells (Harvey et al., 2001; Kamynina et al., 2001a; McDonald et al., 2002).  
 
Prior to completing the interaction between Nedd4-2 and ENaC, the phosphorylation of Nedd4-
2 is further stabilised by 14-3-3 protein binding (Ichimura et al., 2005; Bhalla et al., 2006; 
Liang et al., 2006; Liang et al., 2008; Liang et al., 2010). The afore mentioned studies have 
reported that 14-3-3 is involved in this regulatory process and modulates the Na+ current by 
cooperating with the SGK1 mediated response. They proposed that the inactive form of Nedd4-
2 could increase the density of ENaC on the cell surface as 14-3-3 appears to be a binding 
partner of Nedd4-2 (Ichimura et al., 2005). Therefore, the 14-3-3 family represents a novel 
class of Nedd4-2-binding proteins and affects the way that Nedd4-2 interacts with ENaC.  
 
Cyclic AMP-coupled agonists can also promote the PKA-mediated phosphorylation of Nedd4-
2 and this kinase appears to catalyse the phospho-sites in a similar way to the residues involved 
in the SGK1 pathway (Snyder et al., 2004a). This has also been shown to be mediated by the 
binding of the 14-3-3 protein (Nagaki et al., 2006) which triggers phosphorylation at specific 
residues of Ser/Thr (Muslin et al., 1996). The data suggested that PKA and SGK1 congregate 
near Nedd4-2 so that they can phosphorylate it and therefore enhance ENaC at the cell surface. 
This notion is based on the phosphorylation of Nedd4-2 through the cAMP-activated PKA 
pathway in over-expressing SGK1 cells (Snyder et al., 2004a). The concept of integration may 
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thus involve multiple pathways that are known to promote Na+ transport and that are dependent 
on Nedd4-2 and 14-3-3 protein binding.  
 
1.5.7 Cleavage by serine-proteases 
A substantial body of work has shown that the activation of ENaC is also dependent on the 
cleavage of α- and γ-ENaC, by intracellular and extracellular proteases (see e.g., Vallet et al., 
1997; Vuagniaux et al., 2000; Hughey et al., 2003; Caldwell et al., 2004; Hughey et al., 2004; 
Caldwell et al., 2005; Myerburg et al., 2006; Diakov et al., 2008; Passero et al., 2008; Rossier 
& Stutts, 2009; Myerburg et al., 2010; Tan et al., 2011). The cleavage occurs during channel 
maturation within the biosynthetic pathway, which involves the cleavage of both the α- and γ-
subunits by furin at the serine residue (Kellenberger et al., 1999a;b; Vallet et al., 1997; Kashlan 
et al., 2005). However, cleavage can also occur in the extracellular space, prior to full 
activation of the ENaC subunits. This was first suggested by Hughey and colleagues, when they 
detected a mixture of mature and immature ENaC in the pool of plasma from the surface of 
stably transfected Madin-Darby canine kidney cells (MDCK) (Hughey et al., 2004a, b). They 
demonstrated that the immature channel complexes at the plasma membrane with a reserve of 
poorly functional channels needed to be activated by proteases in post-Golgi compartments. 
They also observed that both α- and γ- subunits have consensus sites for cleavage by furin, a 
serine-protease family protein, or other serine proteases such as prostasin and trypsin, at the cell 
surface prior to ENaC activation (Hughey et al., 2004a; b). However, it is possible that either 
individual channels at the surface undergo maturation through the cleavage process, or that 
some subunits escaped maturation, producing a mixture of both mature and immature subunits 
(Hughey et al., 2004a; b). These events contribute to ENaC residency in the membrane (see 
review, Butterworth et al., 2009, 2010).  
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Whilst it has been suggested that both α- and γ-ENaC are cleaved prior to activation, this is not 
the case for the β-subunit (Figure 1-8). The β-subunit is not thought to be subject to cleavage 
because it is insensitive to both endogenous and exogenous proteolytic cleavage. One may, 
however, speculate that the N-glycosylation of the β-subunit has fewer than 12 N glycosylation 
sites (Harris et al., 2007) which could protect the proteolytic cleavage sites from enzyme access 
to their substrate. In addition, the primary sequence of the β-subunit does not have any 
consensus sequences for furin cleavage. The discrepancy in primary sequence and protein 
folding / maturation might explain the striking difference between the β- subunit and the α- and 
γ-subunits (Harris et al., 2007).  
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Figure 1-8: Prediction of linear models for ENaC subunit cleavage (adapted from Rossier 
& Stutts, 2009) 
 
Each subunit has common features, including two transmembrane domains (M1 
and M2) with short N- and C- termini, known and suspected sites of ENaC 
cleavage, and that have been detected by N-terminal (*) or C-terminal (**) 
antibodies. (i) α-ENaC contains two possible furin sites, F1 and F2 which 
generate 25, 50, 65 and/or 95 kDa fragments as detected by an N-terminal 
antibody; (ii) β-ENaC does not contain any furin sites and other cleavage sites 
are postulated to be protected by heavy glycosylation, therefore the antibody 
raised to the N- and C- terminal will generate approximately 100 kDa; (iii) γ-
ENaC contains furin, prostasin (P) and channel activating proteases (CAP) 
sites, therefore it will generate approximately 15, 50, 70, and/or 85kDa 
fragments.  
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The models suggested by the Hughey, Kleyman and Harris groups are complementary to 
studies of heterologously expressed ENaC subunits incorporating synthetic epitopes (eg: 
FLAG) that facilitate the identification of cleavage products. Proteases / protease inhibitors 
clearly modify electrogenic Na+ transport in absorptive cells / tissues (see e.g. Myerburg et al., 
2006; Lazrak et al., 2009; Tan et al., 2011). In many epithelia, ENaC appears to be 
constitutively activated through the endogenous serine proteases because basal transepithelial 
Na+ transport cannot be further activated by the addition of trypsin. However, the addition of 
aprotinin (protease inhibitor) on the apical side of the epithelium typically inhibits baseline Na+ 
transport; this effect is reversible by exposing the cells to trypsin. In Xenopus kidney cells, 
aprotinin can block up to 90% of amiloride sensitive electrogenic Na+ transport (Vallet et al., 
1997; Adebamiro et al., 2005) and 50% in the mouse cortical collecting duct cell line (mpk-
CCDc14) (Vuagniaux et al., 2000), whereas aprotinin inhibited 30% of the basal INa+ current in 
human nasal cells (Bridges et al., 2001). Channel activating proteases (CAPs) have been shown 
to be expressed in tissues including the distal lung epithelium (Vallet et al., 2002) and found in 
the secreted lung liquid (Verghese et al., 2004; Planes et al., 2005). A lack of the CAP1 gene in 
mice has been shown to inhibit lung fluid clearance by β-adrenergic agonists; however, the 
effect was reversed by treatment with a non epithelial soluble serine protease (Planes et al., 
2009). This could be taken as further evidence of the synergistic action of hormones in the 
control of fluid clearance, where GCs and thyroid hormones prime the lung for fluid clearance 
and epinephrine/adrenaline causes activation of ENaC in the membrane via a mechanism of 
proteolytic cleavage to increase channel activity. 
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1.6 Closing remarks 
This chapter has provided a basic insight into the regulation of lung fluid homeostasis. The 
importance of ENaC can be seen through the knockout studies of α-ENaC in mice that resulted 
in death due to a failure to clear the lungs of fluid. Most studies have pointed out that α-ENaC 
activation for lung fluid clearance must be mediated by SGK1. However, this remains 
controversial because mouse models that lack this gene (sgk1-/-) are viable and show near 
normal fluid homeostasis in the lung. Thus, the role of SGK1 is not fully understood and 
requires further examination. Investigation into the role of SGK1 can be performed using 
inhibitors that have been specifically developed to block the protein kinase activities that 
underlie the SGK1 pathway, including the PI3K and TORC2 regulation of SGK1 activity. 
When SGK1 is active, it must phosphorylate an ubiquitin ligase protein, Nedd4-2, which is 
crucial for maintaining ENaC at the cell surface.  
 
Such activation of ENaC can also be regulated by the cAMP activating PKA pathway. Whilst 
this is activated by different hormones, this pathway must converge at Nedd4-2, which serves 
as a general mechanism to ubiquitinate ENaC prior to internalisation. If this is true, Nedd4-2 
may serve as a useful tool to observe how both SGK1 and PKA affect ENaC surface 
abundance. Furthermore, we also need to distinguish whether PKA acts alone in ENaC 
regulation or via SGK1.  
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1.7 Thesis Aims 
The main aim of the proposed study is to determine how hormones alter ENaC subunit 
recruitment to the cell surface of the H441 cell line. The relative expression of each subunit of 
ENaC will also be observed subject to hormonal stimulation by dexamethasone and cAMP 
elevating drugs. Further questions that may arise are summarised in Figure 1-9 and as follows: 
 
1) Does dexamethasone increase the surface expression of ENaC subunits by activating the 
PI3K - SGK1 pathway? 
2) Is the ubiquitin ligase Nedd4-2 dependent on SGK1 to maintain ENaC at the cell surface? 
3) Do cAMP activating drugs affect ENaC subunits through the PKA pathway? 
4) If so, do cAMP activating drugs involve Nedd4-2? 
5) Is Nedd4-2 subject to the mechanisms of both the SGK1 and PKA pathways? 
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Figure 1-9: Diagram showing the regulation of ENaC in three different conditions 
 
 (i) basal condition, where ENaC subunits at the cell surface are normally 
expressed and further internalised by Nedd4-2; (ii) activation of ENaC and 
deactivation of Nedd4-2 by the effect of dexamethasone, through SGK1 activity 
and (iii) activation of ENaC and deactivation of Nedd4-2 by the cAMP elevating 
PKA pathway. 
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1.8 Thesis overview 
 
Figure 1-10: General thesis overview 
 
 
 
This thesis presents a study on the expression of epithelium sodium channels, ENaC. Here I 
examine in detail the expression of each subunit and explore the potential pathways involved in 
the modulation of the endogenous expression of ENaC in the human epithelial airway cell line, 
H441.  
 
A literature review is presented in Chapter 1. The first part of the chapter offers a general 
description of Na+ transport in epithelial airway cells through ENaC. This description includes 
information on the functional structure of ENaC at the lung epithelial cell surface subject to 
hormonal responses. Next, the chapter focuses on ENaC activation through the glucocorticoid-
induced pathway which specifically involves PI3K-TORC2-SGK1-Nedd4-2, and enhances 
ENaC expression by protein trafficking from the intracellular pool of proteins towards the cell 
surface. This activation is also thought to be mediated by protein kinase A (PKA pathway). 
Since the information provided in this chapter is more of a general introduction, it will be 
supplemented by a specific introduction at the beginning of each small project, thereby linking 
together the four main chapters (3, 4, 5, 6). 
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Before proceeding to the main chapters of the thesis, the general methodology is described in 
Chapter 2. This describes the experimental procedures that were adopted throughout the thesis, 
including each solution/chemical/antibody where relevant. The introduction to each chapter is 
then followed by a short section detailing the experimental design and clarification of the aims 
and objectives for each main chapter. 
 
The first project begins in Chapter 3. I initially aim to investigate the characteristics of the 
endogenous ENaC subunit proteins. I explore the expression of each subunit from the 
intracellular and cell surface pool of proteins in presence of dexamethasone. 
 
Preliminary data is then collated for significance. In Chapter 4 I investigate the modulation of 
ENaC through protein kinase signalling up-stream and down-stream of the SGK1 pathway to 
confirm a role for dexamethasone in the physical stimulation of Na+ transport in H441 cells 
(Clunes et al., 2004; Ramminger et al., 2004; Husband, 2006; Brown et al., 2008; Gallacher et 
al., 2009; Watt et al., 2012). The relative expression of ENaC between glucocorticoid-deprived 
and glucocorticoid-treated cells, provides the answer to an intriguing question:  Does 
dexamethasone participate in glucocorticoid regulated kinase (SGK1) activation to assist ENaC 
translocation from the intracellular compartment to the cell surface? The pharmacological 
compounds PI-103, TORIN1, GSK650394 and rapamycin are used to explore the role of SGK1 
in ENaC expression.  
 
To further confirm these results, Chapter 5 describes the expression of a ubiquitin ligase 
protein, Nedd4-2, under the influence of dexamethasone. This hormone is thought to stimulate 
SGK1 expression prior to the phosphorylation of Nedd4-2 (Debonneville et al., 2001; Snyder et 
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al., 2002). Therefore, it would be interesting to determine the correlation between Nedd4-2 and 
ENaC protein subunits expression on cell surface through SGK1 pathway. 
 
Chapter 6 investigates the role of cAMP agonists on the elevation of ENaC expression by 
activating Nedd4-2, which is also thought to be dependent on the PKA pathway. Thus the 
findings complement the physiological ENaC activity under these treatments (Clunes et al., 
2004; Woollhead & Baines, 2006) which may be a subject to the convergence point of Nedd4-2 
(Snyder et al., 2004a).  
 
Finally, each of the main chapters concludes with a discussion of the findings from that chapter. 
Chapter 7 concludes the thesis, containing a summary of the completed work, a general 
discussion of the findings and suggestions for future work.  
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2 
Materials & Methods 
 
 
2.1 Methods overview 
 
 
 
 
Figure 2-1: A methodology overview, as applied throughout the thesis 
 
 
This chapter describes the methods applied throughout the thesis, starting with the extraction of 
the H441 cell line, the detection of ENaC subunits and the expression of the Nedd4-2 protein 
(Figure 2-1). Once the H441 cells reached confluence, they were treated with hormones and 
drugs as appropriate. Then, the cells were extracted through a standard protein extraction, 
subjected to Western analysis to detect ENaC subunit expression and the protein kinases 
involved in the P13K, SGK1 and PKA pathways. Subsequently, another two crucial protocols 
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were applied to the cell lysates: (i) cell surface extraction through biotinylation and (ii) 
immunoprecipitation of the Nedd4-2 protein. Each of the protocols were processed using 
Western analysis and probed for ENaC subunits and Nedd4-2 protein, respectively. 
 
 
 
2.2 H441 cell line culture 
2.2.1 The H441 cell model 
The H441 human bronchiolar epithelial cell line was used throughout the experiments. The cell 
line was purchased from The American Type Culture Collection (ATCC) and had been 
originally isolated through pericardial effusion from a male patient suffering from a pulmonary 
adenocarcinoma in May, 1982 (Gazdar et al., 1990). The cells form an adherent monolayer 
therefore they are suitable for cell culture. A characteristic of the H441 cell line is that it 
contains cytoplasmic granules that resemble those found in bronchiolar Clara cells (Gazdar et 
al., 1990) which constitute about 80% of the cell population of the distal airways (Kulaksiz et 
al., 2002). The authors have also shown that the cell line has the ability to express RNA for 
surfactant protein A and B. They also reported that these cells can be activated by cAMP 
agonists to generate a Cl- conductance (Kulaksiz et al., 2002). Despite this, the cells display an 
absorptive phenotype with additional treatment of the synthetic glucocorticoid, dexamethasone 
(Lazrak & Matalon, 2003; Clunes et al., 2004; Ramminger et al., 2004; Thomas et al., 2004; 
Shlyonsky et al., 2005; Brown et al., 2008; Inglis et al., 2009; Watt et al., 2012), suggesting 
that they are a useful model for investigating the activation of ENaC through hormonal control 
in the human distal airway. 
 
2.2.2 Media 
RPMI-1640 was developed by Moore et al., (1966) at the Roswell Park Memorial Institute, 
hence the acronym RPMI.  The formula is based on the bicarbonate buffering system and 
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alteration of the amounts of amino acids and vitamins. The medium has been used for the 
culture of human normal and neoplastic leukocytes. When properly supplemented, it has been 
shown to support the growth of many types of cultured cells, including fresh human 
lymphocytes in the 72 h phytohemaglutinin (PHA) stimulation assay. 
 
The H441 cells were first brought up in RPMI 1640 medium (Sigma Aldrich, Poole, UK) with 
foetal bovine serum (FBS) and bovine calf serum (BCS) as main supplements. For the 
experiment, the growth medium then was changed to a fully defined medium identical to that 
described in Table 2-1, except that the insulin concentration was reduced to 20 nM, and the 
serum components were replaced with FBS (8.5%) that had been dialysed to remove 
hormones/growth factors. Each supplement was stored in aliquots to minimise thaw-refreeze 
and contamination in the media. All components were stored in the freezer (-20oC) and were 
thawed in a 37oC water bath prior to use. 
 
The cells were maintained in a humidified incubator at 37oC and exposed to 5% CO2, 13% O2, 
and 82% N2 to stimulate the conditions found in the distal airways, where the PO2 is 
approximately 100 mmHg (West, 2000). To ensure a tightly defined hormone condition during 
the experiments, cells were bathed in a defined media for at least 24 hours before conducting 
the experiments. For some experiments, dexamethasone (200 nM) was added to the media for 
24 h and others for 3 h in order to explore the effects of both long and brief stimulation with the 
hormone. Throughout the experiment, appropriate age-matched control cells lacking the 
hormone were also studied.  
 53 
 
Table 2-1: Composition of components in both complete and dialysed media 
 
Supplement Function Complete 
Media 
Dialysed 
Media 
Bovine Calf Serum 
(BCS) 
Contained a mixture of Bovine Serum 
Albumin (BSA) and growth hormones 
to allow eukaryotic cells to survive, 
grow and divide 
8.5% - 
Foetal Bovine Serum 
(FBS) 
Same as above 8.5% - 
Dialysed FBS As above except growth hormones were 
dialysed to minimise the effect of 
hormones in the experiment. 
- 8.5% 
Glutamine Supports energy to the cells whenever 
the energy demands are high. 
2 mM 2 mM 
Transferrin An inert energy to facilitate iron in the 
cells (Fletcher & Huehns 1968) 
5 µg/ml 5 µg/ml 
Selenium Essential trace element to prevent 
oxidative damage in the cells.  
5 ng/ml 5 ng/ml 
Antibiotic/Antimycotic Reduces the growth of bacteria and 
fungus by inhibiting bacterial/fungus 
protein synthesis (Pearlman 1979) 
0.2% 0.2% 
 
All supplements were purchased from Sigma Aldrich, Poole, UK except BCS (from Gibco, Paisley, 
UK). 
 
 
2.2.3 Routine culture 
Cells were routinely cultured in a 75 cm2 filter capped culture flask (Greiner Bio-one, 
Frickenhausen, Germany) using complete media per passage per week. Each passage was 
approximately 95% confluent after one week. Cells were dissociated from the flask using warm 
trypsin/EDTA solution (Sigma Aldrich, Poole, UK); then fresh complete media was added to 
the flask to deactivate the dissociation. Cells were suspended using low spin centrifugation 
(500 x g for 3 min) and the density was determined using disposable plastic haemocytometers 
(ISL ―Fast Read‖, Paignton, UK). 106 cells were plated into a fresh flask containing fresh 
complete media. The volume of cells varied according to the receptacle used: in flasks, 6-well 
plates (0.5 x 106), transwells (1.0 x 106) and petri dishes (1.0 x 106). The media was changed 
every other day unless mentioned otherwise.  
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2.3 Preparation of samples 
2.3.1 Standard lysates 
H441 cells were routinely cultured in a complete medium until confluent. 24 h before an 
experiment, a fully defined medium supplemented with dialysed FBS was added after the 
complete medium was removed. Then, the confluent cells (~80-90%) were exposed to 
pharmacological agents (Table 2-2) in fully defined media. After the required incubation time, 
cells were washed three times with ice-cold phosphate buffered saline (PBS) to remove any 
agent traces. Cells were then resuspended in lysis buffer (Table 2-3). Each sample was then 
sonicated for 10 seconds (―Soniprep 150‖ MSE Ltd, Kent, UK) and further spun at 14,000 x g 
for 10 min. The concentration of crude protein was determined by the Bradford method. 2 x 
SDS sample buffer (Table 2-4) was added to make 1 x of the final concentration. The samples 
were heated at 95oC for 5 min to denature the protein. The cells were then loaded onto the gel at 
the respective protein mass per well or kept in the -80oC freezer for further use. 
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Table 2-2: Pharmacological agents involved throughout experiment  
Compound Function  Vehicle Final 
concentration 
References 
Insulin* Growth hormone ddH2O 20 nM Clunes et al., 2004; 
Mansley & Wilson, 
2010 a,b 
Dexamethasone* Glucocorticoid 
hormone 
Basal 
media 
0.2 µM Brown et al., 2008; 
Mansley & Wilson, 
2010 b 
TORIN1*** TORC 1/2 inhibitor DMSO 0.1 µM Guertin & Sabatini 
2007; Thoreen et al., 
2009  
PI-103** PI-3 kinase pathway 
inhibitor 
DMSO 1 µM Bain et al., 2007; 
Folkes et al., 2008 
GSK650394** SGK1 pathway 
inhibitor 
DMSO 10 µM Sherk et al., 2008 
Rapamycin** TORC1 inhibitor DMSO 0.1 µM Bain et al., 2007; 
Thoreen & Sabatini, 
2009 
Forskolin* cAMP agonists DMSO 10 µM Ramminger et al., 
2004; Inglis et al., 
2009 
Isobutylmethylxa
nthine (IBMX)* 
cAMP agonists DMSO 100 µM Clunes et al., 2004 
N
6
, 2‘-O-
dibutyryladenosin
e 3‘5‘-cyclic 
monophosphate 
(bucladesine)* 
cAMP agonists ddH2O 1 mM Clunes et al., 2004 
 
Pharmacological agents purchased from: 
 
*Sigma Aldrich, Poole, UK, ** Merck, Beeston, UK, ***TORIN1 was a kindly gift from Professor 
D. Sabatini, Whitehead Institute for Biomedical Research, US 
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Table 2-3: Composition of cell lysis buffer 
 
Component Concentration Function 
Tris-HCl pH 7.5 50 mM pH buffer 
EGTA 1 mM Ca2+ chelating agent 
EDTA 1 mM Ca2+ chelating agent 
Sodium 
Orthovanadate 
1 mM   Broad spectrum inhibitor of protein      
tyrosine phosphatases 
Glycerol Phosphate 10 mM Competitive inhibitor of Ser/Thr and Tyr 
phosphatases 
Sodium 
Pyrophosphate 
5 mM Competitive inhibitor of pyrophosphatases 
Sodium Fluoride 50 mM Ser/Thr phosphatase inhibitor aids protein 
stability 
Sucrose 270 mM Stabilise lysosomal membranes to reduce 
protease release 
Triton x 100 1% (v/v) Non-ionic detergent to solubilise proteins 
β-Mercaptoethanol 0.1% (v/v) Reducing agent, cleaves disulphide bonds 
―Complete mini‖ 
protease inhibitor 
cocktail tablets* 
1 tab per 10 ml Protease inhibitors to block wide spectrum 
of protease activity 
 
The components are all purchased from Sigma Aldrich (Poole, UK) except *Roche Molecular Biochemicals 
(Lewis, UK) 
 
 
Table 2-4: SDS gel loading buffer (2 x concentration) 
Components Concentration 
Tris.HCl (pH 6.8) 50 mM 
SDS 2% (v/v) 
Bromophenol blue 0.1% (v/v) 
Glycerol 10% (v/v) 
Dithiothreitol 100 mM 
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2.3.2 Cell surface extraction 
Cells were seeded in a 10 cm2 petri dish in complete media. The media was then added the 
following day and changed every alternate day until the cells had grown to confluence. The 
dexamethasone (0.2 µM) was then added for a duration of either 3 h or 24 h. Further incubation 
with pharmacological compounds was performed in the 3 h prior to extraction, unless otherwise 
stated (Table 2-2).  
 
 
Figure 2-2: Cell surface extraction protocol 
 
This protocol was initially carried out and modified from Planés et al., (2002) and Harris et al., 
(2007) (Figure 2-2). This was conducted on ice (0oC) to fix and reduce the chances of surface 
protein being internalised. The cells were washed with ice-cold PBS twice to remove any media 
residue. Then the cells were exposed to 10 mM sulfosuccinimidyl-2-(biotinamido)-ethyl-1,3‘ 
dithioproprionate (EZ-Link Sulfo-NHS-SS-Biotin, Pierce, Fischer Scientific, UK) to label the 
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surface for ~1 h then gently agitated. The reagent covalently modifies the proteins by attaching 
a cleavable biotin moiety to an amine group on the N-terminal amino acid residue and lysine 
side chains. The biotinylation reaction was quenched by adding cold glycine (100 mM). The 
cells were scraped in glycine then they were spun down, and the cells were lysed as described 
above. Then the lysates were further spun at 14,000 x g for 30 mins at 4oC to precipitate the cell 
debris / insoluble proteins. The protein contents were then determined using Bradford reagent 
(Protein assay I) (Bio-Rad, Hemel Hempstead, UK). Protein that was extracted in this way is 
referred to as ―total lysates‖ in the thesis.  
 
In the initial series of experiments, 500 µg of total lysates were mixed with streptavidin-coated 
agarose beads (Pierce, Fischer Scientific, UK) and allowed to equilibrate for 60 mins at room 
temperature with continual agitation. Streptavidin beads bind the biotins with a high affinity 
which implies that the proteins that have been modified by the sulpho-NHS-SS-biotin reagent. 
The beads were then washed extensively to remove the unbound proteins and heated to 95% 
under strongly reducing / denaturing conditions (5% β-mercaptoethanol / 2% SDS) to cleave 
the disulphide bonds in the biotin moiety and release the bound proteins. The protein released 
in this way is referred to as ―biotinylated protein‖. These experiments were repeated (n = 8) and 
measurement was performed using the protein assay RC-DC (RC-DC reagent, Bio-Rad, Hemel 
Hempstead, UK) (Protein assay II). The results showed that 48 ± 0.69 µg of protein could be 
recovered from an initial 500 µg. Since the binding capacity of the streptavidin-coated beads is 
1-3 mg per ml per slurry, all subsequent experiments used 150 µl of slurry to isolate the 
biotinylated protein from 500 µg. Under these conditions there is a ~ 3 fold excess binding 
capacity and the smaller bead volume allows the biotinylated proteins to be released directly 
into 50µl of the sample buffer used for SDS-polyacrylamide gel electrophoresis.  
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Western analysis showed that β-actin was readily detectible in 1 µg aliquots of total protein 
and, although this protein could also be detected in large aliquots (20 µg) of biotinylated 
protein (see Chapter 3), it was necessary to overexpose the blots in order to detect this protein. 
Since β-actin is a cytoskeletal protein that is confined to the inner leaflet of the plasma 
membrane, this protein would normally be inaccessible to biotinylation reagents in the 
extracellular fluid. The presence of β-actin in the biotinylated protein fraction thus shows that 
this protein pool does contain some intracellular proteins. However, densitometric analysis 
showed that the abundance of β-actin in a 20 μg aliquot of biotinylated protein was ~30% of the 
abundance measured in 1 μg of total protein. The biotinylation-streptavidin binding protocol 
therefore allows surface-exposed proteins to be isolated with 98 – 99% purity, and this protein 
fraction is subsequently referred to as the ―surface-exposed protein‖. The protein assayed was 
loaded into an SDS-Page 8% gel for ENaC subunit protein expression whilst 10% was used for 
endogenous phosphorylation of protein kinases. In all subsequent experiments aliquots of total 
protein (50 μg) and of the surface-exposed protein purified from 500 μg of total protein were 
subjected to Western analysis using antibodies against α-, β-and γ-ENaC. Cell surface labelling 
was restricted to plasma membrane proteins, as shown by the absence of any significant amount 
of actin in this fraction. Essentially, the non-biotinylated protein pool is characterised by a large 
amount of actin.  
 
2.3.3 Immunoprecipitation of total Nedd4-2 
This protocol was used to extract protein bound specifically to anti-Nedd4-2. The idea is to 
isolate the protein of interest through specific binding of the antibody (in this case, anti-Nedd4-
2) to the antigen (Protein G). This technique is used because the total amount of cellular 
Nedd4-2 protein may be very small, therefore prohibiting detection by standard Western 
techniques. Rapid degradation of Nedd4-2 may also prevent detection; however this was 
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avoided thanks to the suggestions made by Professor Carol MacKintosh (University of 
Dundee). 
 
As shown in Figure 2-3, a standard protein extraction of 1 mg of the protein lysates obtained 
using the Bradford protein assay was added to 20 µl of pre-washed Protein G Sepharose beads 
(Sigma Aldrich, Poole, UK) and incubated for 1 h at 4oC. This is to allow clear lysate binding 
to the Sepharose G beads. The cleared lysates were then exposed to Sepharose G beads that had 
been coated with 10 µg of anti-Nedd4-2 for 1 hr at 4oC while being continually agitated. All 
volumes were made up to 1 ml. Then, the bead-bound complexes were harvested by 
centrifugation at 14,000 x g for 5 min. The beads were then sequentially washed, first with a 
high salt buffer to reduce ionic interaction, then a no-salt buffer to reduce non-specific reactions 
(Table 2-5).  
 
 
Figure 2-3: The immunoprecipitation protocol 
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The complexes were then centrifuged at 1000 x g for 1 minute, and this was then repeated 
twice. Following that, the beads were eluted by adding 20 µl of 2 x SDS sample buffer and 
heated up to 95oC for 5 minutes. Finally, the protein-bead mixture was collected by spinning at 
14,000 x g for 5 min and deionised water was added to make a final concentration of 1 x SDS 
sample buffer. They were subsequently fractioned using a 6% SDS polyacrylamide gel and 
Western Analysis, then transferred to Hybond-P membranes (Amersham, Bucks., UK) that 
were probed using antibodies against the Ser221-, Ser327-, or the Thr246-phosphorylated forms of 
Nedd4-2. Blots were then stripped and re-probed using antibodies against the full length 
protein. 
 
 
Table 2-5: Recipe for the wash buffer in the immunoprecipitation 
 
High-salt wash buffer No-salt wash buffer 
2.5 ml 2M Tris.HCl pH7.5 2.5 ml 2M Tris.HCl pH7.5 
12.5 ml 4M NaCl 200 µl 0.5M EDTA 
85 ml deionised water 100 µl β-mercaptoethanol 
 97.2 ml deionised water 
 
 
 
2.4 Western analysis 
 
 
2.4.1 Protein determination by the protein assay 
2.4.1.1 Principle of the assay 
A protein assay was used to determine the concentration of soluble protein in the sample. From 
this, the protein mass can be calculated to obtain the amount desired for further analyses. The 
experiment assesses the concentration of protein using a dye, and measures the colour change at 
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an absorbance of 595 nm. This measurement indicates the extent of protein binding and thus 
the protein concentration. 
 
2.4.2 Performing the assay 
2.4.2.1 Bradford assay 
Bovine serum albumin (BSA, Sigma Aldrich, Poole, UK) was prepared in a variety of 
concentrations: 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5 mg/ml in deionised water (ddH2O). For 
each assay reaction, 5 µl of each BSA standard concentration were added in triplicate to a 96-
well microtiter plate. 5 µl of deionised water were also added in triplicate to act as a control. 1 
µl of each sample was then added in duplicate.  
 
Protein Assay Dye Reagent Concentrate (Bio-Rad, Hemel Hempstead, UK) was diluted to a 
ratio of 1:4 with deionised water and filtered through Whatman no. 1 filter paper. 100 µl of the 
diluted dye reagent was added to each protein standard, control and sample for 10 minutes. The 
reaction was measured at an absorbance of 595 nm using a microplate reader (MRX, Guernsey, 
UK). Absorbances of all the known protein standards obtained were recorded in an Excel 
worksheet in order to produce a standard curve. The absorbance values for the protein lysates 
of the unknown samples were calculated using the standard equation (y = mx + c), where m is 
the gradient of the line and c is where the line intercepts the y-axis.  
 
2.4.2.2 Modified Lowry assay (RC-DC assay) 
A series of concentrations of bovine serum albumin (BSA, Sigma Aldrich, Poole, UK) were 
prepared as follows: 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5 mg/ml in SDS-PAGE buffer, as each 
of corresponding unknown protein sample was processed in similar buffer. This buffer contains 
SDS and is reducing agent compatible (RC) and detergent compatible (DC); RC-DC reagent. 
25 µl of each protein standard, the control (SDS-PAGE buffer) and treated samples were 
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divided into separate 1.5 ml microcentrifuge tubes. 125 µl of RC-Reagent I was added to each 
tube. Each solution was mixed thoroughly. After that, 125 µl of RC-Reagent II was added and 
mixed. The reaction was centrifuged at 14,000 x g for 5 min. The supernatant was then 
discarded. 5 µl of DC-Reagent S was added to 250 µl of DC-Reagent A. 127 µl of this solution 
was added to each tube that contained a pellet. The reaction was incubated at room temperature 
for 5 min, or until the precipitation dissolved. The tubes were then vortexed before adding 1 ml 
of DC Reagent B and incubated for another 15 min. The absorbance (750 nm) was measured 
using a microplate reader (Dynatech Laboratories, UK). All values obtained were calculated 
using Excel. A standard curve was then produced and the protein mass for each of the samples 
was determined.  
 
2.4.3 Gel casting 
SDS – polyacrylamide gels were prepared according to the recipe modified from Harlow & 
Lane (1988). In this thesis, three different percentages of resolving gels were used for better 
protein separation (Table 2-6). A solution of resolving gel was poured into glass plates (Bio-
Rad, Hertforshire, UK) with 1 mm spacers and allowed to set with 500 µl of butanol added to 
the surface to ensure removal of air bubbles. Once the gel had set, the butanol was washed out 
thoroughly and the stacking gel was poured in (Table 2-7). A comb was inserted to the stacking 
gel and left to set so that it could be used for electrophoresis straight away or kept in a 
refrigerator in damp tissue paper. 
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Table 2-6: Recipe for resolving gels 
 
Solution components of resolving gels 
Component volumes (ml) per 2 gels 
6% of SDS 8% of SDS  10% of SDS  
Deionised water 7.9 6.9 5.9 
30% acrylamide mix 3.0 4.0 5.0 
1.5M Tris (pH 8.8) 3.8 3.8 3.8 
10% SDS 0.15 0.15 0.15 
10% ammonium persulfate 0.15 0.15 0.15 
TEMED (N,N,N',N'-Tetramethylethylenediamine) 0.012 0.50 0.5 
 
 
Table 2-7: Recipe for 5% SDS of stacking gels 
Components Component volumes (ml) per 2 gels 
Deionised water 2.1 
30% acrylamide mix 0.5 
1.5M Tris (pH 8.8)  0.38 
10% SDS  0.03 
10% ammonium persulfate  0.03 
TEMED (N,N,N',N'-Tetramethylethylenediamine)    0.003 
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2.4.4 Gel electrophoresis 
 
Gels were placed in a gel tank (Novex mini cell XCell II, Invitrogen, Paisley, UK) with running 
buffer (Table 2-8). Each well was loaded with a protein sample with a determined protein mass 
of 50 µg unless stated otherwise. Rainbow Marker (Precision Plus ProteinTM Standards, Bio-
Rad, Hemel Hempstead, UK) was loaded in to the farthest left well followed by a biotinylated 
marker to allow visualisation of protein movement. The gel was set to run at 200 V for 
approximately 50 min. 
 
 
Table 2-8: Composition of the running buffer 
Composition  Concentration (mM) 
Trizma Base 24.8 
Glycine 191.8 
SDS 3.5 
 
All components are purchased from Sigma Aldrich (Poole, UK). 
 
2.4.5 Protein transfer 
Blotting sponges were soaked in transfer buffer (Table 2-9) and air bubbles were removed by 
pressing the sponges with a glass pipette. The pattern of the blotting sandwich is shown in 
Figure 2-4; it was covered with transfer buffer whilst the main buffer chamber of the tank was 
filled with deionised water. Proteins from the gel were transferred onto Polyvinylidene Fluoride 
(PVDF) membrane (Hybond-P, Amersham, Buckinghamshire, UK) at 30 V for 2 h. The 
negatively charged protein then exited the gel, travelled towards the anode and bound to the 
membrane. 
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Table 2-9: Composition of the transfer buffer 
Composition Concentration (mM) 
Trizma Base 19.8 
Glycine 150.5 
Methanol 20% 
All components were purchased from Sigma Aldrich (Poole, UK). 
 
 
 
 
 
Figure 2-4: Typical pattern for sandwich blotting for protein transfer in a Western standard 
protocol for (A) one gel and (B) two gels 
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2.4.6 Immunodetection 
 
After the transfer process, the PVDF membrane was incubated in TBS-T (8.8 g/l NaCl, 0.2 g/l 
KCl, 3.0 g/l Tris and 0.05% Tween-20 pH 7.5) with 2% non-fat dry milk (hereafter simply 
called ―blocking buffer‖) for 1 h at room temperature. This was to reduce any nonspecific 
binding and to reduce background staining on the membrane. The membrane was incubated 
with the desired primary antibody at the optimum working dilution for blocking buffer, 
respectively (Table 2-10). All incubation was conducted overnight at 4oC on a roller so that 
every part of the membrane was covered with the antibody solution. The next day, the 
membrane was washed with TBS-T (without milk) for 10 min. This was repeated three times 
then followed by incubation with the appropriate secondary antibody conjugated to Horse 
Radish Peroxidase (HRP) for ~1 h at room temperature along with gentle agitation. A further 
three washes with TBS-T for 10 min were then carried out to remove excess milk powder 
residue. 
 
2.4.7 Chemiluminescence and film exposure  
After the final wash with TBS-T, the buffer was discarded and the remaining buffer on the 
membrane was drained off. Enhanced chemiluminescence (ECL) reagent I and II were mixed 
in the appropriate amounts (Table 2-11) and the mixture was added to the membrane then 
incubated at room temperature for 1 min. The excess mixture of reagents was dried before 
being wrapped in clear plastic. All bubbles were gently removed by pressing the plastic with 
tissue. Once in the dark room under safe lighting the membrane was placed protein side up in 
an exposure cassette. A piece of film (Hyperfilm ECL, Amersham, Buckinghamshire, UK) was 
exposed for the required time for the respective antibody and developed using a Compact 4 
automatic film developer (X-ograph imaging systems, Wiltshire, UK). 
 68 
Table 2-10: Antibody application for Western analysis 
Primary Antibody Working 
dilution 
Secondary Antibody Working 
Dilution 
Anti -ENaC1 1 µg/ml Rabbit anti mouse HRP conjugate 1: 3000 
Anti -ENaC2 2 µg/ml Goat anti rabbit HRP conjugate 1: 3000 
Anti -ENaC3 1 µg/ml Goat anti rabbit HRP conjugate 1: 5000 
Anti -Actin3 2 µg/ml Rabbit anti mouse HRP conjugate 1: 10,000 
Anti Phospho 
4
NDRG1-
Thr
346/356/366 
 1.5 µg/ml Rabbit anti sheep HRP conjugate 1: 5000 
Anti Total 
4
NDRG1-Thr
346/356/366 0.35µg/ml Rabbit anti sheep HRP conjugate 1: 10,000 
Anti Phospho 
5
PKB-Ser
473 1 µg/ml Goat anti rabbit HRP conjugate 1: 3,000 
Anti Phospho 
5
PKB-Thr
308  1 µg/ml Goat anti rabbit HRP conjugate 1:2,000 
Anti Total 
5
PKB 1 µg/ml Goat anti rabbit HRP conjugate 1:3,000 
Anti Phospho 
5
PRAS40-Thr
 246 0.3 µg/ml Rabbit anti sheep HRP conjugate 1: 2,000 
Anti Total 
5
PRAS40 0.52µg/ml Rabbit anti sheep HRP conjugate 1: 2,000 
Anti Phospho 
4
Nedd4-2-Ser
 221 5 µg/ml Rabbit anti sheep HRP conjugate 1: 5,000 
Anti Phospho 
4
Nedd4-2-Ser
 327 2 µg/ml Rabbit anti sheep HRP conjugate 1: 5,000 
Anti Phospho 
4
Nedd4-2-Thr
 246 2 µg/ml Rabbit anti sheep HRP conjugate 1: 5,000 
Anti 
4
Nedd4-2 1 µg/ml Rabbit anti sheep HRP conjugate 1:10,000 
Anti 
5
CREB-Ser
133 1 µg/ml Goat anti rabbit HRP conjugate 1: 1000 
Anti 
5
CREB 1 µg/ml Goat anti rabbit HRP conjugate 1:1000 
 
1
 - Gift from Cystic Fibrosis Centre, North Carolina University, US; 
2
 - Santa Cruz Biotechnology, 
Wembley, UK; 
3
 - Sigma Aldrich, Poole, UK; 
4
 - Gift from MRC Phosphorylation Protein Unit, 
University of Dundee, UK; 
5
 - Cell Signalling, Hertfordshire,UK  
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Table 2-11: Recipe for enhanced chemiluminescence (ECL) solutions  
Components Concentration (M) Volume (ml) 
Solution I 
Luminol 0.25  2.5 
p-coumaric acid 0.9 1.1 
Tris (pH 8.5) 1  25.0 
Deionised water - 221.4 
Solution II 
H202 0.3 0.16 
Tris (pH8.5) 1  25.0 
Deionised water - 224.8 
 
All components were purchased from Sigma Aldrich (Poole, UK) 
 
 
2.5 Experimental design and statistical analysis 
A densitometry analysis was performed on each band image on the developed film. Each film 
was scanned using a standard scanner and further analysed with the ImageJ 1.46 software 
(NIH; http://imagej.nih.gov/ij/download.html).  
 
For , , and -ENaC proteins in both the total lysates and cell surface extraction, a raw value 
for the densitometry was taken as the sum of pixel values minus a background value for each 
pixel within a bounded area. The treatment value was determined by relative comparison to the 
control sample. A similar approach was applied to the remaining endogenous phosphorylated 
and total protein kinases individually. Results from at least 3 independent cell passages (strictly 
age-matched cells) and repetitions were presented as the mean ± standard error (SEM) and 
further analysed using a Student’s paired t-test where *p<0.05, **p<0.01 and ***p<0.001 
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represent a significant difference between the means. If there were more than two means 
involved in the analysis, one-way ANOVA and Bonferroni post-hoc tests (SPSS) were 
conducted; †p<0.05. Any values of n refer to independent passages in each group. 
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3 
Epithelium sodium channels (ENaC) expression 
in H441 cells 
 
 
3.1 Introduction 
Fluid clearance from the lungs at birth is vital and is thought to be regulated by glucocorticoids 
(GCs) which are naturally found in blood. GCs are often used to treat cases of respiratory 
distress syndrome (RDS) and pulmonary oedema, as a lack of these hormones can contribute to 
poor fluid regulation during birth and disruption of lung function in adult life. Despite 
considerable evidence to support this theory, the mechanisms by which GCs act are still not 
fully understood. 
 
To investigate GC-stimulated Na+ transport in epithelial sodium channels (ENaC), the H441 
human bronchiolar cell line was used as a model. ENaC proteins are present on the cell surface 
of the lung epithelial. ENaC is a multimeric protein that consists of three structurally related 
subunits: α-, β-and γ- (Cannessa et al., 1996). It is a key component in the regulation of the rate 
of Na+ transport. The channel exhibits a high selectivity for Na+, and is amiloride-sensitive 
when expressed in Xenopus laevis oocytes or mammalian tissue. In the human distal lung 
epithelium of H441 cells, dexamethasone is known to stimulate amiloride sensitive Na+ 
transport (Sayegh et al., 1999; Ramminger et al., 2004; Clunes et al., 2004; Brown et al., 2008; 
Greenwood et al., 2009; Inglis et al., 2009; Watt et al., 2012) by increasing α-ENaC mRNA 
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expression (Sayegh et al., 1999; McTavish et al., 2009), and upregulating α- and β-ENaC 
(Ramminger et al., 2004; Thomas et al., 2004) and all ENaC subunits (Itani et al., 2002b). 
Therefore, H441 cells are a useful model for investigating the activation of ENaC via GCs 
(dexamethasone), and they have been used for other physiological studies of Na+ transport with 
similar hormones (Brown et al., 2008; Gallacher et al., 2009; Watt et al., 2012). 
 
The ENaC protein can be activated by α-ENaC alone or through dual-expression with either β- 
or γ-ENaC (Canessa et al., 1994). The dual expression reflects the different properties of the 
heteromultimer (McNicholas & Canessa, 1997). This illustrates that ENaC can be constructed 
through different stoichiometry to be functional. The most convincing study to date suggests 
that expression of the α-subunit is the most critical, as a lack of this subunit results in an 
inability to clear lung fluid (Hummler et al., 1996). 
 
ENaC expression at the cell surface is thought to be regulated by glucocorticoid-regulated 
kinase 1 (SGK1) (Kamynina et al., 2001a; Kamynina et al., 2001b; Boyd & Fejes-Tóth, 2005; 
Lee et al., 2007). SGK1 is known to stimulate epithelial sodium channel genes in the human 
foetal lung (Venkatesh & Katzberg, 1997). When SGK1 activity is increased, it augments 
ENaC trafficking towards the cell surface by phosphorylating the ubiquitin ligase protein, 
Nedd4-2 (Debonneville et al., 2001; Snyder et al., 2002; Kamynina & Staub, 2002). In normal 
cells, ENaC regulation is controlled through ubiquitination. Thus, when Nedd4-2 is inhibited by 
SGK1, it will no longer bind to ENaC (Debonneville et al., 2001; Snyder et al., 2002) and this 
allows more ENaC proteins to be expressed at the cell surface. An abundance of ENaC proteins 
will generate a higher GNa+ , causing an increase in Na
+ absorption (Paunescu et al., 2000). 
However, the deletion of the SGK1 gene only causes mild effects towards renal Na+ handling 
(Wulff et al., 2002; Fejes-Tóth et al., 2008; Lang et al., 2009), as the viable mice do not display 
any functional abnormalities. Similar observation can also be seen in the colonic ENaC activity 
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(Rexhepaj et al., 2006) which suggests that renal and colonic ENaC regulation may involve 
different mechanisms. It would be expected that lack of SGK1 gene is not the sole regulator in 
trafficking ENaC to the membrane. 
 
Therefore, SGK1 activation needs to be investigated in order to clarify its role in ENaC 
expression. The SGK1 protein needs to be phosphorylated at two distinct residues in order to 
confer its activity (Biondi et al., 2001), which is dependent on PI3K activity (Kobayashi & 
Cohen, 1999; Park et al., 1999; Biondi et al., 2001). However, there is limited information 
available on either SGK1 or PI3K activity in H441 cells or their response to GCs, compared 
with the number of studies on renal epithelia. Therefore, we chose to investigate SGK1 activity 
in the pulmonary epithelia using the H441 cell line. Our group uses transfected H441 cells with 
mutant forms of SGK1 and P13K that are either constitutively active or catalytically inactive 
and have observed a non selective conductance of Na+ transport (Brown et al., 2008; Inglis et 
al., 2009). As yet, the activities of SGK1 and P13K have not been fully investigated in this cell 
line.  
 
The protein kinase N-myc Downstream Regulated Gene 1 protein (NDRG1) is a good indicator 
for SGK1 activity as it is phosphorylated at Thr346/356/366 by SGK1 and not by other related 
kinases such as PKB and S6K1 (Murray et al., 2004). Antibodies raised against phosphorylated 
NDRG1-Thr346/356/366 have been used to monitor SGK1 activity (Murray et al., 2004) in HeLa 
cells and sgk1 knockout mice. The same technique can be applied for observation of SGK1 
activity in mouse cortical collecting duct cells (Mansley & Wilson, 2010a) and H441 cells 
(Inglis et al., 2009; McTavish et al., 2010). 
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3.2 Experimental design: aims and objectives 
Since it corresponds to the activation of SGK1 (Murray et al., 2004; Inglis et al., 2009; 
Mansley & Wilson, 2010a; Watt et al., 2012), the phosphorylation of NDRG1-Thr346/356/366 was 
investigated first. Since dexamethasone is thought to elevate SGK1 activity, an experiment was 
carried out to determine the time and dosage-dependent incubation of dexamethasone on SGK1 
activity. This study complements work done by Watt et al., (2012), who noted an amiloride 
sensitive Na+ current in cells treated with dexamethasone. Therefore, ENaC protein expression 
is a good way to study the rate of Na+ transport. Many studies focusing on the physiological 
mechanisms underlying Na+ transport have used cells cultured on a permeable membrane. 
However since different cell culture conditions may result in different ENaC protein 
expression, I designed an experiment that examined the expression of ENaC subunits on both a 
permeable support with an air-liquid interface (transwell) and on a hard surface (6-well or petri 
dish). 
 
Incubation with dexamethasone (for ~24 h) has been shown to stimulate Na+ transport in H441 
cells due to amiloride sensitivity (Ramminger et al., 2004; Clunes et al., 2004; Brown et al., 
2008; Inglis et al., 2009; Watt et al., 2012). This increased Na+ transport in GC-stimulated cells 
is correlated with an increased expression of ENaC protein at the cell surface suggesting that 
the two may be related. Therefore, in this section of the thesis I investigate ENaC protein 
expression in GC-stimulated H441 cells.  
 
Previous studies have not always succeeded in successfully detecting ENaC subunit protein 
expression due to the low abundance of this protein. On the occasions that ENaC subunit 
expression was thought to be detected, the results were considered inconclusive due to the 
possible nonspecific protein binding of the antibodies. Therefore, at start of this project a wide 
selection of antibodies were used to observe the expression of each subunit in both the total 
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lysates and cell surface pool proteins. This procedure was optimised to select antibodies that 
specifically detected each subunit protein of ENaC, thereby minimising nonspecific protein 
binding. To further assess the specificity, ENaC protein expression was confirmed by 
monitoring the absence of each protein band following competition with immunogenic peptides 
where they were commercially available. The preliminary results then allowed me to identify 
the expression of each subunit of ENaC (α-, β-, and γ-) in H441 cells, in both the intracellular 
pool proteins and at the cell surface. In addition, I observed ENaC protein trafficking towards 
the cell surface in the presence of dexamethasone and compared this to trafficking in GC-
deprived cells. The cell surface proteins were labelled with biotin to further probe for ENaC 
subunits. This method enabled us to successfully extract ENaC subunit protein from the cell 
surface, and compare it to the intracellular pool proteins which were indicated by the absence 
of β-actin, which acted as a marker for the purity of the biotin-labelled protein extracted from 
the cell surface.  
 
 
In summary, the aims of this chapter are: 
1) To observe SGK1 activity using the phosphorylated-NDRG1Thr346/356/366 antibody in 
GC-induced H441 cells. 
2) To identify ENaC protein expression in H441 cells. 
3) To differentiate ENaC protein expression in H441 cells that is cultured on either a 
permeable or on a hard-surface plate. 
4) To establish ENaC protein expression in GC-treated, as well as GC-deprived H441 
cells, both intracellularly and on the cell surface. 
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3.3 Results 
3.3.1 Dose-dependence of dexamethasone-treated H441 cells  
Cells grown on 6-well plates were maintained in complete media until confluent. The media 
was then changed to a defined media but only supplemented with dialysed serum ~24 h prior to 
obtaining the cell lysates. During this period, dexamethasone of varying dosages (0, 10, 50, 
100, 150 and 200 nM) was introduced to the cells in the final ~3 h. After Western analysis, the 
densitometry values of both the phosphorylation of NDRG1-Thr346/356/366 and the total protein 
were analysed (GraphPad Prism) (Figure 3-1A). Figure 3-1B confirms the data previously 
found by our lab, as a dosage of 200 nM (or 0.2 µM) successfully evoked the expression of the 
SGK1 indicator (Ramminger et al., 2004; Clunes et al., 2004; Brown et al., 2008; Inglis et al., 
2009; Watt et al., 2012). A sigmoidal log curve that reaches a peak showing an almost 100% 
ratio over control cells that were treated with the maximum dosage also reconfirms data that 
was found previously in our lab (Mansley, 2010; Watt, 2011). The NDRG1 protein was loaded 
equally to eliminate any error when interpreting changes in protein phosphorylation (Figure 3-
1A). 
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Figure 3-1: Dose-response of dexamethasone (nM) upon phosphorylation of NDRG1-
Thr346/356/366 
 
(A) The densitometry of NDRG1-Thr346/356/366 phosphorylation (upper blot) 
and total protein (lower blot) and their response to concentrations of dexamethasone 
(3 h) in a cumulative manner. (B) The sigmoidal graph represents the log of 
concentrations versus phosphorylation of NDRG1-Thr
346/356/366
. Each point
 
represents 
the mean ± SEM of 3 independent samples.  
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3.3.2 Time-dependence of dexamethasone treated H441 cells 
Cells grown on 6-well plates were maintained in complete media until confluent. The media 
was then changed to a defined media but only supplemented with dialysed serum ~24 h prior to 
collection of the cell lysates. During this period, dexamethasone (0.2 µM) was introduced to the 
cells at a variety of points between 0 - 24 h. Similar groups of age-matched cells were not 
hormonally treated so that they could act as a control. All cells were later probed for NDRG1-
Thr346/356/366. Phosphorylation of this protein at Thr346/356/366 increased due to the effects of 
dexamethasone (0.2 µM) at 1 h and reached maximal expression at 3 h (Figure 3-2A,B). The 
amount of NDRG1-Thr346/356/366 decreased after this and continued to do so up to the 24 h point. 
The phosphorylated expression of NDRG1 did not affect the total protein abundance (Figure 3-
2B). 
 
 
 
 
Figure 3-2: Effects of dexamethasone (0.2 µM) on NDRG1-Thr346/356/366 phosphorylation 
and total protein over time 
 
(A) A typical Western blot showing the effects of dexamethasone (0.2 µM) on 
NDRG1-Thr346/356/366 phosphorylation and total NDRG1 starting from 0 min until 
~24 h. (B) The graph shows the densitometry values for the protein abundance in 
(A). Data represents the mean ± SEM (n = 4). Asterisks denote a significant 
difference towards dexamethasone-deprived cells; *p<0.05, **p<0.01, 
***p<0.001 (one-way ANOVA, Bonferroni post-hoc test). 
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3.3.3 Immunogenic peptides of ENaC  
The expression of ENaC subunits was confirmed by introducing immunogenic peptides raised 
against the antibody. This was crucial to confirm that the protein bands obtained from the 
protein lysates were specific, as the molecular weight suggested. Figure 3.3 illustrates the 
indicative molecular weight of (A) β-ENaC; ~100 kDa and (B) γ-ENaC (~90 kDa and ~75 kDa) 
(left panels) and when they were neutralised after incubation with immunogenic peptides (right 
panels). Expression of α-ENaC could not be performed, as the α-ENaC antibody was a gift 
from North Carolina University, and no commercial immunogenic peptides have been raised to 
this antibody to confirm the molecular weight. Nevertheless, an approximate molecular weight 
of between 95kDa and 75kDa for α-ENaC protein has been shown by other studies (Table 3-1). 
 
 
 
 
Figure 3-3: The validation of ENaC protein  
 
 (A) Inhibitory peptides for the β-ENaC antibody were raised against the C-
terminus. The peptide successfully inhibited the protein at ~100 kDa. (B) 
Inhibitory peptides for the γ-ENaC antibody were raised against the N-terminus. 
The peptide inhibits both isoforms of the protein at ~90 kDa and ~75 kDa. 
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Table 3-1: Molecular weight of ENaC in various cell types 
Cell Surface Bionylation of ENaC 
Cell type 
α-ENaC   
Short Length 
β-ENaC 
  
γ-ENaC   
Short Length Authors Full Length Full Length 
Planés et al., 2002 ATII 85 kDa 65 kDa       
Booth & Stockand, 2003 A6 90 kDa   95 kDa 95 kDa 70 kDa 
Awayda et al., 2004 oesophageal  90 kDa 75 kDa 105 kDa 90 kDa   
Myerburg et al., 2006 HAEC 97 kDa 75 kDa       
Mace et al., 2008 H441 90 kDa 65 kDa 100 kDa 90 kDa   
Woollhead & Baines, 2006 H441 93 kDa         
Xu & Chu, 2007 H441 85 kDa 70 kDa   80 kDa   
Knight et al., 2006 HEK 293T 90 kDa 65 kDa   85 kDa 75 kDa 
Raikwar &Thomas, 2008 HEK293T   75 kDa       
Ruffiex Daidie et al., 2008 HEK293T 110 kDa 90 kDa 95 kDa 77 kDa 73 kDa 
Zhou et al., 2007 HEK293T 90 kDa 65 kDa 100 kDa   
Kim et al., 2007 mature kidney mice 85 kDa   85 kDa 85 kDa 70 kDa 
Randrianason et al., 2007 mature lung transgenic mice 85 kDa 65 kDa 95 kDa 90 kDa 75 kDa 
Hanwell et al., 2002  MDCK (FLAG-AB) 100 kDa 80 kDa 110 kDa   75 kDa 
Butterworth et al., 2005 mpkCCDc14  95 kDa   90 kDa 75 kDa 65 kDa 
Hughey & Kleyman, 2007 MDCK       85 kDa 70kDa 
Hughey et al.,2004 MDCK 96 kDa 65 kDa 110 kDa 95 kDa 75 kDa 
Vasquez et al., 2008 SMG-C6  90 kDa         
Diakov et al., 2008 
  
X.laevis Oocytes 
  
  
  
  
  
  
  
87 kDa 
  
76 kDa (total) 
67 kDa (surface) 
Hu et al., 2009 X.laevis Oocytes 80-85 kDa 60-65 kDa       
Harris et al., 2007 X.laevis Oocytes 80 kDa 65 kDa 105 kDa 87 kDa 76kDa  
Malik et al., 2005 X.laevis Oocytes  86 kDa        
Bruns et al., 2007 X.laevis Oocytes 95 kDa 65 kDa   87 kDa 75 kDa 
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3.3.4 ENaC expression in different growth substances 
 
H441 cells were cultured in complete media prior to confluence. The media was then 
changed to a defined media for a further ~ 24 h. At this point, cells were treated with 
dexamethasone (0.2 µM) for 24h. H441 cells were cultured on two different substances: a 
6-well plate and a porous membrane (transwell). All treatments were added to the basal side 
of the transwell, and to the medium in the 6-well plate, before they were extracted and 
added to the SDS gel. Two bands that correspond to α-ENaC (~95 kDa and ~75 kDa) were 
consistently detected, a single band was seen for β-ENaC (~100 kDa) and the two isoforms 
of γ-ENaC (~90 kDa and ~75 kDa) were detected. This indicated that each antibody was 
able to probe successfully (Figure 3-4A).  
 
Figure 3-4A shows the results for the H441 cells cultured on both 6-well plates and porous 
membranes. Cells treated with dexamethasone showed increased expression of α- and β-
ENaC but not γ-ENaC. This was demonstrated by cells cultured both on the hard surface 
and the porous membrane. This observation is in contrast to that of Zucchi et al., (2002), 
who reported that cells that were cultured on a membrane created a dome-like formation 
that increased the abundance of β-ENaC. Although cells cultured on the membrane 
contribute to an increased GNa+ polarisation and transepithelial resistance (Inglis et al., 
2009), ENaC expression is similar for cells cultured on either a hard-surface or a 
membrane. However, since H441 dexamethasone-treated cells cultured on a hard surface 
can be hyperpolarised and display an amiloride sensitive current (Watt et al., 2012), I 
decided to continue to culture the cells on a hard-surface (6-well plate) in subsequent 
experiments. 
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Figure 3-4: The expression of ENaC (α-, β-, γ-) in the presence of dexamethasone (0.2µM) 
in H441 cells grown on different substances 
 
(A) Western blots showing the expression of the α-, β-, γ- subunits of ENaC in 
H441 cells raised on two different substances; a 6-well plate and a 6-well plate 
containing a porous membrane (Transwell, Corning Star). The cells were maintained 
until confluent for ~5 days in a medium supplemented with insulin. They were then 
changed to a fully defined medium with dexamethasone, Dex. (0.2 µM) for ~ 24 h 
prior to the collection of lysates. The experiment is representative of four 
independent samples. (B) Densitometry analyses of blots (mean ± SEM) as shown in 
(A). Treatment with dexamethasone (0.2 µM) for ~24 h showed a significant 
difference compared to control cells (glucocorticoids-deprived) (paired Student’s t-
test, ***p<0.001, n = 4). 
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3.3.5 Cell surface biotinylation – the access of actin 
The cell surface of H441 cells was labelled with biotin and then bound to streptavidin for 
Western analysis (for a detailed methodology see Chapter 2; 2.3.2). The surface protein that 
was extracted using this method was initially probed for actin; the absence of actin confirms 
a pure extraction from the surface pool proteins and shows if there has been any leakage 
from the intracellular space. To check for such a contamination, cells derived from the 
biotin-streptavidin bound cell surface were analysed using the RC-DC assay and then 
subjected to Western analysis. Eight independent experiments revealed that 48 ± 0.68 µg of 
protein could be recovered from an initial 500 µg of total lysates. An aliquot of 1µg of cell 
lysate served a positive control to compare the intensity of different protein amounts 
derived from the surface pool. Figure 3-5A shows the 30 minute over-exposure blot from 
the 1µg of intracellular protein from the H441 cells, along with 5 µg, 10 µg and 20 µg from 
the cell surface abundance. Figure 3-5B shows the fraction of total lysates and reveals a 
significant difference compared to the cell surface abundance of ENaC. The presence of β-
actin in the biotinylated protein fraction shows that this protein pool does contain some 
intracellular proteins. Hence, the densitometric analysis shows that the abundance of β-actin 
in a 20 μg aliquot of biotinylated protein was ~30% of the abundance measured in 1 μg of 
the total protein. The biotinylation-streptavidin binding protocol therefore allows surface-
exposed proteins to be isolated with 98 – 99% purity. 
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Figure 3-5: Actin purity in overexposure of 30 minutes 
 
(A) A typical Western blot showing the over-expression of actin in the total 
lysate (1µg) and cell surface extraction (5 µg, 10 µg, 20 µg, respectively) in 
30 minutes. (B) Densitometric analysis of the data from (A) showing the ratio 
of the difference in mean abundance on the cell surface compared to total 
lysates. Data are presented as the mean ± SEM (n = 8). Asterisks denote 
statistical significance when compared to the initial values (one-way 
ANOVA, Bonferroni post-hoc test; ***p<0.001). 
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3.3.6 The expression of ENaC subunits intracellularly and on the cell surface  
H441 cells were grown on a 6-well plate, treated with glucocorticoid-deprived media and 
placed in a media supplemented with dexamethasone (0.2 µM) for ~ 24 h. The cells were then 
labelled on ice with biotin-streptavidin and centrifuged (14,000 x g) to extract the cells from 
the surface abundance, then fractioned using Western analysis with samples that were not 
labelled with streptavidin (intracellular lysates). These proteins were then subsequently probed 
for α-, β-, and γ-ENaC.  
 
Figure 3-6A depicts the expression of each subunit of ENaC (α-, β-, and γ-) in two different 
pools of proteins. The absence of β-actin in the cell surface pool proteins confirms that these 
subunits are purely biotinylated and extracted from the surface abundance. As anticipated, α-
ENaC was present in two isoforms, ~ 95 kDa and ~ 75 kDa, in both pools of proteins. A single 
band of β-ENaC (~ 100 kDa) was expressed in both the total lysates and the surface 
abundance. Interestingly, γ-ENaC expression was observed as a single band (~75kDa) from the 
surface abundance as opposed to two isoforms (~90 kDa, ~75kDa) as shown by the 
intracellular pool of proteins. As a housekeeping control, these blots were stripped with acid-
stripped buffer (pH 2.2) and reprobed for actin in order to confirm its presence in the 
intracellular protein pool and its absence from the surface abundance pool proteins.  
 
The bar graphs in Figure 3-6B represent the effects of dexamethasone compared to the control 
cells. As seen previously, dexamethasone enhances the expression of both isoforms of α-ENaC 
in the total lysates. The effect is similar for the surface protein. However, it only increases the 
abundance of β-ENaC in the total lysates, not on the cell surface. Interestingly, dexamethasone 
does not affect the abundance of γ-ENaC isoforms in the intracellular of pool proteins, but 
significantly promotes the expression of the smaller form of the subunit on the endogenous cell 
surface.  
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Figure 3-6: The trafficking of ENaC subunits (α-, β-, γ-) from the total lysates towards 
the cell surface of H441 cells. 
 
(A) Western blots showing the expression of the α-, β-, and γ- subunits of 
ENaC derived from a different location, total lysates and protein derived from 
cell surface biotinylation. Actin expression was also quantified in order to 
ensure that the isolation of cell surface protein extraction was successful. 
Each blot represents 4 independent experiments. (B) Densitometry analyses 
comparing the effect of dexamethasone, Dex. (0.2 μM) upon the abundance of 
ENaC subunits in both the total lysates and the cell surface (n = 4, Student’s t-
test *p<0.05, **p<0.01, ***p<0.001). 
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3.4 Discussion 
3.4.1 Dexamethasone increases SGK1 activity 
Until recently, direct assays of SGK1 protein activity have not been successful due to the 
difficulty in detecting SGK1 protein expression. However, by assaying for NDRG1 –
Thr346/356/366 and using it to track SGK1 activity previous studies in this lab have managed to 
indirectly assess the abundance of the phosphorylated form of the SGK1 target protein in 
the mouse collecting duct of kidney cells (Mansley & Wilson, 2010a) and the human distal 
airway cells, H441 (Inglis et al., 2009; Watt et al.,, 2012). NDRG1–Thr346/356/366 was 
initially discovered as a stress stimuli-induced gene by Kokame et al., (1996) and was 
further identified by Murray et al., (2004). The 43 kDa protein is rapidly phosphorylated by 
SGK1 but poorly regulated by any other protein kinases. The antibody used in this thesis 
recognised 3 phospho-threonine residues (Thr346/356/366) that are specific to NDRG1 but not 
the other two sites; Thr328 and Ser330 which are conserved in NDRG family members. 
Phosphorylation of the three afore mentioned residues showed a direct increase in SGK1 
activity. 
 
Until recently, there has been no other protein indicator that was suitable for reflecting 
cellular SGK1 activity as simply as NDRG1. SGK1 activity can be monitored through the 
phosphorylation of NDRG1-Thr346/356/366 which has been shown to affect SGK1 activation, 
but not other related kinases (Murray et al., 2005; Inglis et al., 2009; Mansley & Wilson, 
2010 a,b; Watt et al., 2012). Dexamethasone has been shown to acutely evoke NDRG1 
phosphorylation, which corresponds to an increase in SGK1 mRNA in the Na+ absorbing 
epithelia (Wang et al., 2001; Itani et al., 2002b; Thomas et al., 2004). The maximal 
response to dexamethasone at 3-6 h indicates that hormonal stimulation promotes ENaC 
function, whereas prolonged exposure results in a return to the basal expression. It is only 
after this period that the amiloride sensitivity that is associated with ENaC activity develops 
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(Watt et al., 2012). However, the data presented here reveal a reduction in expression after 
3-6 h, though minor traces of phosphorylated protein can still be found. Considering these 
results, I propose that SGK1 transiently increases ENaC expression at the cell surface when 
it is active. Over time, when SGK1 activity is low, expression of α-ENaC in both pool 
proteins occurs, suggesting that SGK1 is not involved upon α-ENaC trafficking to the 
membrane. This must be assisted by an unknown mechanism, perhaps by an independent 
activation of α-subunit of the SGK1. The afore mentioned hypothesis supports a study by 
Zhang et al., (2007) which showed that deletion of the sgk1 gene resulted in only modest 
inhibition of the α-ENaC mRNA in the kidneys of mice fed on a low Na+ diet, and showed 
no overt pulmonary phenotype (Wulff et al., 2002). 
 
3.4.2 ENaC expression on different substrates 
A number of studies have suggested that H441 cells that are cultured on a porous membrane 
are better for investigating ENaC expression, as the confluent H441 monolayer cells 
effectively mimic the thin film of the alveolar distal epithelial lung cells (Sayegh et al., 
1999; Lazrak & Matalon, 2003; Thomas et al., 2004; Ramminger et al., 2004; Shlyonsky et 
al., 2005; Inglis et al., 2009). Dexamethasone has been shown to evoke apical Na+ 
conductance and transepithelial resistance under these conditions, which corresponds well 
with the increased abundance of ENaC subunit mRNA (Itani et al., 2002b). In theory, the 
increased levels of ENaC mRNA lead to higher expression of ENaC protein. However, this 
study has shown that the level of ENaC expression in H441 cells cultured on a permeable 
membrane is not significantly different to that of cells grown on a hard surface. This 
indicates that the substrate does affect the endogenous expression of ENaC. Although cells 
cultured on permeable membrane have previously been shown to form dome-structures 
(Zucchi et al., 2001; Shlyonsky et al., 2005) through the increase β-ENaC expression on the 
cell surface; this was not observed here.  
 
 
89 
Previous studies have shown that H441 cells that are cultured on a porous membrane are 
more likely to induce  highly selective Na+ absorption (Ramminger et al., 2004; Inglis et al., 
2009) and demonstrate a non-selective Na+ conductance (Albert et al., 2008). Similarly, 
single H441 cells cultured on a coverslip and then subjected to the patching method (Brown 
et al., 2008) did not display an amiloride-sensitive Na+ conductance in the presence of 
dexamethasone. However, when a small group of 3-5 cells were cultured (prompted by a 
suggestion made by Zucchi et al., (1999)) and the β-ENaC-related gene 133 was activated, 
the cells touched in order to generate an amiloride sensitive Na+ absorption (Shlyonsky et 
al., 2005; Brown et al., 2008). Therefore, cell-cell communication is crucial for the 
amiloride sensitive phenotype by expressing tight junctions and other markers for β-ENaC. 
If this is true, then H441 cells that are cultured on a hard-surface may show a similar result, 
as they contribute to amiloride sensitive Na+ conductance through a patch clamp 
experiments (Clunes et al., 2004; Brown et al., 2008; Watt et al., 2012). Although the data 
in this chapter revealed that ENaC expression was similar under both conditions, I elected 
to grow the cells on a hard surface to make sure that cells were grown under similar 
conditions as those used in parallel patching studies. 
 
3.4.3 ENaC trafficking towards the cell surface 
ENaC is a complex protein that is expressed on the surface of epithelial cells. Theoretically, 
the protein requires the co-expression of three homologous proteins to form a functional 
multimeric channel. The expression of ENaC is thought to be elevated prior to the maximal 
Na+ activity which appears to be initiated in the early phase of protein biosynthesis. ENaC 
trafficking involves protein maturation in the Golgi complex, with glycan processing at the 
N-terminus as it proceeds towards the cell surface (Rotin et al., 2001; Ergonul et al., 2006). 
Prior to activation, each subunit needs to be processed (through glycosylation or cleavage) 
before interacting to form a complex. The N-terminus of each subunit is responsible for this 
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process (Bruns et al., 2003). Only α-ENaC (Ahn et al., 1999) and γ-ENaC (Adam et al., 
1997) are thought to be involved in channel assembly, though  Chalfant and colleagues have 
suggested that all N-termini of ENaC subunits contain an endocytic motif that allows each 
subunit to contribute to the construction of this channel, and therefore functionality at the 
cell surface (Chalfant et al., 1999). Other studies have found that ENaC can bypass this 
process altogether (Hughey et al., 2004b; Yu et al., 2008). This is called the ‗immature 
protein‘ (or full length) and it has been observed in this project. The antibodies for α- and γ-
ENaC have been raised against the N-termini and the molecular weights have been noted 
prior to activation; as reviewed by Rossier and Stutts (2009). 
 
Each individual subunit is expressed constitutively and was individually probed from two 
pools of proteins; the total lysates and the abundance of cell surface ENaC. There were 
similar expression levels for both α- and β-ENaC in both protein pools, however, the γ-
ENaC from the surface pool appeared as a single band unlike its counterpart from the total 
lysate protein. In certain cases, the γ-ENaC from the surface protein was also seen to 
migrate more slowly than the predicted 75 kDa mass. This discrepancy indicates that the 
unglycosylated γ-ENaC may be involved in post-translation prior to trafficking towards the 
cell surface and is therefore restricted to the intracellular compartment.  
 
Once ENaC has been delivered to the cell surface, each subunit can be cleaved, and thus 
activated, by serine proteases near the plasma membrane (Rossier & Stutts, 2009). This 
activation seems to be preserved in cells that express αγ-ENaC, but not αβ-ENaC. 
Therefore, the α-and γ-subunits of ENaC appear to be essential for channel activation by the 
extracellular proteases. This concurs with Hughey et al., (2003), who suggested that both α- 
and γ-ENaC are cleaved prior to activation at the plasma membrane in kidney cells. They 
observed cleavage of α-ENaC twice and γ-ENaC only once in the presence of extracellular 
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furin protease. However, the data in this thesis suggests that α-ENaC and γ-ENaC were only 
cleaved into two isoforms in the total pool of proteins, and then trafficked towards the cell 
surface. Other products of the cleavage may not have been noticed, as the amounts of 
protein were too small to be detected through Western analysis. The two isoforms of α-
ENaC remain at the cell surface for a longer period than the full length γ-ENaC, which 
disappeared due to degradation (Staub et al., 1997a) and was confined to the intracellular 
compartment (Rossier & Stutts, 2009). Irrespective of this, β-ENaC remained uncleaved as 
reported by most other studies (refer to Table 3-1). This may be due to a lack of 
glycosylation sites (Harris et al., 2007), and it may also act as a pre-dominant signal for 
channel removal (Kabra et al., 2008).  
 
3.4.4 Dexamethasone induced changes in ENaC expression 
Dexamethasone-treated H441 cells increase ENaC protein expression. In the total lysates, 
this hormone induced the expression of α- and β-ENaC, which in turn was a consequence of 
increased levels of encoded mRNA (Ramminger et al., 2004; Thomas et al., 2004). Whilst 
all subunits were present in both pools of proteins, the synthetic GCs hormone only affected 
the abundance of α-ENaC. The GC effect is thought to be dependent on GC-response 
elements (GRE) in the α-ENaC gene (Itani et al., 2002b; Thomas & Itani, 2004; McTavish 
et al., 2009). Since activation of α-ENaC continues even after 24 h, this provides a 
mechanism by which amiloride-sensitive ENaC activity can be stimulated, indicating that 
the amiloride binding domain is within the α-subunit (Ismailov et al., 1997; Kieber-
Emmons et al., 1999; Kashlan et al., 2005). This finding is in contrast to previous studies 
which suggested that the whole magnitude of the Na+ current is driven by increasing each 
subunit at the cell surface (Blazer-Yost et al., 1998; Record et al., 1998; Alvarez de la Rosa 
et al., 1999; Paunescu et al., 2000; Debonneville et al., 2001; Alvarez De La Rosa & 
Canessa, 2003; Blazer-Yost et al., 2003). However, though both types of pool proteins can 
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be dependent on α-ENaC alone, the highly functional channels may require a combination 
of β-ENaC and γ-ENaC (Jain et al., 1999; Lazrak et al., 2000; Jain et al., 2001) for maximal 
activity.  
 
In addition to the wide range of studies mentioned above, a collaboration carried out with 
Watt et al., (2012) suggested that the amiloride sensitive Na+ current is affected by the 
whole expression of α-ENaC in both pools of proteins as well as the role of γ-ENaC in the 
surface pool of proteins. This corresponds well with the Na+ activity increment in 
dexamethasone-treated H441 cells (Lazrak & Matalon, 2003; Clunes et al., 2004; 
Ramminger et al., 2004; Thomas et al., 2004; Shlyonsky et al., 2005; Brown et al., 2008; 
Inglis et al., 2009). Since ENaC protein expression coincides with SGK1 activation, it 
suggests that the activity of SGK1 and ENaC may be correlated, especially in surface pool 
proteins. Therefore, in the next chapter I explore the role of SGK1 through the activation of 
PI3K and therefore the potential activation of ENaC protein expression in GC-treated H441 
cells. 
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4 
Role of P13-kinase and SGK1 
 in glucocorticoid-induced ENaC expression 
 
4.1 Introduction 
 
The results presented in the previous chapter show a role for dexamethasone, which appears 
to regulate the endogenous α-ENaC in both the total lysates and at the cell surface of H441 
human airway cells. This data corroborates studies that reported that α-ENaC can both 
constitutively increase the natriferic response in the epithelial cells (Lin et al., 1999; 
Otulakowski et al., 1999; Sayegh et al., 1999; Mick et al., 2001; Diakov & Korbmacher, 
2004) and be mediated by the SGK1 pathway upon the induction and maintenance of the 
Na+ absorbing phenotype of the lung epithelium. Therefore, the absence of SGK1 would 
result in a failure to clear lung fluid at birth. However, the role of SGK1 is unclear, as there 
is no discernible lung phenotype in sgk1 gene knockout mice: both histology and function 
are unaffected (Wulff et al., 2002). This finding by Wulff and colleagues prompted us to 
investigate the role of the SGK1 pathway in ENaC expression on the cell surface of H441 
cells. There is some evidence to indicate that PI3K may work independently of SGK1 to 
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induce Na+ transport, as PKB isoforms that are down regulated by PI3K can mediate the 
effect of insulin on ENaC in rat thyroid cells (Lee et al., 2007). This study further suggested 
that both SGK1 and PKB activity were required to maintain Na+ basal transport, as siRNA 
directed against PKB and SGK1 has been shown to reduce amiloride sensitive Na+ 
transport. This was even more successful in silencing both kinases when they were 
transfected together (Lee et al., 2007). 
 
There is some evidence to suggest that other kinases play a role in regulating ENaC. PI3K 
may affect ENaC through its second messengers PIP2 and PIP3, which have been shown to 
be involved in ENaC trafficking (Blazer-Yost et al., 2004) and thus affect the channel 
gating kinetics (Pochynyuk et al., 2007). Whilst the mechanism occurs transiently, a 
chronic effect has not been observed, leading to the conclusion that PIP2 is required for 
constitutive ENaC activity that can be altered via other modulators (Pochynyuk et al., 
2007). Thus, PI3K activity could regulate ENaC independently of SGK1. However, as the 
cells were maintained in media containing corticosteroids, this possibility of PI3K acting 
alone remains experimentally unverified. 
 
There are studies that have further explored the role of PI3K in Na+ transport in H441 cells 
(Brown et al., 2008, Gallagher, 2009; Inglis et al., 2009). A constitutively active PI3K 
subunit (CD2-p110α) was transfected into the H441 cells in both GC-deprived and GC 
induced media. The transfection induced Na+ transport in the presence of dexamethasone 
but not in the GC-deprived cells. This suggests that PI3K activity alone is not sufficient to 
induce Na+ transport in single H441 cells (Brown et al., 2008; Gallagher, 2009) but that it 
must be linked to SGK1 activity somehow. Nevertheless, PI3K is thought to be important 
because LY294002, a PI3K inhibitor, completely abolishes Na+ transport in H441 cells 
(Gallagher, 2009; Inglis et al., 2009). Recently, a more potent and specific PI3K inhibitor, 
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PI-103 (Bain et al., 2007) caused a complete inactivation of PI3K but not SGK1 when 
monitored using NDRG1 phosphorylation (McTavish et al., 2009), suggesting that SGK1 
activity may not be fully dependent on PI3K.  
 
All of the evidence above was taken into consideration when studying ENaC expression in 
the H441 cells. PI3K is thought to activate SGK1 through a signalling pathway involving 
TORC2 (Garcia-Martinez & Alessi, 2008; Lu et al., 2010). TORC2 is responsible for the 
hydrophobic motif phosphorylation of PKB-Ser473 (Sarbassov et al., 2005) therefore it can 
be used as an indicator for both PI3K activity and TORC2 (Thoreen et al., 2009; Lu et al., 
2010; Mansley & Wilson, 2010a; Kuehn et al., 2011). The phosphorylation of PKB-Ser473 
is thought to enhance PDK1‘s dependence on the phosphorylation of PKB-Thr308 (Yang et 
al., 2002; Sarbassov et al., 2005), possibly by providing a docking site for PDK1. As PDK1 
is dependent on PI3K activity, PKB-Thr308 phosphorylation can therefore be used to 
determine PDK1/PI3K activity. By blotting both PKB-Ser473 and PKB-Thr308, PI3K activity 
can be monitored to allow a distinct inhibition between TORC2 and PDK1. However, care 
must be taken when interpreting the results, as PKB-Ser473 phosphorylation affects PDK1 
dependent phosphorylation of PKB-Thr308 (Sarbassov et al., 2005; Lu et al., 2010). 
Therefore, in order to tackle this problem, the experiment was designed to monitor the 
effect of PI-103 on PI3K activity in both GC-induced and GC deprived cells, prior to 
determining whether PI-103 truly affects PI3K. 
 
As described in the previous chapter, dexamethasone successfully evokes SGK1 activity 
through NDRG1-Thr346/356/366. Recent evidence has suggested that TORC2 phosphorylates 
the hydrophobic motif of SGK1 (Lu et al., 2010) through a docking site of PDK1, thereby 
promoting interaction between SGK1 and PDK1, which would cause phosphorylation of the 
activation loop of SGK1 at Thr256 to confer its activity (Biondi et al., 2001). By introducing 
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a novel molecule, TORIN1, as a TORC2 inhibitor (Thoreen et al., 2009), we can investigate 
the mechanism by which TORC2 stimulates SGK1 activity. As the inhibition is specific, it 
may provide an effective way to inactivate these kinases without causing inhibition of other 
closely related kinases involved in the proposed signalling pathway (Sherk et al., 2008). In 
order to test the effects of TORIN1 on P13K activity, PKB-Thr308 phosphorylation was 
monitored. However, the problem with this approach is that TORC2 is responsible for PKB-
Ser473 phosphorylation which in turn facilitates the phosphorylation of the Thr308 site 
(Andjelkovic et al., 1997). This issue has been addressed by Thoreen and colleagues, who 
developed the inhibitor at a low concentration so that it only inhibits TORC2 at 0.1 µM 
(Thoreen et al., 2009). Therefore, in this study I also used this concentration to inhibit 
TORC2 but not PDK1. In order to determine if this compound was specific to TORC2, I 
wanted to observe the expression of PRAS40 (proline-rich Akt/PKB substrate of 40 kDa) at 
Ser246, a protein indicator that marks the activity of the PKB protein but no other protein 
kinases (Wullschleger et al., 2006; Guertin & Sabatini, 2007). In addition, TORC2 activity 
can be observed by introducing rapamycin, an inhibitor that specifically hinders TORC1 
activity but not TORC2. The data from Watt (2011) reported that rapamycin did not affect 
PI3K, SGK1 or ENaC activity, thus any effects of TORIN1 arise as a result of TORC2 
inhibition. The effect of rapamycin is demonstrated by the de-phosphorylation of the 
ribosomal S6 kinase (S70-S6K) at Thr389, a kinase that specifically confers TORC1 activity 
(Proud, 2007). 
 
The lack of a specific inhibitor of SGK1 can be addressed by introducing a small molecule 
inhibitor, GSK650394. This was specifically developed by Sherk and colleagues (2008), 
who demonstrated that this inhibitor was able to block the enzyme activity of both SGK1 
and SGK2 in scintillation proximity assays. This corresponded with the inhibition of an 
aldosterone induced amiloride-sensitive current in mouse cortical collecting duct cells (M1 
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cell line). By using an in vitro kinase assay, they were able to determine that GSK650394 
was selective for SGK1 over PKB, PDK1 and other related kinases (Sherk et al., 2008). 
Therefore, this novel compound can hinder SGK1 activity without affecting PI3K, PKB and 
PDK1. This confers the purpose of this study by inhibiting SGK1-related pathway (Sherk et 
al., (2008); Lang et al., (2009); Lang & Gorlach, (2010); and Mansley & Wilson, (2010a)) 
to further look its role in ENaC trafficking to the cell surface.  
 
 
 
 
 
Figure 4-1: Diagram of the proposed signalling pathway for ENaC regulation. 
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All of the information that relates to the PI3K/SGK1 pathway is summarised in Figure 4-1. 
This figure includes the pharmacological compounds PI-103, TORIN1, GSK650394 and 
also rapamycin which were used to investigate the role of the PI3K/SGK1 pathway in 
ENaC expression in both GC-deprived and GC-treated H441 cells. The objectives of this 
study are listed below: 
 
1) To determine the effect of dexamethasone on P13K and SGK1 activity. 
2) To observe the relationship between PI3K, TORC2 and SGK1 activity. 
3) To test the hypothesis that P13K/SGK1 activity is vital for the hormonal control of 
ENaC expression via GC. 
 
4.2 Experimental design  
Cells were cultured on 6-well plates and processed as described in Chapter 3 to determine 
two different pools of proteins; the endogenous total extract and surface-labelled proteins. 
PI-103, TORIN1, GSK650394 and rapamycin were used as described in Chapter 2.  All 
pharmacological inhibitors were used for approximately 3 h.  
 
In this chapter, the effects of these inhibitors were observed prior to ENaC expression by 
dexamethasone. All inhibitors (except rapamycin) have been shown to physiologically 
abolish ENaC activity in dexamethasone-induced cells (Watt, 2011). Therefore a strictly 
controlled experiment was required to further examine the phosphorylation of the 
endogenous protein kinases down-stream of the PI3K/SGK1 pathway.  
 
To complement this study, the period of dexamethasone incubation was reduced to 3 h. This 
will be used as a control for the longer period of incubation (24 h).The expression of each 
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subunit and how they differ in the presence of compounds that specifically inhibit the PI3-
Kinase (PI-103) and SGK1 (GSK650394) pathway will be monitored. This is conducted by 
assessing the maximal activity of the SGK1 protein indicator, P-NDRG1-Thr346/356/366  as 
seen in Chapter 3. Hopefully, this will provide an insight into the response of both 
dexamethasone and the elected inhibitors. The summary of the experimental design is 
depicted in Figure 4-2. 
 
 
Figure 4-2: The experimental design used to determine the role of the PI3K/SGK1 
pathway in ENaC expression. 
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4.3 Results 
4.3.1 Effects of the P13-kinase inhibitor (PI-103) on protein kinases in cells treated 
with dexamethasone for 24 h 
 
Figure 4-3A proposes that PI-103 selectively inhibits the PI3-kinase and SGK1 pathway 
(Raynaud et al., 2007; Wang et al., 2008; Garcia-Martinez & Alessi, 2008; McTavish et al., 
2009; Mansley & Wilson, 2010a). This substance has been shown to inhibit PI3-kinase and 
thus deactivate the protein kinases downstream of this pathway that connect to SGK1. 
ENaC expression is thought to be dependent on this collaborative pathway so induction of 
this pharmacological component should decrease/abolish the surface expression of ENaC. 
 
Figure 4-3B shows the results of the strictly paired protocol used to study the selective 
effect of PI-103 when under prolonged incubation with dexamethasone (24 h). Based on the 
mechanism proposed in Figure 4-1, dexamethasone activates the phosphorylation of PKB-
Thr308 and PKB-Ser473 indicating the activation of PDK1 and TORC2, respectively, as 
found previously in our lab (Mansley & Wilson, 2010b; Watt, 2011). This compound also 
influences the expression of SGK1, shown by the activation of the Thr346/356/366 
phosphorylated form of NDRG1. Therefore, these results indicate that dexamethasone 
affects the PI3K/SGK1 pathway by elevating the expression of the protein kinases that 
underlie this mechanism. 
 
As this activation by dexamethasone occurs, the presence of PI-103 inhibits TORC2 by 
abolishing the phosphorylation of PKB-Ser473 (Mansley & Wilson, 2010a; Watt, 2011). 
This also greatly diminishes the expression of PDK1 and SGK1 through the de-
phosphorylation of PKB-Thr308 and NDRG1-Thr346/356/366, respectively. Prior to this, PI-103 
had no effect on the total protein. 
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4.3.2 Effects of the P13-kinase inhibitor (PI-103) on ENaC expression in cells treated 
with dexamethasone for 24 h 
 
To investigate the correlation between SGK1 pathway activation and ENaC expression at 
the cell surface, cells were biotinylated and extracted after prolonged exposure to 
dexamethasone (24 h). As shown in the previous chapter, the two isoforms of α-ENaC 
showed an increase in expression in both the total lysates and biotinylated surface proteins. 
Dexamethasone also increased the expression of β-ENaC in the lysates but not at the cell 
surface, though a single form of γ-ENaC had a significant effect on the surface-labelled 
protein. Therefore, from this we can deduce that exposing the cells to dexamethasone for a 
longer period elevates the expression of α-ENaC and γ-ENaC at the cell surface but not β-
ENaC. Whilst the specific P13-kinase inhibitor has been shown to inhibit the endogenous 
protein kinases involved in the PI3K/SGK1 pathway (Bayascas & Alessi, 2005; Mansley & 
Wilson, 2010a; Watt, 2011), it only has a minor effect on ENaC expression in 
dexamethasone treated cells (Figure 4-4B). As shown previously, two isoforms of α-ENaC 
are expressed in the presence of dexamethasone, and PI-103 only reduces the full length 
version (~95 kDa). The expression level was similar for the two different pools: the total 
lysates and the biotinylated surface protein (Figure 4-4B). Treatment with dexamethasone 
resulted in an elevation in β-ENaC expression in the total lysates but not at the cell surface, 
but PI-103 had no effect on the surface abundance or the total lysates (Figure 4-4B). PI-103 
also had no effect on the two isoforms of γ-ENaC in the total lysates but did have a residual 
effect (yet statistically significant) on the single isoform in the surface-labelled pool of 
protein (Figure 4-4B). 
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Figure 4-3: Effects of PI-103 on the phosphorylation of PKB-Thr
308
, PKB-Ser
473
and 
NDRG1-Thr
346/356/366
 in dexamethasone treated cells. 
 
(A) A diagram showing the proposed effects of PI-103. (B) Western blots showing the 
effects of PI-103 (1 µM) on cells induced with dexamethasone (0.2 µM,  24 h) on the 
overall abundance of protein and the phosphorylation of PKB-Thr
308
, PKB-Ser
473
 and 
NDRG1-Thr
346/356/366
, respectively. (C) Bar graphs representing the ratio of the 
densitometry values of PI-103 over control samples for each of the phosphorylated and 
total protein kinases. Each experiment was repeated and presented as the mean ± SEM 
(n = 4). Asterisks denote statistical significance when compared to the control values 
***p<0.001 (Student’s t-test). 
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Figure 4-4: Effects of the PI3K inhibitor, PI-103, on ENaC subunits in the presence of 
dexamethasone (24 h). 
 
(A) Typical Western blots showing the effects of PI-103 (1 µM) on the expression of 
α-, β-, and γ-ENaC in the presence of dexamethasone (0.2 µM). The cells were 
maintained in a hormone deprived medium from day 2 until confluent. 
Dexamethasone was used to induce the cells for 24 h and they were treated with PI-
103 for the final 3 h in the presence of DMSO. Actin is shown as a loading control. 
(B) Densitometric analysis of the data from (A), showing the effects of 
dexamethasone on the cellular abundance of α-ENaC subunits for ~95 kDa (the upper 
band) and ~75 kDa (the lower band), the single band (~100 kDa) of β-ENaC, the two 
isoforms (~90 kDa, ~75 kDa) of γ-ENaC as well as the single isoform from the 
surface protein. Data are normalised to the control sample and presented as the mean 
± SEM (n = 4). The asterisk denotes statistical significance when compared to control 
cells *p<0.05 (Student’s t-test). 
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4.3.3 Effects of the TORC2 inhibitor (TORIN1) on protein kinases in cells treated with 
dexamethasone for 24 h. 
 
A similar experimental design to the one described previously was applied to the cells 
treated with dexamethasone (~24 h). TORIN1 (0.1 µM) was added for the final 3 h of the 
incubation period. This compound is highly potent and selectively inhibits TORC 
complexes to a far greater extent than rapamycin (Thoreen et al., 2009). PI3-kinase has 
been shown to have control over the phosphorylation of SGK1 (Kobayashi & Cohen, 1999; 
Park et al., 1999), and this seems to be mediated by TORC2 (Guertini & Sabatini, 2007; 
Thoreen et al., 2009) to further down-regulate the SGK1 pathway.  
 
Figure 4-5A depicts the proposed effect of TORIN1 on the pathway. Since this compound 
has been shown to abolish TORC2 through the protein indicator PKB-Ser473 only at a lower 
concentration (0.1 µM) (Thoreen et al., 2009; Mansley & Wilson, 2010b; Watt, 2011), it 
may lead to the de-phosphorylation of NDRG1-Thr346/356/366 down-stream of the SGK1 
pathway, thus decreasing ENaC expression at the cell surface.  
 
As seen in Figure 4-5B, TORIN1 abolishes the phosphorylation of PKB-Ser473 marking 
TORC2‘s inhibition, and this effect significantly reduces the phosphorylation of the SGK1 
protein indicator; NDRG1-Thr346/356/366. However, the de-activation does not affect the 
endogenous total protein. Whilst the lower concentration of TORIN1 successfully inhibited 
the protein indicator of TORC2, it also inhibited the protein indicator for PDK1, a kinase 
that is activated in a pathway downstream of PI3-kinase. The expression of phosphorylated- 
PKB-Thr308 opposes the present findings from our lab as they have found that TORIN1 has 
significantly reduced the phosphorylation of this protein kinase (Mansley & Wilson, 2010b; 
Watt, 2011) and Thoreen et al., (2009). This discrepancy suggests that the selectivity of 
TORIN1 is broad and that it is somewhat similar to the effects of PI-103. Subsequently, this 
 
 
105 
drug cannot be used to silence the activation of TORC2-SGK1 and needs to be excluded 
from further study. 
 
4.3.4 Effects of the TORC2 inhibitor (TORIN1) on ENaC expression in cells treated 
with dexamethasone for 24 h. 
 
Despite the issues mentioned above, we investigated the effects of TORIN1 on the ENaC 
subunit, as it was crucial to determine whether TORIN1 had an effect on ENaC similar to 
that of PI-103. The expression of two isoforms of α-ENaC and a single band of β-ENaC 
were noted in both the total lysates and the cell surface. Two isoforms of γ-ENaC were 
expressed in the total cellular extract but only a single band was found from the pool 
proteins of the cell surface (Figure 4-6A). As seen in Figure 4-6, TORIN1 reduces the full 
length isoform of α-ENaC (~95 kDa) in both sets of pool proteins from the H441 cells. It 
has no effect on β-ENaC (~100 kDa) but results in a smaller band for γ-ENaC (~75 kDa) 
from the surface pool proteins (Figure 4-6B). This data is similar to that showing the effects 
of PI-103, therefore this compound is not suitable for any future experiments in this study. 
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Figure 4-5: Effects of TORIN1 on the phosphorylation of PKB-Thr
308
, PKB-Ser
473
and 
NDRG1-Thr
346/356/366 
in dexamethasone-treated cells. 
 
(A) The proposed effects of TORIN1. (B) Western blots showing the effects of 
TORIN1 (0.1 µM) on cells induced with dexamethasone (0.2 µM, 24 h) on the overall 
abundance of protein, and phosphorylation of PKB-Thr
308
, PKB-Ser
473
 and NDRG1-
Thr
346/356/366
, respectively. (C) Bar graphs showing the ratio of densitometry values of 
TORIN1 over control samples. Each experiment was repeated four times and presented 
as the mean ± SEM (n = 4). Asterisks denote statistical significance when compared to 
the initial values, ***p<0.001 (Student’s t-test). 
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Figure 4-6: Effects of TORIN1 on the expression of ENaC subunits in the presence of 
dexamethasone (24 h). 
 
(A) Typical Western blots showing the effects of TORIN1 (0.1 µM) on the 
expression of α-, β-, and γ-ENaC in the presence of dexamethasone (0.2 µM). The 
cells were maintained in a hormone deprived medium from day 2 until confluent. The 
cells were incubated with dexamethasone for 24 h, and further treated with TORIN1 
for 3 h in the presence of DMSO. Actin is shown as a loading control. (B) 
Densitometric analysis of data showing the effects of dexamethasone on the cellular 
abundance of ENaC subunits. Data are normalised to the control and presented as the 
mean ± SEM (n = 4). Asterisks denote statistical significance when compared to the 
initial values ***p< 0.001 (Student’s t-test). 
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4.3.5 Effects of the SGK1 inhibitor (GSK650394) on protein kinases in cells treated 
with dexamethasone for 24 h 
 
The pharmacological substance GSK650394 is a recently developed drug that has been 
shown to successfully abolish SGK1 activity (Sherk et al., 2008; Lang et al., 2009; Lang & 
Gorlach, 2010; Mansley & Wilson, 2010a; Watt, 2011). Figure 4-7A shows the proposed 
effects of this compound, which is thought to act by inhibiting the phosphorylation of 
NDRG1-Thr346/356/366 in the SGK1 pathway, thereby indicating the de-activation of SGK1. 
As a consequence of this, ENaC expression would decrease and be absent from the cell 
surface. 
 
Figure 4-7B shows the effects of GSK650394 (10 µM) and reveals no effect on PKB-
Thr308, indicating that PDK1 is still active when the SGK1 is not active. Additionally, there 
was no change in the phosphorylation of PRAS40-Ser246, which is an indicator for the 
activation of PKB (Fonseca et al., 2007; Miller et al., 2008; Mansley & Wilson, 2010a; 
Nascimento et al., 2010; Watt, 2011). Therefore, this compound specifically inhibits the 
phosphorylation of NDRG1-Thr346/356/366; a protein that indicates SGK1 activity, as shown 
previously by our lab (Mansley & Wilson, 2010a; Watt et al. 2012). Although this 
inhibition is specific, it also appears to de-phosphorylate the Ser473 residue of PKB. This is 
unexpected, however such effect has also been found previously in a mouse kidney cell line 
(Mansley & Wilson, 2010a). Apart from this, no change in the total protein was observed, 
confirming that this compound reliably and specifically reduces/abolishes the 
phosphorylation of PKB. 
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4.3.6 Effects of the SGK1 inhibitor (GSK650394) on ENaC expression in cells treated 
with dexamethasone for 24 h. 
 
To further investigate the effects of GSK650394, we examined ENaC expression in H441 
cells, Figure 4-8 illustrates the expression of the ENaC subunits in the presence of this 
inhibitor. Dexamethasone is known to increase levels of α-ENaC and γ-ENaC, but not the 
β- subunit, at the cell surface. As seen previously with both PI-103 and TORIN1, 
GSK650394 reduces the full length of α-ENaC (~95 kDa) in both pools of proteins, whilst 
showing a slight decrease in the single isoform of γ-ENaC (~75 kDa). However, such 
effects were not detectable for β-ENaC, in either the total lysate or the surface pool of 
proteins. Whilst GSK650394 is known to reduce ENaC activity in dexamethasone-induced 
H441 cells (Watt, 2011), the data shown here only reveals a minor effect on overall ENaC 
expression. Therefore, we cannot explain the relationship between ENaC expression and its 
activity through amiloride sensitive Na+ current.  
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Figure 4-7: Effects of GSK650394 on the phosphorylation of PKB-Thr308, PKB-Ser473, 
NDRG1-Thr346/356/366 and PRAS40-Ser246 in dexamethasone-treated cells. 
 
(A) The proposed effects of GSK650394. (B) Western blots showing the effects of 
GSK650394 (0.1 µM) in dexamethasone-treated cells (0.2 µM, 24 h) on the overall 
abundance of protein and the phosphorylation of PKB-Thr
308
, PKB-Ser
473
, NDRG1-
Thr
346/356/366
 and PRAS40-Ser
246
, respectively. The cells were induced with 
dexamethasone and incubated for 24 h, and treated with GSK650394 in the final 3 h. 
(C) The densitometry values for GSK650394 were calculated as the ratio over the 
control sample. The results are shown as bar graphs for both the phosphorylated and 
the total protein kinases. Each experiment was repeated four times and presented as 
the mean ± SEM (n = 4). Asterisks denote statistical significance when compared to 
control samples; *p<0.05, ***p<0.001 (Student’s t-test). 
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Figure 4-8: Effects of the SGK1 inhibitor, GSK650394, on the expression of ENaC 
subunits in the presence of dexamethasone (24 h). 
 
(A) Typical Western blots showing the effects of GSK650394 (10 µM) on the 
expression of α-, β-, and γ-ENaC in the presence of dexamethasone (0.2 µM). The 
cells were maintained in a hormone deprived medium from day 2 until confluent. 
The cells were induced with dexamethasone and incubated for 24 h and treated 
with GSK650394 for another 3 h. Actin is shown as a loading control. (B) 
Densitometric analysis of the data in (A) showing the effects of dexamethasone on 
the cellular abundance of ENaC subunits. Data are normalised to the control and 
presented as the mean ± SEM (n = 4). Asterisks denote statistical significance 
when compared to the initial values; *p< 0.05, ***p<0.001 (Student’s t-test). 
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4.3.7 Effects of the TORC1 inhibitor (rapamycin) on protein kinases in cells treated 
with dexamethasone for 24 h 
 
Rapamycin does not alter the phosphorylation of PKB-Thr308, PKB-Ser473 or NDRG1-
Thr346/356/366 in GC-stimulated cells (Figure 4-9). Since rapamycin is a selective inhibitor for 
TORC1 (Bain et al., 2007; Proud, 2007; Mansley & Wilson, 2010b), it essentially abolishes 
the expression of P70-S6K-Thr389 with no effect on the overall expression. This 
demonstrates an exquisite selective control for the inhibition of TORC1, but not the protein 
kinases related to the SGK1 pathway. Using rapamycin in this experiment reveals the 
importance of the PI3K/SGK1 pathway in the control of ENaC expression. 
 
 
4.3.8 Effects of the TORC1 inhibitor (rapamycin) on ENaC expression in cells treated 
with dexamethasone for 24 h 
 
As rapamycin only inhibits TORC1 and no other kinases, we expected that it would not 
affect ENaC expression in either pool of proteins. This compound increases cellular 
efficiency and is widely used as an immunosuppressant. However, treatment with 
rapamycin caused a reduction in the full length of α-ENaC (Figure 4-10), but not β- and γ-
ENaC. This was unanticipated and the effects were similar to that seen with PI-103, 
TORIN1, and GSK650394, even though rapamycin does not have an effect on ENaC 
activity (Watt, 2011). Therefore, this data suggests that TORC1 may have an effect on 
ENaC, especially α-ENaC. However, the mechanism that underlies this process still 
requires clarification. 
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Figure 4-9: Effects of rapamycin on the expression of PKB-Thr
308
, PKB-Ser
473
 and 
NDRG1-Thr
346/356/366
 phosphorylation in dexamethasone-treated cells. 
. 
 
(A) The proposed effects of rapamycin. (B) Western blots showing the effects of 
rapamycin (0.1 µM) in cells induced by dexamethasone (0.2 µM, 24 h) on the 
overall abundance of protein and phosphorylation of PKB-Thr
308
, PKB-Ser
473
, 
NDRG1-Thr
346/356/366
 and P70-S6K-Thr
389 
, respectively. (C) The bar graphs 
depict the densitometry values of rapamycin treatment calculated as a ratio over 
the control samples. Each experiment was repeated four times and presented as 
the mean ± SEM (n = 4). Asterisks denote statistical significance when compared 
to control values, ***p<0.001 (Student’s t-test). 
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Figure 4-10: Effects of the TORC1 inhibitor, rapamycin, on the expression of ENaC 
subunits in the presence of dexamethasone (24 h). 
 
(A) Typical Western blots showing the effects of rapamycin (0.1 µM) on the 
expression of α-, β-, and γ-ENaC in the presence of dexamethasone (0.2 µM). The 
cells were maintained in a hormone deprived medium from day 2 until confluent. 
The cells were induced with dexamethasone and incubated for 24 h, and treated 
with rapamycin for the final 3 h in the presence of DMSO. Actin is shown as a 
loading control. (B) Densitometric analysis of the data in (A) showing the effects 
of dexamethasone on the cellular abundance of ENaC subunits. Data are 
normalised to the control and presented as the mean ± SEM (n = 4). Asterisks 
denote statistical significance when compared to the initial values ***p<0.001 
(Student’s t-test). 
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4.3.9 Dexamethasone transiently activates ENaC  
Dexamethasone elevated SGK1 activity and this can be indicated by a transient increased 
phosphorylation of NDRG1-Thr346/356/366 up to the 3 h point, then SGK1 activity decreased 
for the remaining incubation time (up to 24 h; Figure 4-13A), confirming that found by 
Inglis et al., (2009) and Watt, (2011). The GC-induced cells activated SGK1 and activity 
peaked after a brief exposure (3 h) to dexamethasone. This activation also evoked 
expression of the ENaC subunits (α-, β-, γ-) at the cell surface. The level of each protein 
was significantly increased by dexamethasone, returning to the basal level after 24 h with 
the exception of α-ENaC and γ-ENaC which persisted when exposed to prolonged treatment 
(Figure 4-11B).   
 
The augmentation of ENaC indicates that brief exposure to dexamethasone could increase 
SGK1 activity, and thus elevate ENaC expression towards the membrane. However, the 
transient effect of dexamethasone cannot induce ENaC activity in H441 cells (Watt, 2011). 
This suggests that a brief activation of SGK1 mediates the trafficking of each subunit 
towards cell surface, but that over time the functional effect of ENaC can only be seen with 
both α- and γ-ENaC. The increase in α-ENaC occurs in parallel to the elevation of α-ENaC 
mRNA (Nakamura et al., 2002; Mustafa et al., 2004) and the α-ENaC gene promoter 
(McTavish et al., 2009). However, the increment of γ-ENaC is only residual, this reflects 
the modulation of its encoded mRNA through the influence of GCs (Itani et al., 2002b). 
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Figure 4-11: The expression of the α-, β- and γ- subunits of ENaC at two different 
time-points; 24 h and 3 h in dexamethasone-treated H441 cells. 
 
(A) Typical Western blotting using cell surface biotinylation of dexamethasone-
treated H441 cells that have undergone brief (3 h) and chronic (24 h) treatment. 
These blots are representative of three independent samples. (B) Densitometric 
analyses of the Western blotting in (A). *p<0.05, **p<0.01 and ***p<0.001 are 
statistically different to GC-deprived cells.  † indicates significant difference 
between chronic (24 h) and brief treatments (3 h); †p<0.05. (one-way ANOVA, 
Bonferroni post-hoc test). 
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4.3.10 Effects of PI-103 and GSK650394 on ENaC expression after cells are briefly 
exposed to dexamethasone 
 
Subsequent results revealed two important compounds (PI-103, Figure 4-12; and 
GSK650394, Figure 4-13) that are known to knock-out PI3-kinase and SGK, respectively. 
Brief treatment with dexamethasone (3 h) resulted in an increase in ENaC cell surface 
expression. By using these compounds to block the PI3-kinase and SGK1 pathways the 
transient effect of dexamethasone on ENaC expression at the cell surface was revealed.  
 
PI-103 successfully reduces the expression of each subunit of ENaC at the cell surface 
when briefly exposed to dexamethasone. However, in GC-deprived cells, this compound 
seems to decrease the expression of both α-ENaC isoforms, though there is no obvious 
effect on β- and γ-ENaC (Figure 4-12). 
 
The SGK1 inhibitor, GSK650394 (10 µM) reduces the two isoforms of α-ENaC (Figure 4-
13) but completely abolishes β- and γ-ENaC in cells when treated with dexamethasone for 
3h. In GC-deprived cells, the substance reduces the expression of the full length α-ENaC 
and β-ENaC but not γ-ENaC. 
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Figure 4-12: Effects of the PI3K inhibitor, PI-103 on ENaC subunits in the presence of 
dexamethasone (3 h). 
 
(A) Typical Western blots showing the effects of PI-103 (1 µM) on expression of α-
, β-, and γ-ENaC in the presence of dexamethasone (0.2 µM). Dexamethasone and 
PI-103 were brought together for the final 3 h of incubation in the presence of 
DMSO. Cell surface proteins were extracted and subjected to Western analysis (B) 
Densitometric analysis of the data in (A) showing the effects of PI-103 on the 
cellular abundance of α-ENaC subunits: ~95 kDa (the upper band) and ~75 kDa 
(the lower band), a single band (~100 kDa) for β-ENaC, two isoforms (~90 kDa, 
~75 kDa) for γ-ENaC as well as a single isoform from the surface protein. Data are 
normalised to the control and presented as the mean ± SEM (n = 4). Asterisks 
denote statistical significance when compared to control cells, *p<0.05, 
***p<0.001; whilst the daggers show the effect of PI-103 in the presence of GC, 
†p<0.001 and control cells, (‡p<0.001)  (one-way ANOVA, Bonferroni post-hoc-
test). 
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Figure 4-13: Effects of the SGK1 inhibitor, GSK650394, on the expression of ENaC 
subunits in the presence of dexamethasone (3 h). 
 
(A) Typical Western blots showing the effects of GSK650394 (10 µM) on the 
expression of α-, β-, and γ-ENaC in the presence of dexamethasone (0.2 µM). The 
cells were maintained in a hormone deprived medium from day 2 until confluent. 
Dialysed media was changed 24 h prior to the experiment. Dexamethasone and 
GSK650394 were used to induce the cells in the final 3 h of incubation in the 
presence of DMSO. Cell surface proteins were extracted and subjected to Western 
analyses. (B) Densitometric analysis of the data in (A) showing the effects of 
GSK650394 on the cellular abundance of α-, β, and γ- ENaC in the surface pool 
proteins. Data are normalised to the control and presented as the mean ± SEM (n 
= 4). Asterisks denote statistical significance when compared to control cells; 
***p<0.001 whilst the daggers indicate a decreased effect of GSK650394 to the 
stimulation of dexamethasone (†p<0.001) and control cells (‡p<0.05) (one-way 
ANOVA, Bonferroni post-hoc-test).  
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4.4 Discussion 
 
Dexamethasone-treated H441 cells activate endogenous ENaC expression that is associated 
with an increase in membrane Na+ conductance. The results reported in this chapter confirm 
that ENaC expression is strictly dependent on GC stimulation (see also Lazrak & Matalon, 
2003; Clunes et al., 2004; Brown et al., 2008; Althaus et al., 2010). GCs are physiologically 
important regulators of pulmonary Na+ transport and, since these hormones stimulate the 
removal of fluid from the alveolar space (Matalon & O'Brodovich, 1999; Matthay et al., 
2002; Olver et al., 2004), synthetic GCs are used in the clinical management of conditions 
such as neonatal respiratory distress syndrome and pulmonary oedema that are characterised 
by the accumulation of liquid in this region of the lung. Moreover, since GCs also exert 
powerful anti-inflammatory actions, GC receptor agonists are also used in the treatment of 
lung diseases such as asthma and chronic obstructive pulmonary disease that are 
characterised by chronic inflammation (Barnes, 2011). It is therefore important to 
understand the mechanisms that allow pulmonary epithelial cells to respond to these 
hormones and, in order to study the mechanisms that underlie the activation of endogenous 
ENaC, we have now explored the effects of small molecule inhibitors of various kinases 
upon the dexamethasone-dependent Na+ currents seen in these cells (Watt, 2011). This 
approach is, however, complicated by the fact that such compounds almost invariably act 
upon multiple targets (Bain et al., 2007). To control for this, we also used phospho-specific 
antibodies to monitor the phosphorylation status of endogenous kinase substrates in order to 
ensure that the tested compounds caused full inhibition of their targets without inactivating 
other, closely related kinases.  
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4.4.1 Inhibition of the PI3-Kinase / SGK1 pathway in GC-induced cells by endogenous 
protein kinases 
 
Pooled data from the endogenous protein extracted from dexamethasone-treated H441 cells 
revealed the phosphorylation of PKB-Ser473/Thr308, NDRG1-Thr346/356/366, PRAS40-Ser246 
and P70-S6K-Thr389. This indicates that the activation of the P13-kinase/SGK1 pathway 
occurred as proposed in Figure 4-1, and thus confirms the physiological effects of 
dexamethasone on PDK1 and TORC2 (Watt, 2011). Since these kinases depend on the 
presence of PIP2/PIP3 at the plasma membrane (Biondi et al., 2001; Bayascas & Alessi, 
2005; Garcia-Martinez & Alessi, 2008), PI3-kinase seems to be activated under these 
conditions. These studies revealed activity of SGK1 and PKB; this was anticipated since 
these regulatory kinases lie downstream of PI3K – TORC2 / PDK1 (Kobayashi & Cohen, 
1999; Park et al., 1999; Biondi et al., 2001; Bayascas & Alessi, 2005; Sarbassov et al., 
2005; García-Martínez & Alessi, 2008). PI-103 successfully inactivated these substrates 
which are important downstream targets of PI3-kinase (Kobayashi & Cohen, 1999; Park et 
al., 1999; Bayascas & Alessi, 2005), including PKB-Ser473/Thr308, NDRG1-Thr346/356/366, 
and did not affect overall protein expression, which happened previously with kidney 
epithelial cells (Mansley & Wilson, 2010a). This suggests that the compound specifically 
suppresses the phosphorylation of PDK1 and also inactivates protein kinases downstream of 
TORC2-SGK1 (see Figure 4-1). The inactivation is consistent with the depletion of 
PIP2/PIP3 which leads to decreased activity of PDK1 and TORC2, and thus inactivates 
SGK1 and PKB (Kobayashi & Cohen, 1999; Park et al., 1999; Bayascas & Alessi, 2005; 
Sarbassov et al., 2005, Garcia-Martinez & Alessi, 2008).  
 
Our subsequent experiments explored the effects of TORIN1, that inhibits TORC2, the 
protein that allows PI3K to control both PKB and SGK1 (Sarbassov et al., 2005; García-
Martínez & Alessi, 2008; Thoreen et al., 2009). TORIN1 virtually abolished the 
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phosphorylation of PKB-Ser473 as well as Thr308 and NDRG1-Thr346/356/366 without any 
effect on the total protein. However, this experiment was performed in a low concentration 
(0.1 µM) of the substance, since TORIN1 abolishes TORC1/2 complexes and may inhibit 
PI3-kinase and/or PDK1 at > 1 µM (Thoreen et al., 2009). The data is quite surprising when 
compared to the findings of Mansley & Wilson (2010b) and Watt (2011), where inhibition 
was shown to be complete at < 0.1 µM, indicating that PDK1 is still sensitive to this 
compound at this concentration. One possible explanation is that TORC2 acts as a protein 
mediator, allowing SGK1 activation through PKB. The mechanism can be explained thus: 
TORC2 catalyses the phosphorylation of PKB-Ser473 to facilitate subsequent activation of 
PKB-Thr308 by PDK1 (Biondi et al., 2001; Sarbassov et al., 2005), so the inhibition of 
TORC2 may also restrict the phosphorylation of PKB-Thr308 (Biondi et al., 2001; Sarbassov 
et al., 2005). Therefore, this inhibition confirms that TORC2 plays a critical part in the 
mechanism that allows PI3-kinase to regulate ENaC through the SGK1 pathway (Kobayashi 
& Cohen, 1999; Park et al., 1999; Garcia-Martinez & Alessi, 2008; Lu et al., 2010). 
Though TORIN1 does not inhibit PI3-kinase (Thoreen et al., 2009), it may allow the 
presence of PIP2/PIP3 phospholipid second messengers to activate ENaC at the cell surface 
by binding to the channel complex (Blazer-Yost et al., 2004; Blazer-Yost & Nofziger, 
2005; Ma et al., 2007; Pochynyuk et al., 2007a). Where TORIN1 only contributes a minor 
effect towards ENaC surface expression as seen in the treatment of PI-103, it is implying 
that PIP2/PIP3 still can support ENaC expression when TORC2 is inactive. However, this 
mechanism must be of secondary importance in H441 cells. 
 
Prior to determining the role of SGK1 in GC-induced ENaC expression, we used a selective 
inhibitor of SGK1, GSK650394 (Sherk et al., 2008; Mansley & Wilson, 2010a), which has 
been shown to completely abolish SGK1 protein expression through NDRG1-Thr346/356/366 at 
a concentration of 10 µM (Mansley & Wilson, 2010a). This effect withdraws the amiloride 
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sensitive Na+ current (Watt, 2011) suggesting that SGK1 is critical for maintaining ENaC at 
the cell surface. Apart from this, the compound had a slight effect on PKB-Ser473, may be 
caused by an inhibitory feedback loop effect via PKB and several AGC kinases between 
TORC2/SGK1 (Chan et al., 1999). PKB may be involved in the hormonal control of Na+ 
absorption in Xenopus oocytes and Fischer rat thyroid cells, and it has been suggested that 
PKB might be involved in the hormonal control of Na+ transport via ENaC (Lee et al., 
2007; Diakov et al., 2010). However, judging by the effect of GSK650394 on PRAS40-
Thr256 phosphorylation, which indicates PKB activation, this compound had a negligible 
effect on PKB activity, suggesting that PKB is not involved in the hormonal control of Na+ 
transport via ENaC expression. Although the data presented here does not exclude this 
possibility, both of the studies on Xenopus oocytes and Fischer rat thyroid cells showed that 
PKB could not maintain ENaC activity independently of SGK1 in dexamethasone-
stimulated H441 cells (Lee et al., 2007; Diakov et al., 2010). 
 
Rapamycin is known to inhibit TORC1 (Bain et al., 2007; Thoreen & Sabatini; Mansley & 
Wilson, 2010a), which was crucial for understanding the activation downstream of PI3-
kinase. While PI-103 abolishes TORC1 and other protein kinases of the SGK1 pathway 
(Mansley & Wilson, 2010a; Watt, 2011), rapamycin only causes the inactivation of P70-
S6K-Thr389, a TORC1 protein indicator, but no other protein kinases. The inhibition of 
TORC1 but not TORC2 allows further activation of SGK1 through the phosphorylation of 
the Ser422 residue. PI-103 has been shown to inhibit the dexamethasone-induced Na+ current 
but this effect cannot be seen using rapamycin (Watt, 2011). This leads us to conclude that 
GCs must activate ENaC at the cell surface through a mechanism that depends on PI3-
kinase / SGK1 through TORC2, which concurs with previous reports (Blazer-Yost et al., 
1998; Record et al., 1998; Alvarez de la Rosa et al., 1999; Paunescu et al., 2000; 
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Debonneville et al., 2001; Alvarez de la Rosa & Canessa, 2003; Blazer-Yost et al., 2003; 
Inglis et al., 2009). 
 
 
4.4.2 Effects of inhibition of the PI3-Kinase / SGK1 pathway on ENaC expression in 
GC-induced cells. 
 
The initial basis for this study was the findings reported in Chapter 3 and Watt, (2011) 
which describe an elevation in ENaC activity when cells are treated for 24 h with 
dexamethasone. This elevation seems to be driven by the abundance of α-ENaC. All 
pharmacological inhibitions of the PI3-kinase/TORC2/SGK1 pathway only had a minor 
effect on α-ENaC in both the total lysates and the surface protein, especially the 95 kDa 
form, suggesting that the PI3-kinase/TORC2/SGK1 pathway is involved in the control of α-
ENaC synthesis (Boyd & Náray-Fejes-Tóth, 2005; Zhang et al., 2007; Reisenauer et al., 
2009). However, most of these compounds also inhibit TORC1 so it is interesting that 
rapamycin, a selective TORC1 inhibitor (Bain et al., 2007), also reduced the abundance of 
α-ENaC (95 kDa). It is possible that TORC1 may contribute to the control of α-ENaC 
expression and, in this context, it is relevant that rapamycin has also been shown to disrupt 
the dexamethasone-induced activation of ENaC in renal epithelia (Mansley & Wilson, 
2010a). However, none of the compounds tested in the present study had a discernible 
effect on the expression of the 75 kDa form of α-ENaC, and the data presented here shows 
that rapamycin-induced inhibition of TORC1 does not suppress ENaC activity in H441 cells 
(Watt, 2011). The physiological significance of the effect of the 95 kDa form of α-ENaC is 
therefore not clear. 
 
In addition, these compounds reduced the expression of γ-ENaC at the cell surface. Since 
this action was not mimicked by rapamycin, the dexamethasone-induced increase in the 
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surface expression of this subunit seems to be dependent upon the PI3K – TORC2 – SGK1 
pathway. Despite this, there was no effect on β-ENaC. Therefore, PI-103, TORIN1 and 
GSK650394 clearly abolish the Na+ current in GC-induced ENaC activity (Watt, 2011), but 
this cannot be correlated to the withdrawal of ENaC subunits from the plasma membrane. 
 
Whilst dexamethasone clearly activated SGK1, this response was not associated with any 
change in the activity of TORC2, which is similar to that documented for renal epithelia, 
where the dexamethasone-induced activation of SGK1 seems to reflect de novo synthesis of 
the SGK1 protein (Wang et al., 2001; Gonzalez-Rodriguez et al., 2007). However, since the 
nascent protein is catalytically inactive, the PI3K – TORC2 pathway is needed to 
phosphorylate SGK1-Ser422 and confer catalytic activity upon the newly synthesised protein 
(Kobayashi & Cohen, 1999; Park et al., 1999; García-Martínez & Alessi, 2008; Lu et al., 
2010). 
 
Whilst undertaking these studies, we noted that GC-deprived and dexamethasone-
stimulated (24 h) cells often appeared to display very similar levels of NDRG1-Thr346/356/366 
phosphorylation, and this observation (see also Inglis et al., 2009) prompted us to compare 
the effects of both brief (3 h) and prolonged (24 h) dexamethasone stimulation on the 
phosphorylation of these residues. These studies confirmed that brief exposure to 
dexamethasone does increase SGK1 activity without altering the activity of TORC2, but 
also showed that prolonged (24 h) stimulation had no apparent effect on the activity of 
either kinase (Watt, 2011). Despite the sustained activation of ENaC, the present data 
therefore suggest that SGK1 activity returns to its basal level after ~24 h of continuous 
exposure to dexamethasone. Moreover, experiments that explored the effects of brief (3 h) 
exposure to dexamethasone on the surface abundance of ENaC subunits showed that the 
period of increased SGK1 activity was associated with an unambiguous increase in the 
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surface abundance of α-, β- and γ-ENaC. Furthermore, this response was abolished by 
GSK650394, indicating that SGK1 does provide a mechanism that allows hormonal control 
over the surface expression of ENaC subunits. However, despite this clear finding, 
electrophysiological studies showed that brief (3 h) exposure to dexamethasone did not 
induce Na+ currents (Watt, 2011), whilst studies of cells exposed to dexamethasone for ~24 
h confirmed the sustained activation of endogenous ENaC as described above. 
 
In conclusion, brief exposure to dexamethasone activated ENaC expression at the cell 
surface. However, the complex of ENaC subunits detected through Western analysis might 
not be wholly functional, which may explain the negligible Na+ current. In addition, these 
channels may require activation by a secondary mechanism at the plasma membrane (for 
example, serine-proteases). However, ENaC protein subunits are diminished, especially β- 
and γ- ENaC, in the presence of an SGK1 inhibitor. This indicates that SGK1 may be an 
important switch for triggering the hormonal control that governs ENaC abundance on the 
cell surface. If this is true, it would affect the expression of the ubiquitin ligase protein, 
Nedd4-2, as this is involved in the final stages of ENaC expression at the cell surface. This 
leads us to the next chapter, which investigates the effects of dexamethasone on the 
expression of Nedd4-2. 
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5 
Nedd4-2 modulation  
through the SGK1 pathway 
 
5.1 Introduction 
The GC-induced H441 cells are thought to be regulated through the SGK1 pathway, which 
in turn activates ENaC at the surface membrane hence stimulating Na+ transport. The ENaC 
subunit proteins then need to be withdrawn from the membrane via a mechanism that is 
dependent on the neural precursor cell-expressed, developmentally down-regulated gene 4 
isoform 2 (Nedd4-2), a ubiquitin ligase that binds to proline-rich domains in ENaC subunits 
and thus targets them for internalisation and degradation. Genetic deletion of Nedd4-2 
allows ENaC to remain in the plasma membrane, and this abnormality disrupts lung 
function by causing excessive Na+ absorption (Boase et al., 2011; Kimura et al., 2011). 
 
The Nedd4-2 protein consists of four WW domains (Huibregtse et al., 1995; Kamynina et 
al., 2001a; Asher et al., 2003; Itani et al., 2003) which normally interact with the PY motifs 
of ENaC (Staub et al., 1997b; Debonneville et al., 2001; Snyder et al., 2002). Due to this 
interaction, ENaC proteins are ubiquitinated to accelerate the rate of degradation, hence 
decrementing the channels at the surface membrane which ultimately results in a drastic 
decrease in the Na+ current. This has also been observed when Nedd4-2 and ENaC are over-
expressed in Xenopus laevis oocytes (Malik et al., 2005) and collecting duct cells (Itani et 
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al., 2005), resulting in reduced ENaC activity. This interaction can be reversed by inducing 
cells with dexamethasone, which is associated with an increase in SGK1, an important 
molecule for the interaction between the substrate protein ENaC and the ubiquitin protein 
ligase Nedd4-2. 
 
These findings prompted us to perform subsequent experiments to investigate the 
association of ENaC-Nedd4-2 in H441 cells. In theory, Nedd4-2 reduces ENaC surface 
expression, therefore the phosphorylation of Nedd4-2 by protein kinases (eg: in this chapter, 
SGK1) might hinder the association of ENaC-Nedd4-2 thereby increasing ENaC abundance 
at the plasma membrane and elevating Na+ transport. As revealed in Chapter 4, ENaC 
subunit expression on the surface of H441 cells is enhanced by the SGK1 pathway and 
coincides with ENaC activity (Watt, 2011). Indeed, phosphorylation of the Nedd4-2 protein 
is affected by SGK1, especially Ser327, Thr246 and Ser221, hindering the interaction of 
Nedd4-2 with the PY-motifs of α-, β-, and γ- ENaC and preventing ENaC from being 
internalised (Debonneville et al., 2001; Snyder et al., 2002). This raises a pertinent question 
– does SGK1 directly phosphorylate Nedd4-2 to regulate ENaC? This question is addressed 
at the end of this chapter. 
 
5.2 Experimental design – aims and objectives 
Chapter 4 revealed a transient activation of NDRG1-Thr346/356/366 in dexamethasone-treated 
cells, and increased ENaC expression at the cell surface. This chapter investigates whether 
SGK1 activity is involved in the phosphorylation of Nedd4-2. Nedd4-2 is thought to be a 
physiological regulator of ENaC that is essentially regulated downstream of SGK1, 
inhibiting the ubiquitination-dependent degradation and thus controlling ENaC surface 
expression (Debonneville et al., 2001; Snyder et al., 2002). As a protein mediator, SGK1 
phosphorylates three residues; Ser221, Thr246, and Ser327, to reduce Nedd4-2 binding to 
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ENaC (Debonneville et al., 2001; Snyder et al., 2002; Zhou & Snyder, 2005). Therefore, I 
wanted to observe the phosphorylation of Nedd4-2 (Ser221, Thr246, and Ser327) in both GC-
induced and GC-deprived H441 cells. 
 
To achieve this, the cell lysates needed to be fully extracted through immunoprecipitation 
(see a detailed protocol in Chapter 2: Materials & Methods) to enable purification of 
Nedd4-2 from a large amount of lysates. To do this, 1 mg of cell lysates was incubated with 
the total protein of Nedd4-2 to allow antibody/antigen binding in solution. The protein was 
then collected using Protein G-coupled agarose beads. This physically isolated the protein 
of interest from the rest of sample and it was then separated using Western analysis to probe 
for Ser221, Thr246, and Ser327 and total Nedd4-2, respectively. 
 
Since Nedd4-2 consists of multiple isoforms, an experiment was designed to determine a 
specific protein that corresponds to Nedd4-2 expression. To perform this, 1 mg of protein 
lysates were incubated with a differential amount of total-Nedd4-2 antibody (0 µg, 1 µg, 3 
µg, 5 µg, 10µg) to observe the optimum dosage for Nedd4-2 antibody binding to the protein 
lysates. Then, a similar experiment was performed with a different amount of protein 
lysates (0 mg, 0.1 mg, 0.5 mg, 1 mg) and further incubated with an elected amount of total 
Nedd4-2 (10 µg) to verify protein expression.  
 
Once this had been optimised, the expression of each residue and the total Nedd4-2 protein 
was further examined. In Chapter 4, dexamethasone was shown to transiently increase the 
phosphorylation of NDRG1-Thr346/356/366 and subunits of ENaC (3 h), though this activation 
was reduced over a longer period (24 h). Therefore, with this data in mind, we chose to 
investigate whether SGK1 activity correlates with the expression of Nedd4-2. This can be 
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achieved by inhibition of the SGK1 pathway (PI-103 and GSK650394), as explained in 
Figure 5-1. 
 
Figure 5-1: A methodology overview of Nedd4-2 expression in human airway cells. 
 
In summary, the aims of this chapter are: 
1) To optimise the method of immunoprecipitation prior to Nedd4-2 extraction. 
2) To investigate the activation of SGK1-Nedd4-2-ENaC expression in dexamethasone-treated 
cells at two different time points (3h and 24h). 
3) To determine the role of SGK1 in the phosphorylation of Nedd4-2. 
 
 
131 
5.3 Results 
 
5.3.1 Nedd4-2 verification in H441 cells 
 
H441 cells (1 mg of lysates) were immunoprecipitated against 1, 3, 10 µg of total Nedd4-2 
protein. Each sample was electroblotted through 6% SDS polyacrylamide and further 
probed for total Nedd4-2 antibody. Figure 5-2A represents the isoform-binding to the 
Nedd4-2 antibody. The control sample, containing no protein lysates, expressed nonspecific 
binding at approximately 80 kDa. Other protein bands also appeared at ~125 kDa and ~105 
kDa, which corresponds with other findings shown in Table 5-1. These results confirmed 
that immunoprecipitation works with a large amount of cellular protein (1 mg). 
 
However, Nedd4-2 protein was also observed at approximately 125 kDa, which corresponds 
to the PC12 cellular extract (Dr. James Hastie, MRC Phosphorylation Unit, University of 
Dundee; unpublished data). Due to this discrepancy, an experiment was conducted to 
observe whether protein lysates were mass dependent in the presence/absence of the Nedd4-
2 antibody. Figure 5-2B illustrates that the expression of each Nedd4-2 isoform is elevated 
with each increment of protein mass, from 0.1 mg to 1 mg of protein lysates. Where the 
cellular protein is absent, samples containing Sepharose beads expressed a nonspecific 
binding at ~80 kDa, confirming the expression of the heavy chain of Sepharose G protein 
beads and thus showing that both isoforms (~125 kDa and ~105 kDa) correspond to Nedd4-
2 protein. 
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Figure 5-2: Total Nedd4-2 expression in H441 cells extracted through 
immunoprecipitation. 
 
(A) Antibody mass dependence reveals nonspecific binding and the heavy chain 
derived from Protein G Sepharose expressing isoforms of total-Nedd4-2. (B) 
Further experiment to observe whether the protein lysates are mass dependent in 
the presence/absence of anti-total-Nedd4-2. This confirms the expression of two 
isoforms of total-Nedd4-2. 
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Table 5-1: Molecular weight of total Nedd4-2 
 
Authors Cell Type 
Molecular Weight 
(kDa) 
Snyder et al., 2001 COS-7 110 
Itani et al., 2005 COS-7 116, 101, 83 (isoforms) 
Ichimura et al., 2005 X. laevis oocytes 120 
Zhou & Snyder, 2005 HEK293T 110 
Nagaki et al., 2006 X. laevis oocytes 116 
Raikwar & Thomas, 2008 HEK293T 116, 101, 83 (isoforms) 
Bruce et al., 2008 HEK293T 110 
Liang et al., 2010 mpkCCD 100 
Hallows et al., 2010 X. laevis oocytes 130 
Zhang et al., 2010 X. laevis oocytes 110 
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5.3.2 Phosphorylation of endogenous Nedd4-2 in dexamethasone-treated H441 cells  
Next, we investigated the phosphorylation of Nedd4-2 in the presence of dexamethasone at 
24 h and 3 h. Cells were cultured on a hard surface from day 2 until confluent. 24 h prior to 
the extraction, a defined media was treated with dexamethasone (0.2 µM) and towards the 
final 3 h of incubation the other plate was treated with a similar hormone. A control plate of 
GC-deprived cells was also treated with this hormone. A Bradford assay was conducted to 
determine 1 mg of cell lysates. The lysates were immuno-precipitated against the total 
protein, subjected to Western analysis and further probed for three antibodies against the 
phosphorylated Nedd4-2 (Ser221, Ser327, Thr246), along with Nedd4-2 total protein antibody. 
 
Figure 5-2B shows the significant increase in expression of the three residues of Nedd4-2 
(Ser221, Ser327, Thr246), as well as the total Nedd4-2 after a brief (3 h) incubation. However, 
when the incubation period was extended to 24 h, the expression levels were similar to the 
control level (Figure 5-3B). As anticipated, this finding concurs with the data presented 
earlier (Chapter 3, 4) regarding the activation of SGK1 and ENaC subunits at the cell 
surface. The mechanism is thought to act rapidly (Staub et al., 1997a; Zhou et al., 2007; 
Kabra et al., 2008), explained by the increased expression in response to brief exposure to 
dexamethasone. At the initiation of this project, we found a single protein band for each 
phosphorylated residue of Nedd4-2. However, as we further optimised the protocol, we 
noted the expression of two isoforms (~125 kDa and ~105 kDa) that were very similar to 
the total protein. 
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 Figure 5-3: The expression of endogenous Nedd4-2 in H441 cells. 
  
(A)  Culture conditions 24 h prior to the collection of cell lysates. (B) The blots 
showing the phosphorylation of Nedd4-2 at three residues (Ser
221
, Ser
327
, Thr
246
)  at 
two different time-points of dexamethasone incubation (20 µM; 24 h and 3 h) as 
well as total Nedd4-2 expression. (C) Densitometry values of pooled data (n = 8) 
from (B). Any significant difference to the control is represented by ***p<0.001 
whilst †p<0.001 indicates a difference in dexamethasone treatment for 24 h (one-
way ANOVA, Bonferroni post-hoc test). 
 
 
136 
5.3.3 Effects of PI-103 on Nedd4-2 in dexamethasone-treated H441 cells 
Though previous findings revealed a correlation between the activation of SGK1 and ENaC 
expression at the cell surface, it was not clear if these phosphorylations were dependent on 
the PI3-kinase/SGK1 pathway. Using a similar set of experiments to those performed 
before, the cells were incubated with dexamethasone (0.2 µM) for 24 h and 3 h respectively. 
GC-deprived control cells were kept in a defined media for 24 h. For the final 3 h of 
incubation, a pharmacological compound, PI-103, which specifically inhibits PI3-kinase 
(Mansley & Wilson, 2010a; Watt et al., 2012) was added. The samples were then 
immunoprecipitated against total Nedd4-2 antibody and later processed through Western 
analysis and probed for the Ser221, Ser327, Thr246 residues of Nedd4-2 and the total protein. 
Figure 5-4B shows an increase in the expression of each residue and the total protein level 
of Nedd4-2 after brief incubation with dexamethasone, but a reduction in expression to the 
basal level after 24 h. This confirms the previous findings detailed in Figure 5-3.  
 
PI-103 successfully inhibited (if not, reduced) each residue of Nedd4-2 (Figure 5-4 C, D, 
E). However, the inhibition was not clear in GC-deprived cells and cells treated with 
dexamethasone for 24 h, as any initial expression was not apparent. Interestingly, this effect 
could not be seen in the total Nedd4-2, as its expression increased despite the inhibition 
(Figure 5-4F). The ultimate effect of this inhibition was shown by cells treated with 
dexamethasone at 3 h, where the expression was further reduced to the basal level.  
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Figure 5-4: Effects of the PI3-kinase inhibitor (PI-103) on phosphorylation of Nedd4-2 
in dexamethasone-treated cells. 
 
(A)  Culture conditions 24 h prior to the extraction. Western blots in (B) illustrate the 
expression of phosphorylation sites of (C) Ser
221
, (D) Ser
327
, (E)Thr
246
 and (F) total 
Nedd4-2 in the presence of the PI3-kinase inhibitor, PI103 (1 µM) through immuno-
precipitation. These data were pooled (n = 4) and statistically analysed (one-way 
ANOVA, Bonferroni post-hoc test). Asterisks denote significant effects of 
dexamethasone upon control cells (***p<0.001) whilst the dagger shows the effect of 
PI-103 on dexamethasone-induced cells (†p<0.001). 
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5.3.4 Effects of GSK650394 on Nedd4-2 in dexamethasone-treated H441 cells 
A specific inhibitor of the SGK1 pathway, GSK650394, successfully inhibited the 
expression of NDRG1-Thr346/356/366 and ENaC at the cell surface, as discussed previously in 
Chapter 4. Therefore, we anticipated a similar effect in this experiment, that the drug would 
also inhibit the expression of Nedd4-2. As seen in previous experiments, inhibition only has 
a minor effect on cells that undergo a prolonged treatment with dexamethasone (~24 h), 
therefore we designed an experiment to assess the effect of this inhibitor on transient 
dexamethasone-treated cells (3 h). 
 
H441 cells were cultured in a strictly defined medium until confluent. There were three 
conditions; the GC-free cells, dexamethasone (0.2 µM) induced cells, and GSK650394-
treated cells – all treatments were induced approximately 3 h before extraction. These cells 
were later extracted through immunoprecipitation and subjected to Western analysis. 
 
As anticipated, a brief period of dexamethasone incubation enhances the expression of 
Nedd4-2 residues and total protein. Figure 5-5B illustrates the dramatic increase in 
expression of these residues in dexamethasone-treated cells. The inhibitor also reduced the 
expression in GC-deprived cells (Figure 5-5C, D, E). Interestingly, for total Nedd4-2 
(Figure 5-5F) GSK650394 does not completely inhibit GC-free cells but does reduce 
expression to a point close to that of the basal expression.  
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Figure 5-5: Effects of the SGK1 inhibitor, GSK650394, on the phosphorylation of 
Nedd4-2 in dexamethasone-treated cells. 
 
(A)  Culture conditions 24 h prior to the extraction. Western blots in (B) represent the 
effect of the SGK1 inhibitor, GSK650394, on the phosphorylation of Nedd4-2 
(Ser
221
, Ser
327
, Thr
246
) as well as total protein. (C), (D), (E), (F) Bar graphs showing 
the densitometry value of pooled data (n = 4) and asterisks indicate a significant 
difference between dexamethasone-treated cells and control cells (***p<0.001). A 
dagger shows the effect of GSK650394 on control cells (†p<0.05) and double 
daggers indicate the effect of GSK650394 on dexamethasone-treated cells (‡p<0.001) 
(one-way ANOVA, Bonferroni post-hoc test). 
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5.4 Discussion 
Nedd4-2 is a member of the Nedd4 family, which is similar to the E6-Associated Protein C-
Terminus (HECT) domain type E3 ubiquitin protein ligase that is widely expressed in 
mammalian tissues and cells. This protein is important because it assists various cellular 
functions, from regulation of transcription to intracellular trafficking, as well as protein 
degradation (Rotin et al., 2000) which involves multiple WW domains. A number of in 
vitro binding studies have suggested that different WW domains produce various affinities 
against the PY motif of ENaC (Kamynina et al., 2001a; Fotia et al.,  2003; Henry et al., 
2003; Itani et al., 2003; Bhalla et al., 2005).  
 
Nedd4-2 appears to comprise a higher affinity for ENaC binding than the Nedd4 protein. 
This is due to the high number of consensus SGK1 phosphorylation sites that specifically 
bind to the WW domains of Nedd4-2 (Debonneville et al., 2001; Snyder et al., 2002). The 
form of Nedd4-2 found in human cells (hNedd4-2) reportedly exists in multiple isoforms, 
which possibly arose from alternate transcription and translation due to the variable splicing 
of some internal exons (Itani et al., 2003). These domains are approximately 40 amino acids 
in length and are located in the WW domains of Nedd4-2 to mediate the interaction of 
SGK1-Nedd4-2. Whilst some isoforms involved in the phospho-binding domain may 
dictate membrane localisation (Plant et al., 1997), the others have a strong affinity for 
SGK1 phosphorylation sites (Itani et al., 2003). Out of all the four WW domains of 
hNedd4-2, WW 3 and 4 are proposed to bind strongly to the PY motif of ENaC whilst WW 
1 and WW 2 have little or no affinity binding (Itani et al., 2003). 
 
In theory, Ser221 and Thr246 are found between WW domains 1 and 2 while Ser327 is located 
between WW domains 2 and 3 (Synder et al., 2002). Increased expression of Ser327 is 
thought to be the most crucial for Nedd4-2 activation and this is further elevated by Ser221 
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and Thr246 to achieve maximum activity. Snyder et al., (2004a) have suggested that only 
Ser327 and Thr246 potentiate the binding of SGK1 to inhibit binding to ENaC, however this 
does not concur with the data presented in this chapter. Although all three phosphorylation 
sites of Nedd4-2 are successfully expressed in conjunction with SGK1 activity, it is worth 
noting that SGK1 activation is absolutely essential for ENaC regulation and this must be 
mediated by Nedd4-2 (Figure 5-5). In addition, SGK1 itself can stimulate ENaC at the cell 
surface without phosphorylating Nedd4-2 (Wang et al., 2001), mainly through the 
activation of α-ENaC (Diakov & Korbmacher, 2004), as this subunit contains a possible 
activation site at the promoter region that can be stimulated by SGK1 (McTavish et al., 
2009). 
 
 
 
Figure 5-6: A proposed model for endogenous ENaC modulation through the SGK1 
pathway involving the phosphorylation of Nedd4-2. 
 
 
Dexamethasone has been shown to increase SGK1 activity transiently (3 h - 6 h) but the 
expression is reduced to the basal level after 24 h. This was anticipated in the previous 
chapter and also coincides with the findings observed by Itani et al., (2005); Inglis et al., 
(2009); Mansley & Wilson, (2010a) and Watt et al., (2012). The brief effect of 
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dexamethasone on the SGK1 protein indicator (i.e., P-NDRG1-Thr346/356/366) therefore 
provides an attractive model showing the activation of endogenous Nedd4-2 and thus the 
regulation of ENaC at the cell surface. Total Nedd4-2 expression was elevated after 3 h of 
dexamethasone treatment but returned to normal after prolonged treatment (24 h). 
Interestingly, three residues of Ser-Thr in Nedd4-2 also increased due to the effects of 
dexamethasone (Figure 5-6), possibly due to the augmentation of total protein.  
 
The activation of phosphorylation sites of Nedd4-2 is thought to correspond well with the 
overall expression of the total protein, leading to a functioning Nedd4-2 and thus a decrease 
in the number of ENaC channels and reduction of epithelial Na+ absorption. Many studies 
have shown that this process occurs rapidly, consistent with the data in this chapter (Staub 
et al., 1997a; Zhou et al., 2007; Kabra et al., 2008). A recent study by Chandran and 
colleagues investigated heterologously expressed Xenopus Nedd4-2 and found that Nedd4-2 
degradation is prevented by the phosphorylation of a residue equivalent to Ser327 in the 
human protein (Chandran et al., 2011). As far as we are aware, the present study is the first 
to explore the effect of agents that control Na+ transport (e.g., dexamethasone) which might 
modulate the expression / phosphorylation of endogenous Nedd4-2. Studies by Chandran et 
al., (2011) have noted that physiological stimuli that evoke phosphorylation of this residue 
can stabilise the protein and increase its abundance, an effect which may well explain the 
present findings in this chapter. Moreover, it has been suggested that such control over 
Nedd4-2 expression may provide a novel aspect to the mechanism that allows the hormonal 
control of Na+ absorption; the data presented here are consistent with this hypothesis. 
Therefore, these findings support the idea that Nedd4-2 can play a role in maintaining 
ENaC at the cell surface. This mechanism may be crucial for preventing build up of 
excessive Na+ in the plasma membrane. The targeted disruption of Nedd4-2 in the mouse 
has been shown to cause hypertension as result of the excessive Na+ intake (Shi et al., 
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2008). Nedd4-2 can be switched off to maximise ENaC activity and the mechanism is 
assisted by phosphorylation through Ser-Thr, as presented in this chapter.  
 
The effect of Nedd4-2 on ENaC expression at the cell surface also correlates with an 
increase in SGK1 activity. However, this theory contradicts other studies by Itani et al., 
(2005) and Zhou & Snyder, (2005) where a reduced level of Nedd4-2 was  linked to an 
increment in the SGK1 level. The mechanism was also shown to be reversible; where 
Nedd4-2 was reactivated in a low level of SGK1 (Itani et al., 2005; Zhou & Snyder, 2005). 
The discrepancy is due to the over-expression of Nedd4-2 in the cells where SGK1 has a 
synergistic effect controlling the excess production of Nedd4-2. In contrast, in this project 
all samples were derived from the endogenous cellular extract (as opposed to an over-
expression experiment) which was better for investigating the relationship between SGK1 
and Nedd4-2. 
 
 
 
 
Figure 5-7: SGK1 pathway inactivation leads to the inhibition of residues of Nedd4-2 
and thus increases rapid degradation of ENaC. 
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SGK1 activity was revealed by inducing cells with PI-103 and GSK650394, which 
successfully silenced the pathway (Chapter 4). Figure 5-7 depicts the role of these drugs on 
the SGK1 pathway. They act by preventing the interaction between SGK1 and Nedd4-2, 
leading to increased internalisation of ENaC. Therefore, SGK1 inhibition stops the PY 
motif binding to the phosphorylated residues of Nedd4-2, as demonstrated in this chapter. 
As a result, Nedd4-2 rapidly degrades ENaC at the cell surface (Figure 5-7), especially the 
β- and γ-ENaC subunits (see reduction of these subunits as a result of GSK650394 
treatment in Chapter 4). 
 
The reduction of both β- and γ- ENaC indicates the importance of Nedd4-2 which is linked 
to Liddle‘s Syndrome, caused by deletion or alteration of the PY motif in β- and γ- ENaC 
(Staub et al., 1996; Goulet et al., 1998). This results in an increase in ENaC at the cell 
surface due to the inability of Nedd4-2 to internalise ENaC from the membrane (Harvey et 
al., 2001; Kamynina et al., 2001c). The mechanism also leads to increased renal Na+ 
absorption which  is associated with hypertension, as a result of a mutation at the C-
terminus of the PY motif of β- and γ- ENaC (Shimkets et al., 1994; Hansson et al., 1995a; 
Hansson et al., 1995b). 
 
In conclusion, the endogenously expressed hNedd4-2 protein coincides with the transient 
activation of SGK1 in H441 cells, to further elevate ENaC at the cell surface in the presence 
of the SGK1 stimulator, dexamethasone. This effect is reduced in the presence of the PI3-
kinase downregulated SGK1 pathway inhibitor (PI-103) and GSK650394 which specifically 
inhibit the SGK1 protein. Whilst both β- and γ- ENaC were abolished in the absence of 
SGK1, these compounds only had a minor effect on the expression of α-ENaC (especially 
GSK650394, see Chapter 4), suggesting that there may be an independent mechanism that 
stimulates subunit expression outside of the SGK1 pathway. One possible mechanism 
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would be a direct α-ENaC activation by SGK1 (Wang et al., 2001; Diakov & Korbmacher, 
2004) which might not involve Nedd4-2. Others have proposed that ENaC can be 
stimulated by PKA (Snyder et al., 2004a), which is explored in the next chapter: 
investigating the regulation of ENaC by the PKA-activating pathway. 
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6 
Regulation of ENaC and Nedd4-2  
by the PKA pathway 
 
6.1 Introduction 
The data presented in this thesis supports the theory that GC-induced expression of ENaC at 
the surface of H441 cells can be regulated via the SGK1 pathway. SGK1 phosphorylates the 
endogenous ubiquitin ligase Nedd4-2 to prevent internalisation of ENaC from the cell 
surface; however, others have proposed that the cAMP activating protein kinase A (PKA) 
pathway could modulate ENaC through a similar mechanism (Debonneville et al., 2001; 
Snyder et al., 2002; Snyder et al., 2004a). The most notable theory was reported by Snyder 
(2000) when investigating the role of cAMP in Liddle‘s syndrome. This study found that 
cAMP mediated the translocation of ENaC towards the cell surface, but that this was then 
disrupted by the mutation of the cytoplasmic COOH-termini of the β- and γ- ENaC subunits 
(Snyder, 2000). A subsequent study by the same group proposed that the cAMP activating 
PKA pathway interacts with residues of Nedd4-2 in the SGK1 pathway (Snyder et al., 
2004a) prior to ENaC subunit expression at the cell surface. The physiological role of 
Nedd4-2 is to limit the rate of Na+ absorption (Snyder et al., 2002; Snyder et al., 2004a; 
Snyder et al., 2004b), this ubiquitin ligase can be phosphorylated, and thus inactivated, by 
protein kinase A (PKA) and serum and GC-inducible kinase 1 (SGK1). Moreover, since the 
activities of these regulatory kinases are under the control of hormones / neurotransmitters 
in the extracellular space, the regulated inactivation of Nedd4-2 is thought to contribute to 
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the hormonal control of Na+ absorption by allowing -, - and -ENaC to remain at the cell 
surface, an event that would lead to increases Na+ transport by increasing the membrane‘s 
permeability to Na+ (Snyder et al., 2002; Flores et al., 2005; Debonneville et al., 2001; 
Lang et al., 2006; Snyder, 2005). 
 
GC hormones are physiologically-important regulators of pulmonary Na+ transport. 
Dexamethasone, a synthetic GC, can evoke ENaC-dependent Na+ currents in H441 human 
airway epithelial cells via an SGK1-dependent mechanism. Moreover, these GC-induced 
Na+ currents can be augmented by agents that activate PKA (Murray et al., 2005; Thomas et 
al., 2004; Ramminger et al., 2004; Clunes et al., 2004; Vasquez et al., 2008) and these 
findings are therefore in accordance with the conceptual model outlined above. However, 
dexamethasone-induced SGK1 activity in these cells peaks after ~3 h of stimulation and 
then declines to its basal value within ~24 h. Moreover, only minor changes to the surface 
abundance of -, - and -ENaC persist in cells that have been exposed to dexamethasone 
for ~24 h (Chapter 3), and the dexamethasone-induced Na+ currents are well maintained 
(Watt et al., 2012). Despite the evidence implicating the SGK1 – Nedd4-2 signalling 
pathway in the control of Na+ absorption, it is not easy to see how this hypothesis can 
explain the persistent activation of ENaC activity seen in GC-treated human airway 
epithelial cells (Watt et al., 2012). In order to clarify the mechanisms that allow signalling 
via PKA / SGK1 to control ENaC activity in these cells, we used phospho- specific 
antibodies to explore the effects of these kinases upon the phosphorylation / expression of 
endogenous Nedd4-2, whilst parallel analyses of surface-exposed proteins monitored 
changes to the amounts of -, - and -ENaC present in the plasma membrane. 
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6.2 Experimental design - aims and objectives 
As seen previously in Chapter 5, three residues of Nedd4-2 (Ser221, Ser327, and Thr246) were 
transiently phosphorylated in the presence of the GC hormone. In theory, this would lead to 
a failure in PY motif binding to ENaC and thus increase ENaC expression at the cell 
surface. Therefore, in this chapter, further examination into the acute effect of cAMP 
agonists towards Ser-Thr residues of Nedd4-2 is conducted, in addition to investigating the 
abundance of ENaC in the surface pool of proteins. This idea was prompted by previous 
data from our lab (Clunes et al., 2004; Inglis et al., 2009) which reported a natriferic 
response in H441 cells that had been treated with an acute cAMP agonist cocktail after 
prolonged exposure to dexamethasone (~ 24 h; Woollhead & Baines, 2006).  
 
First, we needed to monitor PKA activity, which can be observed using CREB-Ser133, a 
substrate that indicates the activation of the cAMP-dependent PKA protein messenger. 
Concurrently, we also needed to monitor the effects of cAMP agonists on the expression of 
NDRG1-Thr346/356/366, a specific protein indicator for SGK1. Then, a time-dependent 
experiment was performed to determine when the protein substrates of PKA were activated. 
At the same time, similar experimental methods were applied to the target of Nedd4-2 
residues. Protein lysates were extracted using an immunoprecipitation protocol with an 
antibody for Nedd4-2 and then probed for the protein residues as well as the total protein. 
Next, ENaC subunit proteins were extracted using biotin-labelled surface cells treated with 
dexamethasone and cAMP agonists. The inhibition of SGK1 activity using GSK650394 
allowed us to predict the actual effect of cAMP agonists on the abundance of ENaC and the 
phosphorylation of Nedd4-2. 
 
The cells were cultured using the standard procedure detailed in the Materials & Methods 
(Figure 6-1). A set of experiments were designed to test the acute effect of cAMP agonists 
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that contained 10 µM forskolin, 100 µM isobutylmethylxanthine, 1 mM N6, 2‘-O-
dibutyryladenosine 3‘5‘-cyclic monophosphate for 20 mins (Clunes et al., 2004) or/and 
dexamethasone (0.2 µM) treatment for 24 h and 3 h, respectively. The cAMP agonists were 
added for the final 20 mins of the experiment. Hormone-deprived cells were maintained in a 
fully defined medium for the final 24 h prior to extraction. The SGK1 inhibitor 
(GSK650394, 0.1 µM) was added in the final 3 h of the experiment to the dexamethasone or 
cAMP agonist incubation. A combination of the techniques used in Chapters 4 and 5 (i.e., 
cell surface biotinylation and immunoprecipitation) were carried out, then the proteins were 
processed using Western analysis. We probed for subunits of ENaC (α-, β-, γ-) and residues 
of Nedd4-2 (Ser221, Ser327, Thr246 and total protein). Incubation with the endogenous protein 
kinases CREB-Ser133 and NDRG1-Thr346/356/366 served a complementary test in this chapter 
to indicate the activation of PKA and SGK1, respectively. 
 
 
 
Figure 6-1: An overview of the experimental design used throughout the chapter. 
 
 
 
 
 
150 
The objectives of this chapter can be summarised as follows: 
 
1) To observe the expression of PKA/SGK1 in cAMP-induced H441 cells.  
2) To determine the effect of cAMP agonists on Nedd4-2 and the abundance of ENaC at 
the cell surface. 
3) To establish the role of cAMP agonists in dexamethasone-induced cells on Nedd4-2 and 
the abundance of ENaC at the cell surface. 
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6.3 Results 
6.3.1 Cyclic AMP induced activation of PKA and SGK1  
Exposing GC-deprived cells to a cocktail of cAMP agonists, which are designed to promote 
activation of cAMP-dependent signalling pathways, increased the abundance of the Ser133-
phosphorylated CREB without altering the overall CREB expression level (Figure 6-2B). 
These drugs therefore promote phosphorylation of CREB-Ser133 and, since this residue is an 
archetypal PKA substrate, it is clear that PKA becomes active under these conditions. The 
response peaked within ~20 mins and, although there was some decline from this 
maximum, the response persisted for at least 24 h (Figure 6-2B,C). The cAMP agonists also 
evoked phosphorylation of NDRG1-Thr346/356/366 (Figure 6-2D,E) and, since these residues 
are phosphorylated by SGK1 and not by other, closely related kinases (Murray et al., 2004; 
Murray et al., 2005), SGK1 must also become active under these conditions. This response, 
in contrast to the activation of PKA, did not become apparent until ~ 2 h and had elapsed 
and peaked after ~12 h (Figure 6-2D, E). 
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Figure 6-2: cAMP agonists phosphorylate the endogenous protein kinase PKA and 
SGK1 pathways 
 
(A) H441 cells were prepared as indicated. Typical Western blots show the effects of 
cAMP elevating drugs on the abundance of (B) phosphorylation of CREB-Ser
133
 
(upper panel), total protein (lower panel) and (C) phosphorylation of NDRG1-
Thr
346/356/366 
(upper panel) and total protein (lower panel) initially at 20 mins for a 24 
h period of incubation. The expression of both phosphorylated and total proteins are 
presented in the pooled data (n = 3) which indicates significant effects of exposure 
compared to unstimulated cells. *p<0.05, ***p<0.001 (one-way ANOVA, Bonferroni 
post-hoc test). 
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6.3.2 cAMP agonists phosphorylate Nedd4-2 and the total protein  
 
The immunoprecipitation protocol (see Materials & Methods) allowed the recovery of two 
proteins with molecular weights of ~105 kDa and ~125 kDa, which is consistent with the 
expression of Nedd4-2 (Boase et al., 2011). Preliminary experiments verified that the 
isolation of these proteins was dependent on the inclusion of the Nedd4-2 antibody in the 
immunoprecipitation reaction. To explore the extent to which Nedd4-2 is phosphorylated at 
each of three physiologically-relevant (Snyder et al., 2004; Debonneville et al., 2001) sites 
(Ser221, Ser327 and Thr246), proteins immuno-purified in this way were subjected to Western 
analysis using phospho-specific antibodies directed against these residues (Figure 6-3B). 
Exposing GC-deprived cells to cAMP agonists increased the abundance of the Ser221- 
(Figure 6-3C) and Ser327- (Figure 6-3D) phosphorylated forms of Nedd4-2 and, initially, 
these responses followed a time course very similar to the activation of PKA. Although 
increased abundance of Thr246-phosphorylated Nedd4-2 also occurred, this did not become 
apparent until ~2 h had elapsed and reached a peak after ~12 h (Figure 6-3E). However, 
despite these initial effects, prolonged exposure to cAMP agonists eventually caused a 
marked fall in the abundance of each phospho-protein, and phosphorylated Nedd4-2 thus 
became barely detectible in cells that had been exposed to these drugs for 12 – 24 h (Figure 
6-3 C, D, E). Western analysis of immunoprecipitated proteins using the antibody against 
full length Nedd4-2 showed that the cAMP agonists also caused an initial increase in the 
overall abundance of this protein and this response, in common with the effects on the 
Ser221/327-phosphorylated forms of Nedd4-2, initially followed a time course similar to the 
activation of PKA (Figure 6-3F). However, prolonged exposure to cAMP agonists caused a 
marked fall in Nedd4-2 expression and this protein also became virtually undetectable after 
12 – 24 h (Figure 6-3F). These experiments were undertaken by stripping / re-probing blots 
that had initially been probed with a phospho-specific antibody and we were therefore 
concerned that the apparent changes in overall abundance may be artefacts caused by the 
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incomplete removal of the phospho-specific antibodies from the blots. This possibility was, 
however, discounted by additional experiments in which the blots were initially probed with 
the antibody against full length Nedd4-2. The data obtained in this way were virtually 
identical to those described above, and it is therefore clear that the cAMP agonists cause 
biphasic changes to the Nedd4-2 expression level in GC-deprived cells. 
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Figure 6-3: Time-course dependence of cAMP agonists on the phosphorylation of 
Nedd4-2 (Ser221, Ser327, and Thr246) and total Nedd4-2 protein. 
 
(A) The experimental design was applied to H441 cells as indicated. Cells were 
precipitated against total Nedd4-2 and probed for (B) three residues of Nedd4-2 
(Ser
221
, Ser
327
, and Thr
246
) as well as the total protein. Figures in C, D, E and F 
represent the densitometry value of the protein against the duration of incubation 
(h) as shown in (B) to indicate activation over time. *p<0.05 and ***p<0.001 
denote a significant increase in the effect of cAMP agonists whilst the dagger (†) 
p<0.05 represents a significantly decreased effect compared to control cells (one-
way ANOVA, Bonferroni post-hoc test).   
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6.3.3 Direct comparison of the effects of cAMP / dexamethasone  
 
Exposing GC-deprived cells to cAMP agonists for 20 mins in order to activate PKA and not 
SGK1 increased the abundance of the Ser221-phosphorylated, Ser327-phosphorylated and 
total forms of Nedd4-2 but did not alter the abundance of the Thr246-phosphorylated protein. 
This response is essentially identical to that described above, and parallel studies of cells 
acutely (3 h) exposed to dexamethasone in order to activate SGK1 independently of PKA, 
confirmed that this stimulus also causes a clear increase in the abundance of the Thr246-
phosphorylated Nedd4-2 (Figure 6-4). Further experiments used this protocol to compare 
the effects of selectively activating PKA and SGK1 on the surface abundance of the ENaC 
subunits. Data from unstimulated cells confirmed the pattern expression described above 
and, as anticipated, activating SGK1 increased the surface abundance of -, - and -ENaC 
(Figure 6-5). Activating PKA (i.e., cAMP agonists for 20 mins), on the other hand, 
increased the amount of -ENaC in the membrane (Figure 6-5C) but had no effect on - 
and -ENaC (Figure 6-5D,E). Activation of SGK1 and PKA in GC deprived cells therefore 
has different effects on the phosphorylation / abundance of Nedd4-2, and on the surface 
expression of ENaC subunits. 
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Figure 6-4: The response of Nedd4-2 expression to cAMP agonists in the presence of 
transient dexamethasone-treated cells. 
 
(A) Three independent sets of cells were treated as dexamethasone-deprived. 
Cells were exposed to dexamethasone for 3 h and cAMP agonists were added for 
the final 20 mins of incubation. (B) These cells were probed for three 
phosphorylated Nedd4-2 residues (Ser
221
, Thr
246
, and Ser
327
) and total Nedd4-2. 
Densitometry values were determined from the blots and depicted as in C, D, E, F. 
Asterisks denote statistically significant effects towards hormone deprived cells 
(control), *p<0.05, ***p<0.001. The dagger shows a significant increase resulting 
from the effects of cAMP elevating drugs, †p<0.001 (one-way ANOVA, 
Bonferroni post-hoc test). 
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Figure 6-5: The abundance of ENaC at the cell surface in response to cAMP agonists 
in the presence of transient dexamethasone-treated cells. 
 
(A) Three independent sets of cells were treated as dexamethasone-deprived. 
Cells were exposed to dexamethasone for 3 h and cAMP agonists were added for 
the final 20 mins of incubation. (B) These cells were probed for α-ENaC, β-ENaC 
and γ-ENaC from the cell surface protein pool. Densitometry values were 
determined from the blots and are depicted as in C, D, and E. Asterisks denote 
statistically significant effects from the hormone deprived cells (control), *p<0.05, 
***p<0.001. The dagger shows a significant increase resulting from the effects of 
cAMP elevating drugs, †p<0.05 (one-way ANOVA, Bonferroni post-hoc test). 
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6.3.4 Effects of cAMP agonists on dexamethasone-treated cells 
 
Cells that had been stimulated with dexamethasone (0.2 µM) for 24 h and the cAMP 
agonists (20 min) increased the abundance of the Ser221- and Ser327-phosphorylated Nedd4-2 
(Figure 6-6C,D) and also increased the overall Nedd4-2 expression level (Figure 6-6F). 
Whilst these responses resembled those seen in dexamethasone-treated cells (see above), 
the cAMP agonists did not increase the abundance of Thr246-phosphorylated Nedd4-2 in 
dexamethasone-treated cells (Figure 6-6E). Moreover, analysis of surface-exposed proteins 
showed that activating PKA did not further alter the amount of -ENaC in the membrane 
(Figure 6-7C), but did augment the surface abundance of - and -ENaC (Figure 6-7D, E). 
Since these responses also differed from those seen in GC-deprived cells, this indicates that 
chronic (24 h) exposure to dexamethasone modifies the effects of cAMP agonists on the 
phosphorylation / expression of Nedd4-2 (Figure 6-6) and the surface expression of ENaC 
subunits (Figure 6-7). 
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Figure 6-6: Effects of cAMP agonists on Nedd4-2 phosphorylated protein in unstimulated 
and dexamethasone-treated cells. 
 
(A) Culture conditions prior to lysates. (B) Each blot illustrates the effects of 
cAMP agonists on the abundance of Nedd4-2 in dexamethasone-treated cells for 3 h 
and 24 h. Figures in (C), (D), (E) and (F) represent densitometry values for each 
subunit respectively. Pooled data from these values are shown as the mean ± SEM 
(n = 11). Asterisks denote statistically significant effects when compared to 
hormone deprived cells (control), *p<0.05, ***p<0.001. The dagger denotes a 
statistically significant difference between cAMP agonists and dexamethasone (24 
h) treated cells; †p<0.05 (one-way ANOVA, Bonferroni post-hoc test).  
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Figure 6-7: Effects of cAMP agonists on the abundance of cell surface ENaC in 
unstimulated and dexamethasone-treated cells. 
 
(A) Culture conditions prior to cell extraction. Each blot illustrates the effects 
of cAMP agonists after incubation for 20 mins on the abundance of (B) ENaC at the 
cell surface (α-, β-, and γ-ENaC) in dexamethasone-treated cells for 3 h and 24 h. 
Figures in (C), (D) and (E) represent the densitometry values for each subunit 
respectively (α-ENaC, n = 11; β-ENaC, n = 7; γ-ENaC, n = 7) . Pooled data for 
these values are shown as the mean ± SEM. Asterisks denote statistically significant 
effects when compared to hormone deprived cells (control), *p<0.05, **p<0.01, 
***p<0.001, The dagger denotes a statistically significant difference resulting from 
the effects of cAMP agonists compared to dexamethasone (24 h) treated cells; 
†p<0.05 difference (one-way ANOVA, Bonferroni post-hoc test).  
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6.3.5 Effects of GSK650394 on the responses to cAMP agonists in dexamethasone-
treated cells on protein kinases 
 
Exposing dexamethasone-treated (0.2 µM, 24 h) cells to GSK650394 (10 µM) for 3h 
reduced the abundance of Thr346/356/366-phosphorylated NDRG1 without altering the overall 
NDRG1 expression level (Figure 6-8D), confirming that GSK650394 inactivates SGK1 
(Sherk et al., 2008). As anticipated, briefly (20 mins) exposing such cells to cAMP agonists 
evoked phosphorylation of CREB-Ser133 and, since this response was unaffected by 
GSK650394 (Figure 6-8E), it is clear that GSK650394 does not inhibit PKA. Moreover, we 
have recently shown that GSK650394 also has no effect upon phosphoinositide-3-kinase, 
phospholipid-dependent kinase 1, protein kinase B and the target of rapamycin signalling 
complex 2 (Chapter 4). This substance therefore provides a means by which to selectively 
inhibit SGK1 in human airway epithelial cells (Watt et al., 2012). 
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Figure 6-8: Effects of cAMP agonists on endogenous phosphorylation of CREB-Ser133 
and NDRG1-Thr346/356/366 in dexamethasone and GSK650394 treated 
H441 cells. 
 
(A) H441 cells were exposed to dexamethasone (0.2 µM) for 24 h (control) and the  
SGK1 inhibitor GSK650394 to allow observation of the phosphorylation of CREB-
Ser
133
 and NDRG1-Thr
346/356/366
. A similar age-matched set of cells were pre-treated 
with dexamethasone for 24 h (control) and incubated with GSK650394 for the final 3 
h and cAMP agonists for the final 20 min of the experiment. The upper blots show a 
Western analysis of the phosphorylated and total protein from (B) NDRG1-
Thr
346/356/366 
and (C) CREB-Ser
133
. (D) and (E) show pooled data from 3 independent 
experiments represented as the mean ± SEM. Asterisks denote a statistically 
significant increase (***p<0.001). The dagger denotes a decreased effect compared 
to control cells, †p<0.01  (one-way ANOVA, Bonferroni post-hoc-test). 
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6.3.6 Effects of GSK650394 on the responses to cAMP agonists in dexamethasone-
treated cells on Nedd4-2 and ENaC 
 
Exposing dexamethasone-treated (0.2 µM, 24 h) cells to GSK650394 (10 µM, 3 h) reduced 
the abundance of the Ser221- and Ser327-phosphorylated forms of Nedd4-2 (Figure 6-9 C,D) 
without altering the overall Nedd4-2 expression level (Figure 6-9 F), a result which 
indicates that the basal phosphorylation of these residues must be maintained by SGK1. 
However, despite this clear finding, GSK650394 did not impair the phosphorylation of 
Nedd4-2-Thr246 (Figure 6-9 E) and the persistent phosphorylation of this residue in 
dexamethasone-treated (24 h) cells is therefore independent of SGK1. Exposing 
GSK650394-treated cells to cAMP agonists (20 mins) evoked clear increases in the 
abundance of Ser221-phosphorylated, Ser327-phosphorylated, Thr246-phosphorylated and total 
forms of Nedd4-2 and it is therefore clear that the effects of PKA on the expression / 
phosphorylation of Nedd4-2 are independent of SGK1.  
 
Parallel analysis of surface-exposed proteins showed that GSK650394 reduced the surface 
abundance of - (Figure 6-10C), - (Figure 6-10D), and -ENaC (Figure 6-10E), but, 
despite this clear finding, activating PKA under these conditions clearly increased the 
surface abundance of each subunit. Indeed, the responses to cAMP agonists seen in 
GSK650394-treated cells were virtually identical to the control and it is therefore clear the 
effects of cAMP agonists on the surface expression of ENaC subunits are also independent 
of SGK1. 
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Figure 6-9: Effects of cAMP agonists on Nedd4-2 proteins in dexamethasone and 
GSK650394 treated cells. 
 
(A) Cells were treated as indicated (B) Immunoblots of cells were treated with 
dexamethasone for 24 h and co-incubated with the SGK1 inhibitor compound 
GSK650394 for the final 3 h of the experiment. cAMP agonists were later added for 
the final 20 mins before cell extraction. The cell lysates were immuno-precipitated 
against a total Nedd4-2 antibody and processed through Western analysis. These 
proteins were probed for three residues of Nedd4-2 (Ser
221
, Ser
327
, and Thr
246
) as well 
as total Nedd4-2. Each blot represents 3 independent experiments.  The bar graphs in 
(C),(D), (E) and (F) show the mean ± SEM of the densitometry values in (A), (n = 4). 
Asterisks show a significant difference in the absence of cAMP agonists; 
***p<0.001. The dagger shows a decreased effect compared to the control cells, 
†p<0.01. An increased effect of cAMP elevating drugs upon GSK650394 is denoted 
by ‡p<0.001 (one-way ANOVA, Bonferroni post-hoc-test). 
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Figure 6-10: Effects of cAMP agonists on cell surface ENaC subunits in 
dexamethasone and GSK650394 treated cells. 
 
(A) H441 cells were treated with dexamethasone for 24 h (control) and co-
incubated with the SGK1 inhibitor compound; GSK650394 for the final 3 h of the 
experiment. cAMP agonists were added for the final 20 mins before cell extraction. 
The cell surface was labelled with biotin-bound streptavidin and processed using 
Western analysis. (B) These proteins were later probed for ENaC subunits (α-, β- 
and γ-). Each blot represents 4 independent experiments.  Bar graphs in (C), (D) and 
(E) represent the densitometry values: mean ± SEM. Asterisks indicate a 
significantly increased effect compared to control cells, *p<0.05. The dagger shows 
a significantly decreased effect compared to control cells, †p<0.01. Double daggers 
indicate a sustainable significant effect of cAMP agonists on GSK650394, ‡p<0.01 
(one-way ANOVA, Bonferroni post-hoc-test). 
 
 
 
167 
6.4 Discussion 
 
ENaC expression can be regulated via phosphorylation and ubiquitination through different 
mechanisms. Among recent regulatory proteins found in vitro, the neural precursor cell-
expressed, developmentally down-regulated isoform 4 protein (Nedd4-2) is known to 
ubiquitinate ENaC at the cell surface. This can be regulated by two different pathways: the 
serum GCs kinase 1 (SGK1) pathway (Debonneville et al., 2001; Snyder et al., 2002; 
Wiemuth et al., 2010) that can be induced with GC hormones (eg: dexamethasone) and the 
cAMP dependent protein kinase A (PKA) pathway (Snyder, 2000; Snyder et al., 2004a) by 
introducing cAMP agonists (eg: forskolin). Both pathways can phosphorylate multiple Thr-
Ser residues of Nedd4-2 (Snyder, 2009) thereby reducing the affinity for ENaC and 
decreasing the inhibitory effect on ENaC at the cell surface. As a result, ENaC protein 
expression is augmented and there is an elevation in epithelial Na+ absorption. This suggests 
that Nedd4-2 plays a central role in regulating Na+ transport in these pathways (Snyder et 
al., 2004a). This study also found that Nedd4-2 can be a substrate for phosphorylation both 
in vitro and in vivo.  
 
6.4.1 Cyclic AMP agonists activate PKA and SGK1 
Exposing GC-deprived cells to cAMP agonists increased the activity of PKA and SGK1. A 
similar response has been demonstrated by previous studies which reported that PKA 
activated SGK1 by phosphorylating SGK1-Thr389 (Morris et al., 2002; Chandran et al., 
2011). Moreover, cAMP-coupled agonists have also been shown to increase the abundance 
of SGK1 mRNA and protein in absorptive epithelial cells (Vasquez et al., 2008) providing 
evidence for cross talk between the PKA-dependent and SGK1-dependent pathways. 
Indeed, it has been suggested that that cAMP / PKA-coupled agonists might control Na+ 
transport via a mechanism dependent on SGK1 (Gonzalez et al., 2000; Perrotti et al., 2001; 
Thomas et al., 2004; Vasquez et al., 2008). However, whilst the activation of PKA 
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described here was complete within ~20 mins, SGK1 activation involved a latency of 1 – 2 
h, and physiological studies of absorptive epithelia have shown that cAMP-coupled agonists 
can induce Na+ transport within 5 – 10 min (Morris et al., 2002; Lazrak et al., 2003; 
Thomas et al., 2004; Ramminger et al., 2004; Clunes et al., 2004; Mansley & Wilson, 
2010a). Although SGK1 could contribute to the maintenance of stimulation, PKA-induced 
activation of SGK1 cannot account for the rapid responses to cAMP-coupled agonists as 
seen in human airway epithelial cells (Lazrak et al., 2003; Thomas et al., 2004; Ramminger 
et al., 2004; Clunes et al., 2004). 
 
6.4.2 Cyclic AMP agonists alter the expression / phosphorylation of Nedd4-2 
Exposing GC-deprived cells to cAMP agonists increased the abundance of the Ser221- and 
Ser327-phosphorylated forms of Nedd4-2 and these responses initially followed a time 
course similar to the activation of PKA. Whilst these data suggest that PKA might 
phosphorylate Nedd4-2 at Ser221 and -Ser327, the cAMP agonists also caused clear increases 
in the overall abundance of Nedd4-2 and, initially, this response followed a time course 
similar to that seen with the Ser221/327-phosphorylated protein (Snyder et al., 2004a; 
Chandran et al., 2011). The apparent phosphorylation of these residues may thus be due, at 
least in part, to an increase in overall abundance. It is therefore interesting that studies of 
heterologously expressed Xenopus Nedd4-2 have shown that the degradation of Nedd4-2 is 
blocked by the phosphorylation of a residue equivalent to human Nedd4-2-Ser327, and 
stimuli that promote the phosphorylation of this residue can thus increase the overall 
abundance and prevent its degradation (Chandran et al., 2011). Indeed, it has been 
suggested that such control over the abundance of Nedd4-2 might contribute to the 
hormonal control of Na+ absorption (Chandran et al., 2011). Whilst the present data are 
consistent with this hypothesis, studies of murine cortical collecting duct cells suggest that 
the aldosterone-induced phosphorylation of a residue equivalent to human Nedd4-2-Ser327 
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has no effect on the overall abundance of this protein (Flores et al., 2005). Moreover, 
although the activation of PKA was well maintained, prolonged exposure to cAMP agonists 
led to a reduction in the overall abundance of Nedd4-2 and this protein thus became 
virtually undetectable after 12 – 24 h. The effects of cAMP agonists on Nedd4-2 expression 
in human airway epithelial cells therefore appears to be biphasic, however the reason for 
this is unknown. More detailed studies of endogenous Nedd4-2 using fully quantitative 
methods are therefore needed to define the changes to the expression / phosphorylation of 
this protein that accompany regulated Na+ transport. 
 
6.4.3 PKA and SGK1 have different effects on Nedd4-2 and ENaC in GC-deprived 
cells 
 
Although the cAMP agonists did increase the abundance of Thr246-phosphorylated Nedd4-2, 
this response developed much more slowly that the effects on the Ser221/327-phosphorylated 
forms of this protein and therefore coincide with the delayed activation of SGK1. This 
observation raises the possibility that Nedd4-2-Thr246 might be a substrate for SGK1 and 
not PKA. Further evidence for this came from studies of cells that had been briefly exposed 
to dexamethasone for 3 h in order to activate SGK1 independently of PKA. This stimulus 
increased the abundance of the Ser221-phosphorylated, Ser327-phosphorylated and total 
Nedd4-2, and these responses resembled those seen in cAMP-stimulated cells. However, 
dexamethasone also evoked a clear increase in the abundance of Thr246-phosphorylated 
Nedd4-2, and this additional effect was confirmed by a separate series of experiments that 
used a strictly paired experimental design to compare the effects PKA and SGK1 directly. 
Work undertaken by Snyder et al. is relevant in this context since these authors showed that 
Nedd4-2 could be inactivated by PKA or SGK1 (Snyder et al., 2002; Snyder et al., 2004a). 
However, since PKA acted by phosphorylating the protein at Ser327 and Ser221, but not at 
Thr246, the authors then proposed that the inhibitory action of SGK1 was due to the 
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phosphorylation of Ser327 and Thr246, but not Ser221 (Snyder et al., 2002; Snyder et al., 
2004a). Moreover, recent studies of heterologously expressed Xenopus Nedd4-2 show that 
the retrieval of ENaC subunits from the plasma membrane is dependent on the 
phosphorylation of Nedd4-2 at sites equivalent to Nedd4-2-Thr246 and Nedd4-2-Ser221 
(Chandran et al., 2011). Similarly, studies using mass spectroscopy have suggested that 
aldosterone-induced Na+ transport in mouse cortical collecting duct cells involves the 
phosphorylation of Nedd4-2 at a site equivalent to Thr246  (Chandran et al., 2011). 
 
A considerable body of work now suggests that the regulated phosphorylation of Nedd4-2-
Thr246 is central to the control of Na+-transport (Snyder et al., 2004a; Chandran et al., 
2011). These data suggest that the phosphorylation of Nedd4-2-Ser221/327 might not provide 
a stimulus that can sufficiently suppress internalisation / degradation of ENaC. It is 
therefore interesting that analysis of surface-exposed proteins showed that cAMP agonists 
increased the amount of -ENaC in the membrane but had no effect upon the surface 
abundance of - or -ENaC. The fact that the cAMP agonists could control the surface 
abundance of -ENaC was surprising and we have no clear explanation for this effect, 
although signalling via cAMP / PKA can increase the overall expression of -ENaC by 
inducing gene expression. However, the most important result to emerge from the 
experiments presented here was that selective activation of PKA in GC-deprived cells did 
not provide a stimulus that was sufficient to evoke a coordinated increase the surface 
expression of -, - and -ENaC. Parallel studies of dexamethasone-stimulated (3 h) cells, 
on the other hand, confirmed that this synthetic GC does increase the surface abundance of 
all three subunits, and these data therefore support the view that phosphorylation of Nedd4-
2-Thr246 is critical for controlling the abundance of ENaC subunits at the membrane.  
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6.4.4 Prolonged (24h) exposure to dexamethasone evokes Nedd4-2-Thr246 
phosphorylation 
 
The fact that the cAMP agonists were unable to regulate the surface abundance of all three 
ENaC subunits was surprising since cAMP-agonists do stimulate Na+ transport in H441 
cells (Lazrak et al., 2003; Thomas et al., 2004; Ramminger et al., 2004; Clunes et al., 2004; 
Vasquez et al., 2008) and this response is almost invariably attributed to changes in the 
surface abundance of ENaC subunits (Morris et al., 2002). However, these earlier studies 
were undertaken using cells that had been exposed to GCs and / or serum before being used 
in experiments (Lazrak et al., 2003; Thomas et al., 2004; Ramminger et al., 2004; Clunes et 
al., 2004), whereas the present experiments were undertaken using GC-deprived cells. 
Further experiments therefore explored the effects of stimulating cells with dexamethasone 
for ~24 h.  
 
Our initial analysis of the extracted proteins confirmed that the GC-induced activation of 
SGK1 could not be sustained for 24 h (Chapter 3; see also Watt et al., 2012; Inglis et al., 
2009) and, although the surface abundance of -ENaC was elevated, the amounts of - and 
-ENaC present in the membrane were similar to the levels measured in GC-deprived cells. 
Although ENaC-dependent Na+ currents have been recorded from such dexamethasone-
treated cells (Lazrak et al., 2003; Ramminger et al., 2004; Clunes et al., 2004), the data 
presented here confirms that these currents cannot be attributed to a coordinated increase in 
the surface abundance of -, - and -ENaC (Watt et al., 2012). Moreover, the effects of 
dexamethasone (3 h) on the abundance of Ser221/327-phosphorylated and total Nedd4-2 did 
not persist for ~24 h, a response that correlates well with changes to the activity of SGK1. 
Prolonged (24 h) exposure to dexamethasone did, however, cause a persistent increase in 
the abundance of the Thr246-phosphorylated Nedd4-2 and, since this was not associated with 
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any change in overall expression, it is now clear that chronic exposure to dexamethasone 
evokes sustained phosphorylation of Nedd4-2 at Thr246. 
 
6.4.5 Prolonged (24h) exposure to dexamethasone modifies the response to cAMP 
agonists 
 
Exposing dexamethasone-treated (24 h) cells to cAMP agonists increased the abundance of 
the Ser221-phosphorylated, Ser327-phosphorylated and total forms of Nedd4-2 but, in contrast 
to the situation seen in GC-deprived cells, these responses were accompanied by an increase 
in the abundance of the Thr246-phosphorylated Nedd4-2. Moreover, the cAMP agonists also 
increased the surface abundance of - and -ENaC in such cells, whilst functional studies 
showed that chronic (24 h) dexamethasone stimulation also enhanced the electrometric 
response to cAMP agonists. Prolonged (24 h) exposure to GC hormones therefore enhances 
the effects of cAMP, so it is interesting that earlier studies of pulmonary epithelia showed 
that cAMP-coupled agonists can only evoke increased Na+ transport in cells that have been 
exposed to GC / thyroid hormones (Barker et al., 1991; Ramminger et al., 2002; Olver et 
al., 2004). These hormones thus exert a permissive action that is an important aspect of lung 
development (Olver et al., 1986; Barker et al., 1991; Ramminger et al., 2002; Olver et al., 
2004). 
 
Whilst our data (see also Snyder et al., 2002; Snyder et al., 2004a; Chandran et al., 2011) 
suggests that phosphorylation of Nedd4-2-Thr246 is needed to control the surface expression 
of ENaC subunits, this residue does not seem to be a PKA substrate and this may well 
explain why cAMP agonists cannot evoke coordinated increases in the surface abundance 
of the ENaC subunits in GC deprived cells. Moreover, by demonstrating that prolonged (24 
h) exposure to GCs leads to the sustained phosphorylation of Nedd4-2-Thr246, we have 
identified a mechanism that may allow GCs to facilitate the responses to cAMP-coupled 
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agonists. Since many effects of GC hormones are mediated via SGK1, we also explored the 
effects resulting from exposure of dexamethasone-treated (24 h) cells to GSK650394 in 
order to inactivate this kinase. GSK650394 reduced the abundance of the Ser221- and Ser327-
phosphorylated forms of Nedd4-2 indicating that the phosphorylation of these residues in 
dexamethasone-treated cells is dependent on SGK1. However, GSK650394 did not 
suppress the phosphorylation of Nedd4-2-Thr246, and the sustained phosphorylation of this 
residue must therefore depend on a kinase other than SGK1. Identifying the mechanisms 
that allow GCs to maintain the phosphorylation of Nedd4-2-Thr246 may thus clarify the way 
in which pulmonary Na+ transport processes are initiated, maintained and regulated and this, 
in turn, may facilitate the development of novel therapeutic strategies to treat diseases that 
involve disrupted pulmonary Na+ transport. 
 
GSK650394 also reduced the surface abundance of -, - and -ENaC in dexamethasone-
treated (24 h) cells and these data are consistent with the view that the SGK1-dependent 
phosphorylation of Nedd4-2 is a major determinant of the surface abundance of the ENaC 
subunits (Snyder et al., 2002; Flores et al., 2005; Debonneville et al., 2001; Lang et al., 
2006; Snyder, 2005). However, GSK650394 did not block the effects of cAMP agonists 
upon the phosphorylation / expression of Nedd4-2 or the surface expression of the ENaC 
subunits. Moreover, whilst GSK650394 did inhibit the rate of electrogenic Na+ transport, it 
did not suppress the electrometric response to cAMP agonists and, similarly, we have 
shown that cAMP-coupled agonists can regulate Na+ transport via an SGK1-independent 
mechanism in epithelial cells from the airway and distal nephron (Mansley & Wilson, 
2010a). It is therefore interesting that Snyder et al. have proposed that PKA controls Na+ 
transport by directly phosphorylating Nedd4-2, a hypothesis that predicts that the responses 
to cAMP-coupled agonists should occur independent of SGK1 (Snyder et al., 2004a). 
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7 
Conclusions and future work 
 
7.1 Conclusions 
To date, the endogenous expression of ENaC proteins in human airway H441 cells has not 
been fully explored due to the complexity of protein detection using Western analysis. 
Previously, most studies were conducted by either over expressing or knocking out ENaC. 
However, in this thesis ENaC activity was studied using a cell surface biotin-labelled 
protein technique, thus revealing the association between ENaC protein expression and Na+ 
conductance. 
 
The treatment of airway cells with dexamethasone improves the prognosis of patients 
suffering from respiratory distress syndrome and pulmonary oedema. This effect has also 
been demonstrated experimentally in an H441 lung cell model that showed an increased 
Na+ current (Ramminger et al., 2004; Clunes et al., 2004; Brown et al., 2008; Inglis et al., 
2009; Watt et al., 2012). Dexamethasone appears to activate the SGK1 protein indicator, 
NDRG1-Thr346/356/366 , resulting in an increase in expression of α-ENaC in both pools of 
proteins, which may then potentiate Na+ absorption. The expression of β-ENaC is only 
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found in the total lysate during a longer period of activation as a result of a transient effect, 
indicating that β-ENaC is only involved in the internalisation of the channel. Since γ-ENaC 
is involved in both the brief and prolonged activation at the cell surface, this suggests that it 
assists β–ENaC in enhancing the internalisation of the channel and further elevates the 
functional expression of α-ENaC at the cell surface.  
 
The mechanism that lies downstream of dexamethasone is thought to be dependent on PI3-
kinase – TORC2 – SGK1 – Nedd4-2 (Blazer-Yost et al., 1998; Record et al., 1998; Alvarez 
de la Rosa et al., 1999; Paunescu et al., 2000; Debonneville et al., 2001; Alvarez de la Rosa 
& Canessa, 2003; Blazer-Yost et al., 2003; Inglis et al., 2009; Boase et al., 2011), leading 
to the increased expression of ENaC subunits at the cell surface. SGK1 is thought to play a 
role in coordinating the increase in ENaC expression at the cell surface which must be 
mediated through PI3-kinase. The introduction of compounds such as PI-103, TORIN1 and 
GSK650394 inhibit this mechanism, but such effects only cause a modest decrease in the 
number of ENaC subunits. However, brief treatment with dexamethasone in the presence of 
these inhibitors abolished the β- and γ- subunits, and slightly reduced the amount of α-
ENaC, suggesting that SGK1 plays a role in controlling ENaC protein at the cell surface. 
Since there were only minor changes in the level of α-ENaC in response to these inhibitors, 
this suggests that there is another mechanism that controls the expression of this subunit at 
the surface membrane. 
 
Since ENaC proteins are maintained by the SGK1 pathway downstream of PI3K, we predict 
that this mechanism must also influence the expression of the ubiquitin protein ligase 
Nedd4-2. The data in Chapter 5 showed that the expression of Nedd4-2 is transient, and 
corresponds to the activation of SGK1 to further inhibit the interaction with the PY motif of 
ENaC (Debonneville et al., 2001; Snyder et al., 2002). As a result of this, there was a 
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significant elevation in expression of ENaC subunits at the cell surface. This finding is in 
contrast to a similar study which used cells that over-expressed Nedd4-2  (Debonneville et 
al., 2001; Snyder et al., 2002; Snyder et al., 2004a); the endogenous processed cells used in 
this study are thought to better reflect a native system. All three residues of Nedd4-2 (Ser221, 
Thr246 and Ser327) were elevated prior to brief exposure to dexamethasone (3 h) to reflect the 
increment of whole expression of Nedd4-2 total protein.  Inhibition with GSK650394 
reduced SGK1 activity and abolished the expression of Nedd4-2, showing that Nedd4-2 
activation is dependent on SGK1. The data presented in this thesis revealed that the 
expression of GC-induced ENaC subunits at the cell surface is dependent on PI3-kinase – 
TORC2 – SGK1 – Nedd4-2. Whilst the data supports this hypothesis, it does not clarify the 
magnitude of the Na+ current (Watt, 2011). However, this can be explained by the fact that 
SGK1 can also augment the membrane Na+ current without recruitment of all channels to 
the membrane, though it is dependent on the SGK1-consensus motif in the C-terminal 
region of α-ENaC (Diakov & Korbmacher, 2004). However, this pathway still requires 
further study. 
 
Though Nedd4-2 proteins are maintained through the SGK1 pathway, other studies have 
suggested that ubiquitin protein ligase can be induced by another signalling pathway, such 
as Protein Kinase A (PKA) through cyclic AMP (for example: Snyder et al., 2004a). PKA 
activating agonists containing forksolin with IBMX and bucladesine activate amiloride 
sensitive GC-induced ENaC activity (Clunes et al., 2004). The data in this thesis has shown 
that a cocktail of cAMP agonists can activate ENaC surface expression through PKA. 
Increased expression of Nedd4-2 elevates ENaC subunits at the cell surface, which is PKA 
dependent. The brief stimulation by this cocktail is independent of the SGK1 pathway, as 
PKA is shown to be active in the presence of the SGK1 inhibitor, GSK650394. However, 
when the cocktail was added to dexamethasone-treated cells, the PKA-activating agonists 
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modified the response to dexamethasone, resulting in a further increase in both Nedd4-2 
and ENaC. This increment is parallel to the activation of Nedd4-2- Thr246 but not other 
phopshorylation sites suggesting the important role of Thr246 as a key player to regulate 
ENaC at the cell surface. 
 
 
Finally, the conclusions taken from this thesis are summarised below: 
 
 Glucocorticoids induce a transient increase in SGK1 activity in H441 cells. 
 
 Brief activation of SGK1 increases the coordinated expression of α-, β-, γ- ENaC at the 
surface membrane of H441 cells. 
 
 Prolonged activation of glucocorticoids (24 h) results in sustained expression of α-ENaC 
and an increase in γ-ENaC at the membrane, resulting in the induction of amiloride-
sensitive ENaC conductance (Watt, 2011).  
 
 
 The mechanism by which glucocorticoids regulate ENaC cell surface expression in H441 
cells involves the PI3K-TORC2-SGK1 pathway. 
 
 The absence of PI3K/SGK1 leads to the withdrawal of ENaC subunits (especially β- and γ-
ENaC) from the membrane, suggesting an important role for PI3K/SGK1 in glucocorticoid-
treated H441 cells. 
 
 
 Sustained expression of α-ENaC in the absence of PI3K/SGK1 indicates that the α-subunit 
can be activated independently of the above mentioned mechanism. 
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 The same mechanism that glucocorticoids use to regulate ENaC cell surface expression in 
H441 cells is used for regulating the expression of the ubiquitin ligase protein, Nedd4-2 
(Ser221, Ser327, Thr246). This is dependent on the PI3K-TORC2-SGK1 pathway. 
 
 Cyclic AMP agonists can regulate ENaC surface expression in H441 cells through 
activation of the PKA pathway.  
 
 ENaC surface expression can be independently regulated by the PKA and SGK1 pathways 
in H441 cells, but when cAMP agonists are added to dexamethasone-treated cells this 
results in the modification of ENaC expression, resulting in an increased natriferic response 
(Clunes et al., 2004). 
 
 This modified response results from the phosphorylation of the Thr246 residue of Nedd4-2, 
suggesting a convergence role for Nedd4-2 between PKA and SGK1 during the regulation 
of ENaC at the surface membrane of H441 cells. 
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7.2 Future work 
The data from this thesis confirms that the H441 human airway cell line can be used as a 
model to investigate ENaC subunit expression and the hormonal control of the SGK1 and 
PKA pathways. Analysis in vivo could be performed using primary cell culture and lung 
slices or human nasal epithelia, obtained from nasal scrapings. This study only focused on 
the role of the SGK1 and PKA pathways, however, there are many regulators of ENaC that 
should be considered for future experiments. Other regulators might involve GILZ, which 
may be involved in the proteolytic cleavage and independent activation of α-ENaC. 
Studying other potential regulators will help to explain any compensatory effects seen in 
vivo. 
 
In addition to studies on living cells, it would be interesting to investigate the role of other 
hormones on different cell lines, as there may be an alternative model to explain the role of 
SGK1 and PKA or implicate other pathways. We could investigate the effects of the 
hormones on human bronchiolar epithelial cells or cultures of isolated ATI and ATII cells 
from lung slice preparations. These studies would help to clarify the role of each pathway 
(in this case: SGK1 and PKA) in maintaining ENaC expression and controlling Na+ 
transport. Understanding how these pathways work in this context is crucial for the 
development of better treatments. For example, a drug that successfully inhibits SGK1 
could be developed to treat Liddle‘s syndrome, a condition that is underpinned by 
hyperactivation of ENaC. 
 
Since ENaC expression at the cell surface can be evoked by both dexamethasone and cAMP 
agonists, it is thought to be dependent on the SGK1 and PKA pathways via the activation of 
Nedd4-2. Both β- and γ-ENaC are involved in internalisation as they bind to Nedd4-2 at the 
 
 
180 
PY motif, therefore it would be interesting to coimmunoprecipitate the cellular extracts with 
both total Nedd4-2 and each subunit of ENaC to see if there is a specific interaction. 
 
To date, a number of studies have proposed that 14-3-3 proteins mediate the interaction 
between Nedd4-2 and ENaC at the surface membrane by direct interaction with a 
phosphorylated form of human Nedd4-2 (Ichimura et al., 2005; Nagaki et al., 2006).  
Therefore, it would be useful to determine the final effector of the mechanism that 
completes ENaC expression at the cell surface. The interaction between Nedd4-2 and 14-3-
3 proteins can be observed by processing the cell lysates through an immuno-precipitation 
procedure against total Nedd4-2, then probing for 14-3-3 protein. The combined expression 
of both Nedd4-2 and 14-3-3 is also indicated by the effect on ENaC activity. Since there is 
no specific inhibitor known to affect the functional response of these proteins, a knock-
down of Nedd4-2 (Kimura et al., 2011) and/or 14-3-3 would provide an insight into its role 
in hormonally regulated ENaC activity. 
 
Prolonged treatment of cAMP modifies the effect of SGK1 on ENaC at the cell surface, 
suggesting an association between the PKA and SGK1 pathways. Data from this thesis 
revealed that the expression of ENaC can be independent of either pathway individually, 
suggesting that there may be a mechanism that lets them work synergistically. To confirm 
this, we would need to test the effects of prolonged exposure to a number of 
stimulators/inhibitors of both pathways on ENaC/Nedd4-2/14-3-3 expression.  
 
SGK1 certainly serves as an important regulator for maintaining ENaC at the cell surface, 
but there is another novel mechanism that is known to regulate a similar pathway. WNK 
(with no lysine (K)) protein kinase affects ion balance and mutations at the active site lysine 
cause a heritable form of ion imbalance, culminating in hypertension. There are a number of 
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ways that this family of proteins could regulate the pathway. A recent study found strong 
interactions between four WNK proteins and SGK1, especially WNK1 (Heise et al., 2010). 
Moreover, WNK1 is involved in Nedd4-2 binding, thus it can inhibit the Nedd4-2 – ENaC 
interaction at the cell surface, therefore promoting channel expression. Since this 
mechanism is similar to the activation of SGK1, it may be worthy of further study and could 
contribute to a more comprehensive understanding of the mechanisms that underpin ENaC 
expression.  
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